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Introduction: The hemodynamic environment of blood vessels is a 
crucial feature of endothelium-mediated vasoregulation. Flow-associated laminar 
shear stress (LSS) imparts an atheroprotective stimulus on the vascular 
endothelium, causing realignment of endothelial cells in the direction of flow and 
strengthening of intercellular tight junction barriers. Conversely, disturbed shear 
stress (DSS), a contributing factor to vascular diseases such as atherosclerosis 
and coronary artery disease, prevents cellular realignment and causes barrier 
weakening. Equally crucial to endothelium-mediated vasoregulation are 
vasoactive peptidases. Evidence is emerging to show that peptidase expression 
and activity within the vasculature is regulated in a highly coordinated manner by 
vessel hemodynamic forces (Fitzpatrick, et al. 2009). Indeed, this phenomenon 
likely has significant consequences for the net balance of pressor versus 
depressor peptides within the endothelium, subsequently leading to downstream 
effects on vessel wall tone and remodeling events. Of particular importance are 
the „thermolysin-like‟ family of zinc metallopeptidases belonging to the Clan MA 
(Barrett, Rawlings and O'Brien 2001), which hydrolyse peptide hormone 
substrates of less than 40 amino acids, and which are known to contain a single 
copy shear stress response element (-GAGACC-) within their promoter regions. 
In the current study it is therefore hypothesised that, in view of their opposing 
physiological actions in vivo, shear stress can modulate vascular endothelial 
expression of neprilysin (NEP, EC3.4.24.11) and thimet oligopeptidase (TOP, 
EC3.4.24.15) in an inverse manner, with functional consequences for endothelial 
homeostasis.  
Results: Exposure of cultured bovine/human aortic endothelial cells 
(BAECs/HAECs) to LSS of varying magnitude and duration (0-10 dynes/cm
2
, 0-
48 hrs) resulted in dose- and time-dependent modulation of NEP (down-
regulation) and TOP (up-regulation) expression as monitored via qPCR, 
immunocytochemistry, and Western blotting. Using a luciferase reporter vector 
(pGL3-TOP, full-length promoter -901/+120), LSS was also found to 
substantially increase TOP promoter activity. By contrast, DSS had opposite 
effects to LSS on the expression of NEP (up-regulation) and TOP (down-
regulation). We subsequently employed pharmacological antioxidants (N-acetyl-
L-cysteine), inhibitors (Rac1/NSC23766, NADPH oxidase/apocynin) and 
siRNAs (p47Phox) in shearing experiments to confirm a pivotal role for NADPH 
oxidase-mediated superoxide production in the LSS mechanotransduction of 
these reciprocal events. Finally, using a TOP siRNA, an investigation of how 
LSS-induced TOP up-regulation impacts on endothelial functions (i.e. 
proliferation and bradykinin hydrolysis) was carried out, and points to functional 
consequence between these events under shear.  
Conclusions: This study indicates that the expression of NEP and TOP, 
zinc metallopeptidases of high physiological relevance to the endothelium, are 
regulated in an opposing manner by shear stress, with potential consequences for 
endothelial function and flow-dependent vascular pathologies. 
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Chapter   1: 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
 The following section gives an overview of the vascular system, with 
particular focus on endothelial cells, their role in vascular haemostasis and the 
consequences if they become dysfunctional. The ability of endothelial cells to 
sense and respond to changes in blood flow is essential for both vasoregulation 
and arterial wall remodelling, while abnormalities in endothelial responsiveness 
to flow play an important role in the development of atherosclerosis. Endothelial 
cell membranes contain mechanosensors which are responsible for the 
transduction of physical forces into biochemical signals. A tight regulation of the 
signalling pathways activated as a result of mechanosensing is critical to vascular 
health, as these pathways control the regulation of vasoactive peptides, including 
zinc metallopeptidases. The production of reactive oxygen species, especially 
superoxide, is a crucial step in the divergent regulation of shear sensitive genes. 
The functional aspects of the regulation and dysregulation of these essential 
signalling molecules will also be discussed in greater detail below.  
 
1.1 The vascular system 
 
The human heart starts to beat around 22 days after conception and on 
average beats 100,000 times in one day, or 35 million times in a year. During an 
average lifetime, the human heart will beat more than 2.5 billion times. The 
human body contains 5.6 litres of blood, which circulates through the body three 
times every minute. In one day, blood travels a total of 19,000 km through the 
cardiovascular system; that's roughly the distance between Ireland and New 
Zealand. 
 
1.1.1 Cardiovascular disease 
 
Cardiovascular disease (CVD) is a general diagnostic term characterised 
by dysfunction of the heart or circulatory system. This broad ranging condition 
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includes diseases such as arteriosclerosis, coronary artery disease, heart failure, 
hypertension and congenital heart disease. 
Cardiovascular disease is the leading cause of death in the western world 
today. Figures from the Irish Heart Foundation state that approximately 10,000 
Irish people die each year from CVD - including coronary heart disease (CHD), 
stroke and other circulatory diseases. This is the most common cause of death in 
Ireland, accounting for 36% of all deaths. The largest number of these deaths 
relates to CHD, mainly heart attack, at 5,000 people. Twenty two percent of 
premature deaths (under age 65) are from CVD. 
In Ireland mortality rates from CVD increased up to the 1970s when they 
peaked at 54% of all deaths in 1974. Since then the trend has been moving 
towards a reduction in mortalities from 13,241 in 1998, to 9,662 in 2006. 
However, these figures relate only to CVD-related deaths and do not include 
patients who presented with symptoms and were treated successfully. In 2009, 
Ireland‟s mortality rate from CHD was similar to the European Union (EU) 
average for both men and women. With respect to stroke mortality in Ireland, 
men and women had among the lowest rates in the EuroHeart countries, with 
French women being the only EuroHeart country with lower stroke mortality 
rates than Ireland. 
Figures from the Central Statistics Office show that before 2004, Ireland 
was still above average for premature deaths from CVD for the EU member 
countries, with available figures showing that Ireland had 52 premature deaths 
per 100,000 in comparison with the (pre-2004) EU average of 42. However, with 
the inclusion of the Eastern European accession states, the average EU figure for 
the equivalent period rises to 101 premature deaths per 100,000. 
In Europe each year CVD causes over 4.3 million deaths, of which over 
2.0 million deaths occur in the EU. This accounts for almost half of all deaths in 
Europe (48%) and in the EU (42%). CVD is the main cause of death in women in 
all the countries of Europe and is the main cause of death in men in all countries 
except France, the Netherlands and Spain. 
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Overall CVD is estimated to cost the EU economy €192 billion a year. 
Approximately 57% of this is due to health care costs, 21% is due to productivity 
losses and 22% is due to informal care of people with CVD. In 2008, the direct 
health care fee alone costs each resident of the EU €231 (Allender, et al. 2008). 
A report from the American Heart Association states that 1 in 3 
Americans has some form of CVD and since 1900 CVD has been the number 
one killer in the United States every year except 1918, during the Spanish flu 
epidemic. Nearly 2,500 Americans die of CVD each day, which is an average of 
one person every 35 seconds. The direct and indirect cost of CVD for 2006 in the 
United States was $403.1 billion (Leal, et al. 2006). The World Health 
Organisation estimates that 16.7 million people around the world die from the 
disease annually, which is 29% of all deaths worldwide per year, with a projected 
increase of this figure to 40% of all deaths by 2020. 
There are nine easily measurable and potentially modifiable risk factors 
that account for over 90% of the initial acute myocardial infarction. These nine 
factors are cigarette smoking, abnormal blood lipid levels, hypertension, 
diabetes, abnormal obesity, a lack of physical activity, low daily fruit and 
vegetable consumption, alcohol over-consumption and psychosocial index. 
Other uncontrollable factors that place subjects into a risk category for 
developing CVD are age, gender, family history and ethnicity. The above risk 
factors play a critical role in initiating or exacerbating the effects of CVD. These 
risk factors have been extensively studied and links proven with respect to CVD 
and the endothelium, through studies on atherosclerosis, stroke or the regulation 
of blood flow-associated hemodynamic forces and blood pressure. 
 
1.1.2 The vasculature 
 
The vasculature is made up of both the microvasculature and the 
macrovasculature. The microvasculature is the portion of the circulatory system 
composed of the smallest vessels, such as capillaries, arterioles and venules. The 
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macrovasculature is the portion of the vasculature containing large vessels; those 
with an internal diameter of greater than 100 microns (arteries and veins). 
All of the blood vessels of the microvasculature and macrovasculature, 
except for capillaries, share a common three layered structure (Figure 1.1). These 
three layers are the: (i) tunica adventitia; (ii) tunica media and; (iii) tunica intima. 
(i) Tunica adventitia 
The tunica adventitia is the outer-most layer covering of the blood vessel. It 
consists of elastic and collagen fibres. A network of elastic fibres separates the 
tunica adventitia from the tunica media. The external adventitia contains 
numerous nerves and, especially in larger vessels, tiny blood vessels that supply 
the tissues of the vessel wall. These small vessels that supply blood to the tissues 
of the vessel are called vasa vasorum, or “vessels to the vessels”. In addition to 
the important role of supplying the vessel wall with nerves and self-vessels, the 
tunica adventitia also helps anchor the vessels to surrounding tissues. 
(ii) Tunica media 
The tunica media is a muscular and connective tissue layer that is composed 
of a relatively thick layer of smooth muscle cells (SMCs) and large amounts of 
elastic fibres. The smooth muscle cells are spindle shaped and take up a circular 
arrangement around the vessel, perpendicular to the direction of flow. This 
regulates the diameter of the lumen and, as a direct result, regulates the blood 
pressure in the vessel. 
(iii) Tunica intima 
The tunica intima forms the inner lining of the blood vessel and is in direct 
contact with the blood as it flows through the lumen of the vessel. It consists of 
the endothelium and a basement membrane. The basement membrane provides a 
physical support base for the endothelium. Its framework of collagen fibres gives 
the basal lamina significant tensile strength, while also providing resilience for 
pulsatile stretch and recoil. The basement membrane is also involved in 
regulating molecular movement between the endothelium and SMCs and vice 
versa. The endothelium is a 0.2-4 μm thick monolayer of cells that completely 
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covers the luminal surface of the blood vessel, which is composed entirely of 
endothelial cells (ECs). This is now considered to be one of the body‟s largest 
organs, composed of approximately 6 trillion cells and weighing roughly 1.5 kg 
(Vanhoutte, Perrault and Vilaine 2007). 
 
 
Figure 1.1: Anatomical structure of arteries and veins, showing the layers of 
blood vessels (McKinley and O'loughlin 2006). 
 
1.2.1 The vascular endothelium  
 
The ability of the vascular endothelium to sense and respond to the flow 
of blood was observed more than 150 years ago by the famous pathologist 
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Rudolf Virchow. Virchow pointed to the heterogeneous morphology of the 
endothelium along the arterial tree, which correlated with the patterns of flow to 
which the cells were exposed (Resnick, et al. 2003). Virchow also postulated a 
passive role of the endothelium in transferring nutrients from the bloodstream to 
tissues and functioning as an insulation barrier, separating platelets from the 
thrombogenic sub-endothelial connective tissue. It is now known that the 
vascular endothelium is not only a barrier between the blood and vessel wall or a 
metabolic exchanger, but because of its unique position it works as a receptor-
effector organ which plays a critical role in vessel homesostasis and is implicated 
in the pathogenesis of CVD. The endothelium plays an important role in the 
control of vascular tone, blood pressure, hemostatic balance, permeability, 
proliferation, survival and innate and adaptive immunity. The endothelium is 
involved in most if not all vascular disease stages, either as a primary 
determinant of pathophysiology or as a victim of collateral damage (Aird 2008). 
Under normal physiological conditions the endothelium expresses a 
vasodilatory, anti-coagulant and anti-adhesive phenotype which is referred to as 
„quiescent‟ or „non-activated‟ (Aird 2008). These terms have given the illusion of 
the endothelium as being just a static barrier. However, studies have indicated 
that ECs have several essential roles in vascular maintenance including: (i) 
vascular remodelling through the production of growth-promoting and growth-
inhibiting substances; (ii) modulating hemostasis and thrombosis through the 
secretions of pro-coagulant, anti-coagulant and fibrinolytic agents; (iii) mediating 
inflammatory responses through the expression of chemotactic and adhesion 
molecules on their membrane surfaces and; (iv) regulating vascular smooth 
muscle cell contraction through the release of vasodilators and vasoconstrictors 
(Li, Haga and Chien 2005). 
ECs have three surfaces: cohesive, adhesive and luminal. The “cohesive” 
surface adjoins neighbouring endothelial cells to one another and facilitates 
transport processes. This surface consists of specialised intercellular junctions: 
gap junctions, tight junctions and adherens junctions. The “adhesive” surface of 
endothelial cells adheres to the basal lumina. The “luminal” side of endothelial 
cells are composed of molecules and specific binding proteins that regulate 
trafficking of circulating blood cells (Galbraith, Skalak and Chien 1998). 
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ECs in vivo exhibit an elongated shape that is orientated in parallel to the 
direction of blood flow in relatively straight regions of the vasculature. This 
laminar shear-induced remodelling typically happens in three phases: (i) cell 
elongation, where actin stress fibre and microfilament formation, and 
intracellular junction disruption, are observed within the first three hours of 
shear; (ii) cell movement with the loss of peripheral bands, which together with 
the nucleus become located at the upstream side of the cell body after six hours 
of shear and; (iii) the cell becomes “adjusted” to the flow direction with the 
formation and alignment of thick stress fibres and dense microfilaments and the 
reestablishment of cell junctions after twelve hours of shearing (Li, Haga and 
Chien 2005). In contrast, cells near arterial bifurcations or areas of high curvature 
have a more polygonal shape and the cytoskeleton is more randomly organised. 
These regions of the vasculature correspond to locations of “complex flow 
dynamics” of oscillatory flow and up-regulation of pro-inflammatory processes 
that lead to increased risk of atherosclerotic plaque formation and CVD. 
 
1.2.2 Endothelial dysfunction 
 
 Endothelial dysfunction occurs as a result of the „activation‟ of the 
endothelium. This activation can be stimulated by the action of blood-borne 
constituents, injury, hypoxia, altered hemodynamics etc. If the activation is short 
lived normal physiological conditions prevail. If the activation of the 
endothelium is sustained, endothelial function is impaired and endothelial 
dysfunction ensues. Alterations in EC morphology and phenotype are considered 
as early and crucial steps in the development and progression of cardiovascular 
disease (Ross, 1999). 
 As a direct consequence of the dendritic morphology of the vascular 
system, certain areas are more prone to dysfunction than others, such as 
bifurcations and curves. As such, atherosclerotic plaques are not evenly 
distributed over the arterial system. There are three types of EC response to 
injury: (i) immediate transient response: this response begins immediately after a 
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mild injury and lasts 15-30 min, causing increased vascular permeability; (ii) the 
immediate-sustained response: this occurs after severe injury and is associated 
with necrosis of ECs. Leakage starts immediately after injury and may last for 
several days; (iii) the delayed-prolonged response: in this case, vascular leakage 
occurs after direct injury of ECs caused by mild-to-moderate thermal exposure, 
X-ray or UV radiation etc. Leakage is delayed and lasts for several hours to days 
(Pasyk and Jakobczak, 2004). 
One of the earliest biomarkers of endothelial dysfunction is impaired 
nitric oxide (NO) production in conjunction with excessive oxidative stress 
(Taddei, et al. 2001).  
  
1.2.3 Hemodynamic forces  
 
Due to its location in the blood vessel, the endothelium is in constant 
contact with the circulating blood and all of its components. Due to the non-
Newtonian and pulsate flow of blood it imparts frictional stresses onto the vessel 
in the form of the hemodynamic forces, cyclic strain and frictional shear stress 
(Figure 1.2). The latter stimulus, shear, will form the basis of this PhD report.  
Cyclic strain is generated by the heart pumping and wall stretch in the 
circumferential and longitudinal directions. It is directly related to blood pressure 
and vessel diameter. The vessel wall thickens or thins so that force per unit of 
wall is consistent (Schiffrin 1992), this can be described by Laplace‟s Law 
(Laplace 1899). 
 
Where T = wall tension (or force per unit length of the vessel), P = blood 
pressure, r = radius and h = the thickness of the vessel wall. Arteries also 
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remodel in response to changes in fluid flow so that the vessel diameters are all 
matched to the volume of the blood (Schaper 2009).  
 
 
Figure 1.2: Forces affecting ECs in the vasculature. (A) Cyclic stain, which is 
felt predominantly in larger arterial vessels. (B) Laminar shear stress, which is 
sensed particularly in straight sections of the vasculature. (C) Disturbed shear, 
which is found in areas of high curvature or downstream of bifurcations 
(www.sabiosciences.com/pathwaymagazine/minireview/Adhesionmoleculesmec
hanotransduction.php) 
 
 Cyclic strain is predominant in larger arterial vessels such as the aorta, 
but is less influential in veins. Cyclic strain acts on both EC and SMCs and at 
physiological levels plays an important part in endothelial function such as 
permeability (Collins, et al. 2005) and migration (Von Offenberg Sweeney, et al. 
2005). However, at pathophysiological levels cyclic strain can cause 
hemodynamic dysregulation leading to atherosclerosis (Frangos, Gahtan and 
Sumpio 1999) or intimal hyperplasia (Newby and Zaltsman 2000).  
Any fluid moving along a solid boundary will incur a shear stress on that 
boundary. It is this principle that explains frictional shear stress on the 
endothelium. Shear stress is expressed in units of force / unit area (Newton per 
meter squared [N/m
2
] or Pascal [Pa] or dynes/cm
2
; 1 N/m
2 
= 1 Pa = 10 
dynes/cm
2
). Under normal physiological conditions, the shear stress to which the 
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endothelium is exposed is in the range of 10-20 dyne/cm
2
. In the case of laminar 
flow, vessel shear can be expressed as follows: 
  
Where  τ = shear stress, μ = blood viscosity, Q = flow rate and r = vessel radius. 
Physiologically, flow rate is highest at the centre of the blood vessel and 
decreases toward the endothelium. 
Studies have shown that laminar shear stress (LSS) is an atheroprotective 
stimulus, causing a dose-related reduction of EC proliferation rate (Levesque, 
Nerem and Sprague 1990, Traub and Berk 1998). It has also been shown that 
ECs subjected to a long duration of laminar flow have a lower rate of DNA 
synthesis than ECs under static conditions and that laminar flow reduces the 
number of cells entering the cell cycle (Akimoto, et al. 2000). LSS has also been 
proven to: (i) suppress apoptosis by its up-regulation of NO production 
(Dimmeler, et al. 1997); (ii) to significantly enhance wound healing through its 
effect on focal adhesion remodelling (Li, et al. 1997) and; (iii) to decrease 
microvascular endothelium permeability due to its effect on tight junctions 
(Levesque, Nerem and Sprague 1990, Colgan, et al. 2007). Thus, the continuous 
exposure of the endothelium to a physiological range of LSS, particularly in 
straight sections of the vasculature, promotes the establishment of important 
physiologic characteristics (i.e. anti-inflammatory, anti-thrombotic, anti-
coagulative, pro-fibrinolytic and anti-hypertensive properties).   
Disturbed blood flow usually occurs at branching points and curvatures of 
the arterial tree. At such sites, flow separation leads to transient vortex 
formations and even flow reversal, leading to a variety of different flow patterns 
such as oscillatory flow, low flow velocities and multi-frequency/multi-
directional secondary flows. Studies have shown that cells exposed to disturbed 
or oscillatory shear stress (OSS) have a higher proliferation rate than static cells 
(Levesque, Nerem and Sprague 1990). Also the rate of DNA synthesis is 
significantly higher in areas of disturbed shear than in areas of laminar shear 
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(Chiu 1998). Reactive oxygen species are up-regulated as a result of OSS, thus 
reducing the bioavailability of nitric oxide and inducing inflammatory gene 
expression, migration and dysregulated cell morphology (Helmlinger, et al. 
1991), all of which are central mechanisms for initiation and progression of 
atherosclerosis (Taniyama and Griendling 2003). 
Under these conditions, ECs lose their ability to maintain homeostasis 
and so become dysfunctional, leading to infiltration of lipids and leukocytes 
(monocytes and T-lymphocytes) into the sub-endothelial space. The resultant 
inflammatory response leads to fatty streak appearance, the first step in the 
formation of an atherosclerotic plaque. If the situation persists, fatty streaks 
progress and develop into vulnerable plaques that could potentially rupture 
leading to thrombosis and vascular occlusion (Figure 1.3).   
 
 
Figure 1.3: The progression of atherosclerotic plaque build-up and rupture 
(medmovie.com).  
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1.2.3 Mechanotransduction 
Mechanotransduction is the process by which the cells of the endothelium 
convert these mechanical forces into biochemical signals, which will then lead to 
functional responses from the cells. As a result, shear stress modulates the 
expression of genes that encode for growth factors, adhesion molecules, 
vasoactive substances, oxygen scavengers, coagulation factors and 
chemoattractants. It also regulates activation of several transcription factors, 
which are capable of binding to positive or negative shear stress response 
elements (SSREs) at promoters of mechanosensitive genes, inducing or 
suppressing their expression with downstream consequences for cellular function 
and morphology (Pasyk and Jakobczak 2004, Masatsugu, et al. 2003). 
Endothelial responses to flow occur in a coordinated sequence and exhibit 
time constants ranging from milliseconds to many hours.  Many putative 
mechanotransducers have been proposed to function in sensing flow such as ion 
channels, integrins, receptor tyrosine kinases, the apical glycocalyx, primary 
cilia, heterotrimeric G proteins, platelet and endothelial cell-adhesion molecule-1 
(PECAM-1) and vascular endothelial (VE)-cadherin (Hahn and Schwartz 2009) 
(Figure 1.4). 
 
1.2.3.1 Luminal mechanosensors  
 
1.2.3.1.1 Primary cilia 
 
 Primary cilia are specialised membrane-covered rod-like organelles that 
are several micrometers long, protruding from virtually all mammalian cells 
(D'Angelo and Franco 2009). Primary cilia can sense shear stress as low as 0.007 
dynes/cm
2
 (Goldsmith, Cokelet and Gaehtgens 1989)  and function as flow 
sensors in kidney epithelium (Praetorius and Spring 2003), bile duct epithelium 
and vascular endothelium (Hierck, et al. 2008). The function of primary cilia in 
endothelial shear sensing appears to be biphasic. Fluid flow and the associated 
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ciliary deformation lead to a polycystin-mediated intracellular Ca
2+
 transient 
within seconds (Nauli, et al. 2008). Cilia-associated proteins polycystin 1 and 2 
are expressed in ECs, with mutations or deletions of these genes in either humans 
or mice leading to vascular defects (Kim, et al. 2000). Also, the cilium is 
considered to amplify the cytoskeletal strain, resulting in prolonged effects on 
gene expression of shear-responsive genes (Hierck, et al. 2008). 
 
 
Figure 1.4: Endothelial mechanosensors. The figure shows the cellular 
localisation of the mechanosensors on the luminal, cohesive and adhesive 
surfaces of the EC. (Hahn and Schwartz, 2009). 
 
The distribution of primary cilia has been described to be spatio-
temporally linked to shear stress in vivo. In adult vasculature, primary cilia are 
located at atherosclerotic predilection sites where flow is low and oscillatory. 
Moreover, ECs in areas of high shear stress are devoid of cilia (Van der Heiden, 
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et al. 2008). Therefore, it is plausible that cilia could mediate 
mechanotransduction from these sites (Hahn and Schwartz 2009). 
 
1.2.3.1.2 Endothelial glycocalyx  
 
 The endothelial glycocalyx (EG) was visualised over 40 years ago using 
electron microscopy (Luft 1966). However, until recently little was known of the 
composition and function of this layer. We now know that the EG consists of a 
negatively charged, organised mesh of membranous glycoproteins, 
proteoglycans, glycosaminoglycans and associated plasma proteins, which is 
situated at the luminal side of all blood vessels (Pries, Secomb and Gaehtgens 
2000) (Figure 1.5) 
 
 
Figure 1.5: Visualisation of the endothelial glycocalyx. Figure shows the 
endothelial glycocalyx of a rat left ventricular myocardial capillary, visualised 
using electron microscopy. Bar represents 1 μm (Reitsma et al., 2007). 
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 Its major constituents comprise hyaluronic acid and the negatively 
charged heparin sulphate proteoglycans. Historically, the EG was thought to be 
confined to a thickness of only several nanometers (~400 nm). Now thanks to 
advances in rapid freezing/freeze substitution transmission electron microscopy, 
BAEC EG has been measured at 11 µm (Ebong, et al. 2011). 
 There is increasing evidence that the EG plays a considerable 
physiological role in relation to vascular permeability, adhesion of leucocytes 
and platelets, mediation of vascular stress and modulation of inflammatory 
responses (Weinbaum, Tarbell and Damiano 2007, Levick 2004, Pries and 
Kuebler 2006, Parish 2006). Recent findings also demonstrate that damage to the 
EG plays a role in several pathologies such as diabetes, reperfusion injury and 
atherosclerosis (Nieuwdorp, et al. 2006, Mulivor and Lipowsky 2004, 
Nieuwdorp, et al. 2005).  
 
1.2.3.1.3 G-proteins 
 
 G-proteins are heterotrimers composed of Gα and Gβγ subunits which are 
located at the inner surface of the plasma membrane, where they are associated 
with transmembrane G-protein coupled receptors (GPCRs). G-proteins regulate a 
variety of endothelial functions including migration, proliferation, differentiation, 
survival and tissue homeostasis (Hamm 1998, Wieland and Mittmann 2003, 
Andreeva, et al. 2006, Knezevic, et al. 2009). There are 16 genes encoding for 23 
known Gα subunits, 5 genes for Gβ subunits and 12 genes for Gγ subunits 
(Hurowitz, et al. 2000). The Gβγ dimer anchors the G-protein to the cytoplasmic 
face of the plasma membrane, while the Gα chain exchanges GDP for GTP upon 
GPCR activation (Papadaki and Eskin 1997). This leads to dissociation of the α 
and βγ subunits, both of which are now free to act on specific downstream 
effectors (Wieland and Mittmann 2003). Gudi et al. have shown that G-protein 
activation occurs 1 sec after shear onset, while inhibition of G-proteins using 
antisense Gαq oligonucleotides blocked shear-induced Ras-GTPase activity 
(Gudi, Clark and Frangos 1996, Gudi, et al. 2003). 
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G-proteins associated with transmembrane receptors that are involved in 
signal transduction in ECs include: (i) Gq proteins, which activate phospolipase C 
(PLC); (ii) Gs proteins or stimulatory G-proteins, which activate Ca
2+
 channels 
and adenylate cyclase (AC), and; (iii) Gi proteins or inhibitory G-proteins, which 
inhibit AC and are thought to be involved in the stimulation of K
+
 channels in 
endothelial cells (Simon, Strathmann and Gautam 1991).  
Shear stress activation of G-proteins has also been shown to be involved 
in several flow-initiated endothelial responses that regulate vascular tone, 
including release of the vasodilators NO (Ohno, et al. 1993) and PGI2 
(Berthiaume and Frangos 1992) and vasoconstrictors such as endothelin (Kuchan 
and Frangos 1993). Through the use of a co-culture system, of ECs and vascular 
SMCs, Redmond et al. demonstrated that flow mediates selective changes in EC 
and SMC G-protein expression associated with changes in G-protein 
functionality and cellular signalling capacity. Moreover, flow-induced changes in 
SMC G-protein signalling capacity are endothelium dependent. This suggests 
that G-protein modulation may represent an important mechanism whereby 
hemodynamic forces regulate vessel wall function (Redmond, Cahill and 
Sitzmann 1998). 
 
1.2.3.1.4 Ion channels  
 
The lipid bilayer of cell membranes has high permeability for 
hydrophobic and small polar molecules while it is highly impermeable to ions, a 
function which is critical for the cell to maintain different concentrations of 
solutes from those in the extracellular fluid. Ion channels are responsible for the 
transfer of specific ions across the plasma membrane. One of the most rapid 
endothelial responses to flow is the activation of these flow-sensitive ion 
channels; therefore, these channels have been proposed for candidates as 
mechanotransduction (Davies 1995).  
Inward-rectifying potassium
 
(Kir) channels were the first type of flow-
activated ion channel reported in ECs (Olesen, Claphamt and Davies 1988). 
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Activation of Kir channels is virtually immediate on flow onset and results in 
hyperpolarisation of the EC membrane.  
A second type of flow-sensitive ion channel has also been identified as an 
outward-rectifying chloride (Cl
-
)
 
channel (Barakat, et al. 1999). The outward-
rectifying Cl
-
 current is induced virtually instantaneously on flow onset, a 
response which is independent of Kir activation. The effect of activation of the 
flow-sensitive outward-rectifying Cl
-
 channels on EC membrane potential 
counteracts that of the Kir channels.  
There is mounting evidence that flow-sensitive K
+ 
and Cl
- 
channels play a 
central role in regulating overall endothelial responsiveness to flow. By 
modulating flow-induced responses, ECs activation of flow-sensitive ion 
channels likely plays an important role in regulating aspects of normal vascular 
physiology. These include vasoregulation in response to acute changes in arterial 
blood flow and arterial well remodelling after chronic hemodynamic alterations 
(Barakat, Lieu and Gojova 2006).  
Moreover, flow-sensitive ion channels may play a role in the endothelial 
dysfunction associated with the onset of atherosclerosis. Suvatne et al. have 
demonstrated that blocking flow-sensitive K
+ 
and Cl
- 
channels greatly attenuates 
flow-induced increases in endothelial Na-K-Cl co-transport protein (Suvatne, 
Barakat and O'Donnell 2001). It has also been shown that the blocking of these 
ion channels inhibits EC spreading during endothelial wound closure after 
mechanical injury (Gojova and Barakat 2005) and that blocking K
+ 
channels 
inhibits the induction of NO by shear stress (Shasby 2007). 
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1.2.3.2 Cohesive mechanosensors  
 
1.2.3.2.1 PECAM-1 
 
 Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a 130 kDa 
type I transmembrane glycoprotein that is expressed on the surface of platelets, 
monocytes, macrophages and endothelial cells, where it is localised to the border 
of adjacent cells at 1x10
6
 to 2x10
6
 copies/cell (Newman 1994) (Figure 1.6). 
PECAM-1 is a primary constituent of endothelial cell-cell junctions in confluent 
vascular beds. It is composed of 6 extracellular immunoglobulin domain-like 
loops which participate in homophilic interaction with the neighbouring cell, 
where it plays a role in the transendothelial migration of leukocytes (Vaporciyan, 
Delisser and Yan 1993, Wakelin, et al. 1996). 
Given its abundant expression in ECs, PECAM-1 has been demonstrated 
to be involved in the initial formation and stabilisation of cell-cell contacts at 
lateral junctions of ECs, the maintenance of a vascular permeability barrier, 
modulation of cell migration, transendothelial migration and angiogenesis 
(Newman, et al. 1990, Albelda, et al. 1990, Albelda, et al. 1991, Ferrero, et al. 
1995, Schimmenti, et al. 1992, DeLisser, et al. 1997). More recent results have 
indicated a role for PECAM-1 in mechanosensing, with tyrosine phosphorylation 
of PECAM-1 occurring within 30 sec of shear onset. Once activated, PECAM-1 
activates ERK 1/2 through the Ras signalling pathway (Fujiwara, et al. 2001). 
Kano et al. demonstrated that this phosphorylation could also be induced by 
mechanical pulling applied to PECAM-1 via the twisting of magnetic beads 
coated in PECAM-1 antibodies (Kano, Katoh and Fujiwara 2000) thereby 
confirming the mechanosensitive nature of the molecule. Mechanical stimulation 
of PECAM-1 has been implicated in activating Src family tyrosine kinase, one of 
the earliest known intracellular signalling events in this pathway (Tzima, et al. 
2005). 
 
 
20 
 
1.2.3.2.2 VE-cadherin 
 
Vascular endothelial cadherin (VE-cadherin) is a 140 kDa type II 
classical cadherin (Figure 1.6). It is found exclusively in vascular ECs, where it 
is concentrated in adherens junctions (Breier, et al. 1996). Adherens junctions are 
a dynamic complex present at cell-cell borders between adjacent endothelial and 
epithelial cells.  
VE-cadherin is a calcium-dependent cell-cell adhesion glycoprotein 
composed of 5 extracellular cadherin repeats, a transmembrane region and a 
highly conserved cytoplasmic tail. VE-cadherin‟s extracellular domain binds to 
the extracellular domain of another VE-cadherin expressed in the membrane of 
an adjacent EC. By forming a homotypic bond in this manner, VE-cadherin glues 
the neighbouring cells together (Rudini and Dejana 2008). Intracellularly, VE-
cadherin is connected to the actin cytoskeleton via a family of catenins. Catenins 
not only serve as a structural linker, they also transduce biochemical signals for 
cell-cell communication. The stability of the VE-cadherin-catenin-cytoskeleton 
complex is essential to the maintenance of endothelial barrier function (Sallee, 
Wittchen and Burridge 2006, Vincent, et al. 2004).  
VE-cadherin functions are crucially regulated by the shear stress of blood 
flow (Hahn and Schwartz 2009). Recently published work from our laboratory 
demonstrates a role for VE-cadherin in the transmission of physiological shear 
signals to tight junction occludin through a Tiam1/Rac1 signal mechanism, 
leading to up-regulation of brain microvascular EC barrier integrity (Walsh, et al. 
2011). In vivo studies indicate that VE-cadherin expression at cell-cell junctions 
is weaker in atherosclerosis susceptible sites, such as bifurcations, with 
intermittent staining patterns under low net flow; however, total cellular VE-
cadherin levels remained unaltered, indicating a redistribution within the 
membrane (Hahn and Schwartz 2009). 
Gene deletion studies show that VE-cadherin is essential for embryonic 
angiogenesis, vascular maintenance and restoration of vascular integrity after 
injury (Gentil-dit-Maurin, et al. 2010, Gulino, et al. 1998). Mice deficient in VE-
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cadherin die as a result of severe vascular defects, which are characterised by 
defective capacities in sprouting angiogenesis, suggesting a putative role for VE-
cadherin in vascular morphogenesis (Gory-Faure, et al. 1999). VE-cadherin has 
been found to be an essential molecule in the contact inhibition of EC cell 
proliferation as a result of junctional stabilisation (Lampugnani, et al. 2003). 
 
 
Figure 1.6: General structure of VE-cadherin (A) and PECAM-1 (B). Both 
transmembrane proteins contain an extracellular region responsible for forming 
trans homodimers with neighbouring cells. The intracellular cytoplasmic tails of 
each molecule can interact with the actin cytoskeleton 
(www.sabiosciences.com/pathwaymagazine/minireview/Adhesionmoleculesmec
hanotransduction.php). 
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1.2.3.2.3 Receptor tyrosine kinases  
 
 The kinase family is one of the largest effector families in the human 
genome, with over 500 members. The principal functions of the tyrosine kinase 
sub-family include cell/cell signalling, adhesion and motility (Sharma and 
Priyank 2011). Tyrosine kinases are enzymes that transfer a phosphate group 
from ATP to a target cellular protein, thereby acting as an on/off switch in many 
cellular functions.  
 Receptor tyrosine kinases (RTKs) are monomeric, transmembrane cell 
surface receptors with an extracellular N-terminal and an intracellular C-terminal 
region. To elicit signal transduction cascades, RTKs need to form dimers in the 
plasma membrane, these dimers being stabilised by ligands binding to the 
receptor. The interaction between the cytoplasmic domains stimulates the auto-
phosphorylation of tyrosine within the domains of the RTKs, leading to tyrosine 
kinase activation. In turn, these docking phosphotyrosines recruit specific 
intracellular adaptor proteins (Src, Shc) and activate intracellular signal 
transduction pathways such as phosphatidylinosityl 3-kinase (PI3K)/Akt, 
mitogen-activated protein (MAP) kinases or protein kinase C (PKC) (Lemmon 
and Schlessinger 2010). PI3K and MAP kinases mediate the effect of RTKs on 
cell proliferation, survival, differentiation, migration and cytoskeletal 
reorganisation (Schlessinger 2000, Blume-Jensen and Hunter 2001, Cantley and 
Cantley 1995). 
It has been reported almost all RTKs are activated by shear stress and that 
shear stress causes quick ligand-independent phosphorylation of RTKs (Jong Lee 
and Young Koh 2003). RTKs play a critical role in the regulation of endothelial 
cell proliferation and survival. Their expression, usually low in normal vessels, is 
increased in atherosclerotic lesions, in correlation with an increased expression 
of their ligands (Ross 1993). Mutations in RTKs and attenuated activation of 
their signalling pathways have been linked to numerous diseases including breast 
cancer (Boulay, et al. 2008) and venous malformation (Vikkula, et al. 1996).  
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1.2.3.2.4 VEGFR-2 
 
Vascular endothelial growth factor receptor-2 (VEGFR-2) is a 230 kDa 
class V RTK. VEGFR-2 consists of an extracellular ligand-binding domain with 
seven immunoglobulin-like motifs, a single transmembrane and a cytoplasmic 
domain that contains a juxtamembrane region, a kinase domain and a carboxyl 
terminus.  
VEGFR-2 appears to mediate all known cellular responses to VEGF 
(Holmes, et al. 2007). The critical role of VEGFR-2 in vascular development is 
demonstrated by the death of VEGFR-2
-/- 
mice due to defective development of 
blood islands, ECs and haematopoietic cells (Shalaby, et al. 1995). During shear 
mechanotransduction, VEGFR-2 uses VE-cadherin as an adaptor which brings it 
into proximity with PECAM-1, thereby facilitating the activation of VEGFR-2 
by Src, a ligand-independent transactivation in response to flow. VEGFR-2 is 
activated within 15 sec of the onset of flow and is localised to cell-cell junctions. 
Once activated, VEGFR-2 recruits and activates PI3K, which mediates crucial 
downstream signals (Shay-Salit, et al. 2002, Jin, et al. 2005). One such signal is 
the Akt-dependent phosphorylation of endothelial NO synthase, which 
contributes to the stimulation of NO release and vessel relaxation (Fleming, et al. 
2005). This flow-induced activation of VEGFR-2 was shown to be absent in both 
PECAM-1
-/- 
and VE-cadherin
-/- 
ECs at all times between 15 sec and 5 min. This 
demonstrates that VEGFR-2 activation by shear stress is downstream of the 
junctional receptors (Tzima, et al. 2005). 
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1.2.3.3 Adhesive mechanosensors 
 
1.2.3.3.1 Integrins 
 
 Integrins are membrane-associated glycoproteins found predominantly on 
the basolateral surface of ECs. These glycoproteins are heterodimers composed 
of an α and β subunit. In vertebrates, there are 18 α and 8 β subunits that can 
assemble into 24 different receptors with different binding properties and 
different tissue distributions (Hynes 2002, Barczyk, Carracedo and Gullberg 
2010). The extracellular domain binds directly to extracellular matrix (ECM) 
proteins such as vitronectin, fibronectin, laminin and collagen. The cytoplasmic 
domain of both the α and β subunits interact with signalling molecules and 
cytoskeletal proteins to regulate cellular events such as signal transduction, 
cytoskeletal organisation and cell motility (Shyy and Chien 2002). Integrins have 
been shown to be highly sensitive to hemodynamic forces, and their subsequent 
activation has been shown to be essential to flow-mediated NO release (Muller, 
Chilian and Davis 1997), cellular realignment (Tzima, et al. 2005) and ERK 1/2 
activation (Takahashi and Berk 1996). 
 The specific binding of integrins to extra cellular matrix (ECM) proteins 
or to counter-receptors on adjacent cells, supports cell adhesion and is crucial for 
embryonic development, tissue maintenance and repair, host defence and 
haemostasis (Harburger and Calderwood 2009). Integrins are unique structures 
due to their ability to regulate „inside-out‟ signalling, where intracellular signals 
affect their binding affinity to ECM ligands (Shattil, Kim and Ginsberg 2010). 
Integrins also regulate „outside-in‟ signalling where they transmit signals into the 
endothelial cells providing information on location, adhesive state and 
surrounding matrix (Hynes 2002). 
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1.2.3.3.2 Cytoskeleton 
 
 Endothelial mechanics are largely determined by the cytoskeleton, which 
is mainly composed of actin, intermediate filaments and microtubules. These 
components physically connect different regions of the EC to transmit forces 
from the apical domain, where shear is applied, to the basal or lateral domains, 
where mechanotransduction has been observed (Davies 1995). 
 The cytoskeleton is strong enough to build a scaffold which defines cell 
shape, but which is flexible enough to tolerate the hemodynamic forces acting 
upon it. However, the cytoskeleton is not a constant structure, as is shown 
through the dramatic realignment of actin fibres in the direction of shear 
(Oberleithner, et al. 2007). As such the cytoskeleton is involved in modulating 
hemodynamic forces, transmitting them through the cell and transducing the 
mechanical force into a biochemical signal which finally leads to a change in 
cellular function. Mechanical properties have an impact at each stage of the 
mechano-signalling cascade and as such it is plausible that disturbances in 
mechanical forces can disturb endothelial functions (Kliche, et al. 2011). 
Furthermore, disruption of the actin cytoskeleton has been found to be sufficient 
to negate the effect of shear stress-mediated signalling and changes in gene 
expression (Imberti, et al. 2000).  
 
1.3 Zinc Metallopeptidases  
 
Peptides are used by all cell types to elicit cellular functions. The use of 
peptides as messengers usually involves the following steps: (i) production and 
release of the peptide by a specific cell; (ii) interaction of the peptide with a 
receptor on the surface of the target cell and; (iii) degradation of the peptide to 
terminate action. The first and last steps of this scheme require the participation 
of proteases/peptidases. There is increasing evidence that both soluble and 
membrane-associated zinc-metallopeptidases play important roles in both of 
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these steps (Ghaddar, et al. 2000). Although activation of inactive pro-hormone 
precursors into bioactive peptides is generally performed by proteases of the 
subtilisin family located either in the trans-Golgi network or in secretary granules 
of the cell, a few peptides require a final processing step after secretion (Seidah, 
Chretien and Day 1994). Of particular importance within the blood vessels are 
the membrane-associated zinc metallopeptidases, which hydrolyse peptide bonds 
of less than 40 aa, the length of most bioactive hormones. In addition to their role 
in peptide activation, cell surface zinc-metallopeptidases are also known to 
terminate peptidergic signals by degrading the active peptides into inactive 
fragments. One of the best known of these peptidases is neprilysin (NEP), which 
is involved in the physiological degradation of several bioactive peptides 
(Kohne, et al. 1998) as discussed below.  
Zinc-dependent proteases constitute one of four major types of proteases, 
the others being aspartate, serine and cysteine proteases. Members of the zinc-
dependent class of metallopeptidases are characterised by a catalytic metal ion, 
which cleaves peptide bonds following a common mechanism with the 
participation of a solvent molecule and a polarising general base/acid, usually a 
glutamate (Gomis-Ruth 2008, Bayés, et al. 2007). Upon binding of the substrate, 
the metal simultaneously coordinates the scissile carboxyl oxygen and the 
solvent molecule, and the glutamate activates the latter by degradation of the 
peptide bond (Gomis-Ruth, Botelho and Bode 2011) (Figure 1.7). 
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Figure 1.7: Model of zinc-coordinating residues within the TOP active site. A 
view of conserved residues involved in zinc coordination and substrate catalysis. 
For clarity, only the side chains and C-α′ carbons of the coordinating residues as 
well as the zinc atom and the activated water molecule are shown. Atoms 
proposed to coordinate with zinc are connected by a thin white line. The 
graphical representations were depicted with MOLSCRIPT with subsequent 
renderings using RASTER 3D (Shrimpton, Smith and Lew 2002). 
 
There are several methods to classify metallopeptidases; one such method 
is classification based on the catalytic mechanism, the critical amino acid residue 
involved and amino acid sequence similarity within peptidase moieties.  
Rawlings and Barrett devised a classification system for dividing peptidases into 
clans and sub-clans; there is a constantly evolving classification system that can 
be accessed online (http://merops.sanger.ac.uk). Metallopeptidases are currently 
split into 62 families (M1-M85, with several unassigned numbers) (Rawlings and 
Barrett 1993). 
One of the largest clans in this classification is the Clan MA. These are 
distinguished by the active site motif HEXXH, in which two histidine residues, 
together with a third distant residue (typically a glutamate/histidine residue), bind 
the zinc atom. This clan is again divided into two major sub-clans: MA (E), the 
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gluzincins, where the third ligand is a glutamate, and MA (M), the metzincins, 
where the third ligand is a histidine or an aspartate. The sub clan MA (M) is 
typified by the matrix metalloproteases and their relatives (Lew 2004). 
The gluzincins are further subdivided into families based on homology. 
The families commonly relevant to mammalian signalling systems are M1 (e.g. 
aminopeptidases), M2 (e.g. angiotensin-converting enzyme (ACE)), M3 (e.g. 
thimet oligopeptidase (TOP) and neurolysin), and M13 (e.g. neprilysin (NEP) 
and endothelin-converting enzyme (ECE)).The following sections will discuss 
these metallopeptidases in greater detail. Moreover, of particular interest to this 
project are the peptidases in the family M3, specifically TOP, and in family 
M13, specifically NEP.  
 
1.3.1 M2/M13 family members 
 
1.3.1.1 Neprilysin 
 
Neprilysin (neutral endopeptidase, NEP, EC3.4.24.11) is a member of the 
M13 family of zinc metallopeptidases. It is a type II membrane-bound zinc 
metallopeptidase that cleaves endogenous peptides at the amino side of 
hydrophilic residues. Its target substrates include a number of endogenous 
vasodilator peptides, including atrial natriuretic peptide (ANP), brain natriuretic 
peptide (BNP), C-type natriuretic peptide (CNP), substance P and bradykinin 
(BK), as well as vasoconstrictor peptides such as endothelin-1 (ET-1) and 
angiotensin II (Ang II) (Ferro, et al. 1998) (Figure 1.8). NEP is found in ECs, 
vascular SMCs, cardiac myocytes and renal epithelial cells as well as in 
fibroblasts. A pharmacologically induced NEP blockade typically leads to 
elevated natriuresis and vasodilation (Quaschning, Galle and Wanner 2003), and 
induces anti-proliferative effects on vascular SMCs (Barber, et al. 2005). This 
suggests a potentially important role for NEP in pathologies characterised by 
flow-dependent endothelial dysfunction and remodelling. As such, it is a 
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therapeutically relevant target in the treatment of endothelial dysfunction and 
CVD. In view of its importance to endothelial function (and dysfunction), the 
regulation of NEP by hemodynamic forces is highly relevant and will be studied 
in detail in this project.  
NEP was originally identified as a major antigen of renal membranes over 
30 years ago and was implicated in the metabolism of insulin; however, there is 
little evidence to support this. NEP is now linked to the metabolism of 
neuropeptides in the central nervous system, especially enkephalins and 
substance P (Skidgel, et al. 1984). NEP is also shown to be the principal enzyme 
responsible for inactivating the vasodilator, ANP (Turner 2003). 
 
 
Figure 1.8: Metabolites of NEP in vasodilation and vasoconstriction. NEP 
catalyses the metabolism of the vasoconstrictor peptides ET-1 and Ang II, as well 
as the metabolism of several vasodilator peptides, including BK, ANP, BNP, 
CNP, and substance P. NEP is also involved in the enzymatic conversion of big 
ET-1 to its active form, the vasoconstrictor peptide ET-1. The balance of effects 
of NEP inhibition on vascular tone, therefore, will depend on whether the 
predominant substrate(s) degraded by NEP are vasodilators or vasoconstrictors 
and on the extent of NEP involvement in the processing of big ET-1 (Ferro et al., 
1998). 
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Structurally, NEP consists of a short N-terminal cytoplasmic domain (25 
aa), followed by a single hydrophobic transmembrane helix domain (24 aa), that 
functions as both a transmembrane domain and a signal peptide, and a large C-
terminal extracellular domain that contains the catalytic site with a conserved 
HEXXH motif participating in zinc coordination (D'Adamio, et al. 1989). NEP 
also contains a shear stress response element (SSRE) in its promoter region and 
has been shown to be regulated by hemodynamic forces in a reactive oxygen 
species (ROS)-dependent manner (Fitzpatrick, et al. 2009). The crystal structure 
of human NEP has been resolved at 2.1Å (Figure 1.9). One of the most 
interesting things this has revealed is the restricted active site cleft preventing 
access of large peptides and proteins, thus explaining its oligopeptidase character 
(Carson and Turner 2002). Analysis of the N-terminal sequence of the cytosolic 
domain identified a myristoylation consensus site. Myristoylation is an important 
post-translational function in many cellular pathways, including signal 
transduction, apoptosis and extracellular transport of proteins. It has been shown 
that the second glycine in the NEP protein is myristoylated, and that 
myristoylation results in increased NEP protein at the cell membrane (Zheng, et 
al. 2010).  
 
Figure 1.9:  The structure of NEP. NEPs active site model is shown in the centre 
of the image, with its zinc atom in yellow (Tiraboschi et al., 1998). 
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In addition to roles in the vasculature, central nervous system and 
kidneys, NEP is also implicated in oncogenesis, most notably prostate cancer, in 
which NEP is dramatically down-regulated or indeed absent (Osman, et al. 
2004). A measurement of NEP and ECE in a range or prostate cancers 
demonstrates that there is a balance between levels of NEP and ECE which 
determines the level of malignancy of the cells and that ECE expression in 
metastatic cells may be indicative of its role in metastatic progression (Usmani, 
et al. 2002). Likewise, NEP has been implicated in the removal of amyloid β-
peptide (Aβ), a 4 kDa peptide considered to be a primary trigger for the 
development of Alzheimer‟s disease, whilst NEP loss during normal aging 
contributes to amyloid accumulation in brain tissue (Turner 2003). NEP has also 
been shown to degrade peptides involved in learning and memory such as 
oxytocin, NYP and CCK (Carvajal, et al. 2004, Heinrichs, et al. 2004, 
Hadjiivanova, Belcheva and Belcheva 2003). Recently, NEP knockout mice, 
which are characterised by lower blood pressure and an enhanced lethality to 
endotoxin shock, demonstrated a greater ability to sustain learning and memory 
in older subjects than wild type control subjects (Walther, et al. 2009).  
In addition to its catalytic function, NEP can alter the function of other 
proteins via direct protein–protein interactions. NEP directly binds to 
Ezrin/Radixin/Moesin (ERM) proteins resulting in a decreased binding of ERM 
proteins to actin filaments and, as such, cells expressing NEP demonstrate 
decreased cell adhesion and cell migration (Iwase, et al. 2004). 
Other related proteins to NEP of note include ECE (as discussed below), 
KELL, PEX and ECEL-1. KELL is a protein which constitutes a major antigen 
on human erythrocytes. As a result of its location, incompatibility to KELL 
antigens can cause severe haemolytic reactions to blood transfusions as well as 
erythroblastosis in newborn children.  The human PEX protein was identified 
from studies of patients with X-linked hypophosphatamemic rickets (Francis, et 
al. 1995). It was found to encode an NEP-like protein and subsequent cloning of 
PEX revealed an ability to cleave parathyroid hormone-like peptides. ECEL-1 is 
devoid of enzymatic activity and has no proteolytic activity to Aβ, but can 
hydrolyse synthetic NEP substrates, whilst phosphoramidon has been shown to 
inhibit its activity. ECEL-1, has been shown to be essential to the control of 
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respiration (Schweizer, et al. 1999). Distinct chromosomal locations have been 
identified for the genes encoding the human NEP-like enzymes. NEP, KELL, 
PEX, DINE and ECE-1 are found at chromosomal positions 3q25, 7q33, Xp22, 
2q36-q37 and 1p36, respectively, implying that the gene duplications are ancient 
(Turner, Isaac and Coates 2001). 
 NEP2, a homologue of NEP with 66% sequence identity, has been shown 
to be restricted mainly to developing and differentiated fields of the CNS and to 
the testis, where it has been shown to be involved in sperm function and oocyte 
fertilisation (Bonvouloir, et al. 2001). NEP2 appears to have a unique feature for 
a member of the M13 family, in that NEP2 appears to be synthesised as an 
inactive enzyme, needing post-translational modifications to be transported out 
of the ER and become active (Rose, et al. 2002). Unlike NEP and ECE, which 
are broadly expressed in the CNS and periphery, NEP2 is found exclusively in 
selected populations of neurons and in the spinal cord. The only peripheral areas 
where expression of NEP2 was detected were the pituitary and choroid plexus. 
NEP2 was also found capable of degrading Aβ and its distant localisation from 
NEP suggests that, together with ECE, it may be better poised to catabolise Aβ as 
it is more abundantly expressed in areas relevant to Alzheimer‟s disease 
pathology (Facchinetti, et al. 2003, Thomas, et al. 2005). 
 
1.3.1.2 Angiotensin converting enzyme  
 
 Angiotensin converting enzyme (ACE or EC3.4.15.1) is a member of the 
M2 family of zinc metallopeptidases. ACE is a type I integral membrane zinc-
dependent dipeptidase that is expressed on the surface of epithelial and 
endothelial cells. It is responsible for the conversion of angiotensin I (Ang I) to 
angiotensin II (Ang II), a potent vasoconstrictor, and for the inactivation of BK, a 
vasodilator (Yang, Erdos and Levin 1971). As such, ACE plays an important role 
in the regulation of hypertension and in the development of vascular pathology 
and endothelium remodelling in certain disease states.   
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 Mammalian ACE exists in two distinct isoforms arising from the use of 
alternative promoters. The first is testicular ACE (tACE), which is essential for 
male fertility and which carries a single HEXXH zinc-binding active site as well 
as a catalytic domain. The second isoform is somatic ACE (sACE), which 
consists of two identical catalytic domains both containing a functional zinc-
binding active site (Ehlers and Riordan 1989). Although ACE is primarily a 
membrane bound protein, a soluble form is found in many body fluids which is 
formed as a result of a post-translational proteolytic cleavage in the 
juxtamembrane stalk by a membrane protein secretase (Oppong and Hooper 
1993). 
 ACE 2, a homologue of ACE, is also a type I integral membrane 
peptidase which is found in the kidneys, heart and lungs (Tipnis, et al. 2000). 
ACE 2 converts Ang II to angiotensin (1-7) (Ang (1-7)), which opposes the 
actions of Ang II. Ang II is a vasoconstrictor and also stimulates the secretion of 
aldosterone from the adrenal cortex. Aldosterone causes the tubules of the 
kidneys to increase the reabsorption of sodium and water into the blood. This 
increases the volume of fluid in the body, which also increases blood pressure. 
Ang (1-7) opposes the actions of Ang II. Therefore it is involved in vasodilation, 
vascular protection, cell growth inhibition and has anti-fibrinogenic, anti-
thrombogenic and anti-arrythmogenic effects. Hence, ACE and ACE 2 act as 
counterbalances in metabolism in the renin-angiotensin system (RAS) 
(Crackower, et al. 2002). The RAS is a pivotal physiological regulator of 
cardiovascular homeostasis, potently impacting hydroelectrolyte balance, arterial 
tone, and blood pressure as well as modulating the growth and differentiation of 
vascular SMCs and cardiac myocytes. In contrast, dysregulation of the RAS is 
intrinsically associated with cardiovascular pathologies such as hypertension, 
myocardial infarction, and coronary heart disease (Ferrario 1990). The regulatory 
impact of shear stress on ACE has also been investigated, with ACE mRNA 
expression levels being suppressed under shear conditions, in a ROS-dependent 
manner (Rieder, et al. 1997). ACE is also known to contain two SSREs in its 
promoter region (Miyakawa, de Lourdes Junqueira and Krieger 2004). ACE 
inhibitors, beyond inhibiting the RAS, diminish the inactivation of bradykinin, 
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leading to an increase of NO release. Consequently pathological vasoconstriction 
is prevented and vasodilation occurs (Poredoš 2000).  
 Since 1981, inhibitors of ACE have been targeted as first-line therapy for 
a range of cardiovascular and renal diseases, including hypertension, congestive 
heart failure, myocardial infarction and diabetic nephropathy (Hooper and Turner 
2003). Indeed, as recently as 2002, ACE inhibitors were the most commonly 
prescribed drugs for the treatment of hypertension in the USA (Ibrahim 2006). 
 
1.3.1.3 Endothelin-converting enzyme  
 
Endothelin-converting enzyme (ECE or EC3.4.24.71) is a type II integral 
membrane protein and a member of the M13 family of zinc metallopeptidases. 
ECE has two isoforms, ECE-1 and ECE-2, both of which are composed of a 
short cytoplasmic tail, followed by a membrane-spanning region and a large 
extracellular domain containing the zinc-binding motif essential for enzymatic 
activity. ECE is found predominantly in ECs but is also expressed by exocrine 
cells, smooth muscle cells, neurons and glia. ECE catalyses the final stage in 
post-translational modification of endothelin (ET), cleaving big ET to form ET 
(Khimji and Rockey 2010). 
Endothelin is considered to be one of the most potent vasoconstrictors 
present in ECs. Four isoforms of ET have been discovered, ET-1, ET-2, ET-3 
and ET-4. All are involved in the regulation of vascular tone and are required 
during embryonic development (Kurihara, et al. 1994). Each of the three peptides 
consists of 21 amino acid residues and is expressed, in different patterns, in 
various tissues and cells. The predominant ET produced in endothelial cells is 
ET-1. An important discovery during the early stage of ET research was the 
discovery of ET receptors. These receptors were designated the ETA receptor and 
ETB receptor. The ETA receptor binds ET-1 and ET-2 with greater affinity than it 
does ET-3, while the ETB receptor binds all three isoforms with equal affinity 
(Masaki 2004). 
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Analysis of the promoter region of ECE revealed the presence of four 
SSREs. Masatsugu et al. have also demonstrated that physiological shear stress 
down-regulates the mRNA expression of ECE-1 as well as ET-1, through an 
increase in oxidative stress in endothelial cells (Masatsugu, et al. 2003). Elevated 
levels of ECE and its product ET-1 have been shown to be involved in 
inflammatory conditions such as asthma (Zhang, Adner and Cardell 2004).  
Over-expression of ET-1 in the vasculature has also been noted in different 
models of hypertension (Iglarz and Schiffrin 2003) and atherosclerosis (Ihling, et 
al. 2001), suggesting a pathophysiological role for ET-1 in CVD. ECE is also 
involved in the hydrolysis of a number of active peptidases, such as BK, 
neurotensin, Ang I and amyloid peptide Aβ (Eckman, Reed and Eckman 2001, 
Johnson, Stevenson and Ahn 1999). As a result of its biological activity, ECE is 
a major target of therapeutic inhibitors. An excellent review by Cerdeira et al. 
covers all the major targets of ECE inhibitors and their effectiveness (Cerdeira, 
Bras-Silva and Leite-Moreira 2008).  
 
1.3.2 M3 family members 
 
1.3.2.1 Thimet oligopeptidase  
 
  Thimet oligopeptidase (TOP, EC3.4.24.15) is a member of the M3 family 
of zinc metallopeptidases. It is a predominantly soluble, 77 kDa, thiol-sensitive 
enzyme that preferentially cleaves peptide bonds on the carboxyl side of the 
hydrophobic amino acid residues in substrates of less than 20 aa. It has been 
implicated in the degradation of a range of bioactive peptides, including 
gonadotropin-releasing hormone (GnRH), Ang I, neurotensin and BK, both in the 
central nervous system and in the periphery. High levels of TOP activity have 
been localised, both catalytically and immunohistochemically, to the brain, 
pituitary and testis, with lower levels in tissues such as the lung, liver, kidney and 
spleen. Typically 80% of its activity in a tissue or cell line is cytosolic, with the 
36 
 
remainder being nuclear or membrane-associated (Chu and Orlowski 1985, 
Shrimpton, Smith and Lew 2002). It has been widely reported that ECs exhibit 
secreted and membrane-associated forms of TOP, thereby allowing it to 
putatively degrade peptides intracellularly and extracellularly (Crack, et al. 
1999). 
The structure of TOP has been resolved at 2.0 Å. The structure reveals 
TOP‟s active site to be located at the base of a deep channel that runs the length 
of the elongated molecule, limiting the size of peptides that can be degraded 
(Ray, et al. 2004) (Figure. 1.10). Moreover, like all peptidases in this family, TOP 
exhibits a HEXXH motif in its active site. It has also been shown to contain a 
SSRE (-GAGACC-) within its promoter region and to be regulated by 
hemodynamic forces such as cyclic strain. This study also concluded that cyclic 
strain modulates the release of TOP from bovine aortic endothelial cells (BAECs) 
and thus may have a significant influence on TOP‟s extracellular functions 
(Cotter, et al. 2004). Specific, site-directed inhibitors of TOP have been shown to 
potentiate bradykinin-induced vasodilation in rats (Smith, et al. 2000) and to 
decrease myocardial ischemia/reperfusion injury following 3 to 7 days 
reperfusion in rabbits (Schriefer, Broudy and Hassen 2001). 
Although TOP was classified originally as a metabolising enzyme 
involved in the degradation of neuropeptides, a multiplicity of functions have 
since been ascribed to this enzyme. TOP is a true processing peptidase with the 
following properties. Firstly, the degrading/metabolising activity of TOP can 
terminate function by hydrolysing substrate, such that ligand binding to the 
cognate peptide receptor no longer occurs (Montiel, et al. 1997). Secondly, TOP 
can biotransform an inert precursor neuropeptide to an active moiety such as neo-
endorphin to Leu-enkephalin (Acker, Molineaux and Orlowski 1987). Thirdly, as 
a convertase, TOP can convert a bioactive peptide agonist into a different 
bioactive peptide with agonist properties to another receptor. Lastly, TOP 
manifests a modulating activity, creating a peptide product with the opposite 
physiological effect as the original substrate. This is exemplified by the action of 
TOP cleaving Ang I to Ang (1-7), the latter peptide having a vasodilatory action 
unlike the vasoconstrictive action of the former (Chappell, et al. 1994).  
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Figure 1.10: The structure of TOP. Its active site is indicated by the arrow 
(www.rosalindfranklin.edu/DNN/home/CMS/biochem/Faculty/Glucksman/tabid/
1147/Default.aspx). 
 
Interestingly, examination of TOP‟s protein sequence shows neither a 
readily identifiable secretory signal sequence nor a conventional hydrophobic, 
membrane-spanning domain, structural elements normally associated with 
extracellularly-acting peptidases. Its amino acid sequence also lacks the 
appropriate signals for myristoylation or glycosylphosphatidylinositol (GPI)-
anchoring. However, it has been well documented that TOP has extracellular 
functions such as GnRH degradation and BK signalling (Jeske, et al. 2006, Lew, 
et al. 1997) and as such needs to be “released” from cells. This secretion is 
mediated though the so-called „alternative‟ or „non-classical‟ secretory 
mechanism (Nickel 2003). The various stages involved in protein secretion by 
this mechanism remain to be identiﬁed, and multiple pathways for 
unconventional protein secretion may exist (Nickel 2003, Carreno, et al. 2005). 
Other publications suggest that TOP secretion occurs by an unconventional 
pathway, but also utilises components of the conventional rough endoplasmic 
reticulum-Golgi apparatus (ER-Golgi) secretory pathway (Carreno, et al. 2005, 
Ferro, et al. 2004). 
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Russo et al. have demonstrated that TOP interacts with calmodulin (CaM) 
in a calcium-dependent manner to facilitate secretion (Russo, et al. 2009). CaM 
is a small, ubiquitously expressed acidic protein of approximately 148 aa that 
exists in at least two different conﬁgurations: (i) apo-calmodulin, which lacks 
calcium, and (ii) calcium-CaM, which can bind up to four calcium ions and 
undergo post-translational modiﬁcations, such as phosphorylation, acetylation, 
methylation and proteolytic cleavage, that modulate its action  (Jurado, 
Chockalingam and Jarrett 1999). CaM mediates processes such as inﬂammation, 
metabolism, apoptosis, muscle contraction, intracellular movement, short-term 
and long-term memory, nerve growth and immune response (Colomer and 
Means 2008). Calcium-CaM is a positive regulator of exocytosis in 
neuroendocrine cells (Chen, et al. 1999), where it activates the opening of fusion 
pores at the plasma membrane (Bayer, et al. 2003) and the fusion of secretory 
granules (Cooperstein and Watkins 1995). Jeske et al. observed that TOP 
localises to lipid rafts (Jeske, Glucksman and Roberts 2004). Lipid rafts are 
stable yet dynamic structures that exist within the plasma membrane and can 
serve to centralise signal transduction across the membrane. Additionally, lipid 
rafts serve to anchor signalling molecules to the intra- and extracellular face of 
the plasma membrane (Galbiati, Razani and Lisanti 2001). 
As evidenced above, the majority of work published on TOP has been on 
the functions of TOP as a neuropeptide-processing enzyme in the neural, 
endocrine and vascular systems. As neuropeptide substrates are found in the 
extracellular space, the activity of TOP has traditionally also been 
correspondingly localised to the extracellular milieu. Despite the focus on TOP 
activity in the extracellular space, subcellular fractionation experiments indicate 
that the majority (generally >80% (Crack, et al. 1999) of TOP is localised to the 
cytosol, where several recent studies have identified an important role for TOP in 
the immune system. 
TOP is predominantly found in the brain, pituitary and testes, which are 
classically immune-privileged sites. Such immunoprivileged locations maintain 
low levels of major histocompatibility complex (MHC) class I expression 
relative to levels of MHC class I expression in lymphoid tissues, such as the 
spleen, lymph nodes or liver (Lampson 1995, Lidman, Olsson and Piehl 1999). 
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This implies that cytosolic TOP may have an important role in endogenous MHC 
class I regulation in tissues of elevated TOP expression and activity. As such 
TOP may have the potential to serve as a therapeutically significant protein, 
whose expression could be modulated to manipulate surface MHC class I 
expression to clinical advantage. Kim et al. demonstrated that cells over-
expressing TOP are capable of inducing long-term repression of surface MHC 
class I. Conversely, they showed that the use of a TOP siRNA increased long-
term surface expression of MHC class I. Another interesting result from the same 
study showed that the cells can overcome a small increase in TOP expression 
before MHC class I presentation is affected. After this threshold is crossed 
however, any compensatory cellular mechanisms were not able to overcome the 
quantitative decrease in the available pool of cytosolic peptides, and MHC class I 
surface expression falters (Kim, et al. 2003). 
Recognition of antigens in the peptide-binding groove of surface-
expressed MHC class I and class II molecules by specific T-cell receptors is 
central to T-cell activation. To fulfil their physiological function, MHC proteins 
must first acquire peptide antigens. The role of MHC class I molecules is to 
report on intracellular events (such as viral infection, the presence of intracellular 
bacteria or cellular transformation) to CD8
+
 T cells (Jensen 2007). MHC class I 
molecules are composed of heavy chains and an invariant light chain, known as 
β2‑microglobulin. The temporal events in the biosynthesis of MHC class I 
molecules can be summarised in six steps: (i) acquisition of antigens from 
proteins with errors (for example, due to premature termination or mis-
incorporation); (ii) misfolded proteins are tagged with ubiquitin for degradation; 
(iii) the proteasome degrades these ubiquitinated proteins into peptides; (iv) the 
peptides are delivered to the ER by the TAP complex; (v) the peptide is loaded 
onto nascent MHC class I molecules- this process is facilitated by members of 
the peptide-loading complex such as tapasin and two housekeeping ER proteins 
known as calreticulin and ERp57 and; (vi) the peptide-loaded MHC class I 
molecules are transported via the Golgi complex to the cell surface 
(Figure. 1.11). 
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Figure 1.11: Six steps for loading and trafficking of MHC class I molecules to 
the cell surface. (1), Acquisition of antigenic peptides; (2) tagging of the 
antigenic peptide for destruction by ubiquitinylation; (3) proteolysis; (4) delivery 
of peptides to the ER; (5) binding of peptides to MHC class I molecules; and (6) 
display of peptide–MHC class I complexes on the cell surface. (Vyas et al., 
2008). 
 
Some publications have proposed that TOP may act as a chaperone-like 
molecule, binding to specific MHC class I peptides in the cytosol, thereby 
protecting them from degradation by other cytosolic peptidases (Portaro, et al. 
1999). In a contrasting report, TOP was shown to efficiently degrade MHC class 
I peptides in cell extracts (Saric, et al. 2001). Recently Kessler et al. have shown 
that TOP-mediated processing both reduces the presentation of proteasomal 
products by MHC class I and also enlarges the MHC class I peptide repertoire by 
processing protein-degradation fragments that are not yet fit for antigenic 
presentation (Kessler, et al. 2011). 
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1.3.2.2 Neurolysin 
 
Neurolysin (EC3.4.24.16) is a member of the M3 family of zinc 
metallopeptidases, which has 70% sequence homology with TOP (Kato, et al. 
1997). It is found in the central nervous system and the gastrointestinal tract as 
well as the endothelium. Structurally, neurolysin is composed of two domains, 
with its HEXXH-containing active site located on domain 2, at the bottom of 
restricted cleft formed between domain 1 and 2 (Brown, et al. 2001). Neurolysin 
cleaves a number of peptides including BK and neurotensin. Both NEP and TOP 
also inactivate neurotensin, but at different sites to neurolysin (Kitabgi 2006). 
Neurotensin is a 13 aa neuropeptide which is involved in modulation of 
dopaminergic and cholinergic circuits, thermoregulation, intestinal motility and 
blood pressure regulation (Goedert 1984). Dopamine receptors are divided into 
D1 and D2 sub-families, neurotensin causes antagonising dopamine effects at the 
D2 receptor. As such neurotensin may be involved in dopamine-related disorders 
such as Hungtinton‟s and Parkinson‟s disease. For this reason, modulating the 
concentration of neurotensin in the brain is of therapeutic interest and several 
neurotensin analogues have been developed (Boules, Fredrickson and Richelson 
2006). 
Much of neurolysin‟s activity is cytosolic, but it can be secreted or 
associated with the plasma membrane (Vincent, et al. 1996), or mitochondria 
(Kato, et al. 1997). Six splice variants of neurolysin were discovered by Kato et 
al., which are generated from a single gene as a result of alternative sites for the 
initiation of transcription. These six variants of mRNA are divided into two 
categories: (i) those containing an additional sequence that encodes a 
mitochondrial-targeting sequence and; (ii) those that lack the sequence (Kato, et 
al. 1997). 
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1.4 Vascular signalling 
 
1.4.1 Reactive oxygen species 
 
ROS are classically described as harmful by-products in aerobic 
metabolism (and indeed this is the case at pathologically high levels). ROS 
increase leukocyte adhesion molecule expression, stimulate SMC proliferation 
and migration, promote lipid oxidation, up-regulate matrix metalloproteinase 
activity and alter vasomotor activity. Endothelial ROS may also promote 
apoptosis and cellular injury e.g. during ischemia/reperfusion. Oxidative stress is 
also proposed to be involved in the aging process by inducing damage to 
mitochondrial DNA and by other mechanisms (Taniyama and Griendling 2003, 
Finkel and Holbrook 2000). 
 However, at physiologically minute levels, ROS serve as second 
messengers to activate multiple signalling pathways in vascular cells. Low-level 
ROS production can effectively and rapidly modulate the activity of several 
intracellular signalling pathways, affect the release/activity of paracrine factors 
and alter gene expression. Intracellular sources of ROS in endothelial cells 
include xanthine oxidase (XO), nitric oxide synthase (NOS), NADPH-dependent 
oxidase, cyclooxygenase, lipoxygenase and auto-oxidation of tissue metabolites 
(Bayraktutan, Blayney and Shah 2000). ROS produced by endothelial cells 
include superoxide (O2
-
), hydrogen peroxide (H2O2), hydroxyl radical (
•
OH) and 
other radicals (Dröge 2002).  
ROS include a number of chemically reactive molecules derived from 
oxygen (Fridovich 1999) (Figure 1.12). One of the most important reactive 
oxygen species in the vasculature is O2
-
, which is formed by the univalent 
reduction of oxygen. Due to the fact O2
- 
lacks the ability to penetrate lipid 
membranes, it is confined within the compartment in which it is produced 
(Nordberg and Arnér 2001). Accelerated degradation of NO by ROS accounts for 
a large portion of reduced NO bioavailability and endothelial dysfunction. The 
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major ROS responsible for this is O2
-
. NO is degraded very rapidly by O2
-
 to 
form the vasoinactive peroxynitrite, a powerful and damaging oxidant more 
stable than either O2
-
 or NO. In experimental models of vascular disease, 
increased O2
-
 production participates critically in reduced NO bioavailability and 
endothelial dysfunction (Vanhoutte, Perrault and Vilaine 2007). 
 
 
Figure 1.12: Sources of ROS and their effect on endothelial function (Finkel et 
al., 2000).  
 
Under physiological conditions, super oxide dismutase (SOD), a major 
antioxidant, accelerates the removal of O2
-
. SOD produces the more stable ROS, 
H2O2, which is then converted enzymatically into H2O by catalase and 
glutathione peroxidase (Taniyama and Griendling 2003). The cytosolic form of 
SOD permits the release of NO from the endothelium and NO-mediated vascular 
SMC relaxation. Extracellular SOD likely protects NO during its diffusion from 
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the endothelium to vascular SMCs. In patients with coronary artery disease, the 
activity of endothelial SOD diminishes substantially, contributing to coronary 
endothelial dysfunction (Landmesser, et al. 2000). Mitochondrial SOD (Mn-
SOD) has been shown to be essential, as Mn-SOD
-/-
 mice die soon after birth or 
suffer severe neurodegeneration (Melov, et al. 1998). 
Hydroxyl radical (
•
OH), a short-lived ROS, is produced from H2O2 in a 
metal ion catalysed reaction. Due to its strong reactivity with biomolecules, 
•
OH 
is one of the most reactive ROS and has the potential to cause more damage to 
biological systems than any other ROS (Betteridge 2000). 
•
OH cannot be 
eliminated by enzymatic action; however, the antioxidant vitamin E can 
successfully scavenge 
•
OH.  
 
1.4.2 NADPH oxidase 
 
There are at least five different enzyme systems known to contribute to 
the oxidation state of the vascular wall. These include: (i) lysyl oxidase (LOX), 
responsible for the covalent cross linking of collagen and elastin; (ii) xanthine 
oxidase (XO); (iii) monocyte-derived ROS; (iv) uncoupled eNOS and; (v) the 
NADPH family of oxidases, which are the primary contributors of ROS species 
in the vasculature (Cunningham and Gotlieb 2004). 
NADPH oxidases are a major source of O2
- 
in vascular cells (Robin and 
Ajay 2005). Vascular NADPH oxidase has been found to be essential in the 
physiological response of vascular cells, including growth, migration, and 
modification of the extracellular matrix. They have also been linked to 
hypertension and to pathological states associated with uncontrolled growth and 
inflammation, such as atherosclerosis (Griendling, Sorescu and Ushio-Fukai 
2000). Results from this laboratory also indicate a role for NADPH oxidase in 
the regulation of the zinc metallopeptidase, NEP (Fitzpatrick, et al. 2009).  
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The NADPH oxidases of the cardiovascular system are membrane-
associated enzymes that catalyse the one electron reduction of oxygen, using 
NADH or NADPH as the electron donor. 
2O2+ NADPH → 2O2
-
+ NADP
+
 + H
+
 
Upon stimulation by various agents, O2
- 
is produced within minutes to 
hours by both endothelial and smooth muscle cells. This contrasts with the 
release of O2
- 
within seconds after stimulation by NADPH oxidase in neutrophils. 
One of the most important characteristics of the cardiovascular form of the 
oxidase is its response to vasoactive substances (e.g. Ang II, thrombin, platelet-
derived growth factor etc.), flow-derived hemodynamic forces and local 
metabolic changes. NADPH oxidase activation can be mediated by a variety of 
intracellular second messengers (e.g. Ca
2+
, PKC and lipoxygenase metabolites of 
arachidonic acid) (Meier 1996). 
The core of the NADPH oxidase enzyme comprises five components: 
p40
PHOX
,p47
PHOX
, p67
PHOX
, p22
PHOX
 and gp91
PHOX 
(Figure. 1.13). In the resting 
cell, p40
PHOX
, p47
PHOX
 and p67
PHOX 
exist in the cytosol as a complex. p22
PHOX
 
and gp91
PHOX
 are located in the membranes of secretory vesicles and specific 
granules, where they occur as a heterodimeric flavohemoprotein known as 
cytochrome b558, in a molar ratio of 1:1. Separating these two groups of 
components by distributing them between distinct subcellular compartments 
guarantees that the oxidase is inactive in the resting cell (Babior 1999). 
When the resting cell is exposed to any of a wide variety of stimuli, the 
cytosolic component p47
PHOX
 becomes heavily phosphorylated and the entire 
cytosolic complex migrates to the membrane, where it associates with 
cytochrome b558 to assemble the active oxidase. The assembled oxidase is now 
able to transfer electrons from the substrate to oxygen by means of its electron-
carrying prosthetic groups, its flavin and then its heme group(s). Activation 
requires the participation, not only of the core subunits, but of two low-
molecular-weight guanine nucleotide-binding proteins: Rac1 and Rap1A. During 
activation, Rac1 binds GTP and migrates to the membrane along with the core 
cytosolic complex. At the same time, cytochrome b558 and Rap1A are delivered 
to the cell surface by fusion of the secretory vesicle membranes and later the 
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specific granule membranes with the plasma membrane of the cell. This fusion 
event also releases the contents of the organelles to the exterior (Babior 1999).  
The specific roles for the membrane subunits have been established. 
gp91
PHOX
 is a highly glycosylated membrane-spanning protein. Its N-terminal 
contains six transmembrane α-helixes: the third and fifth each contain two 
invariant histidine residues that are positioned to coordinate two hemes, thereby 
placing one heme towards the inner face and one towards the outer face. The C-
terminal half folds into a cytoplasmic domain containing the FAD- and NADPH-
binding sites. Hence gp91
PHOX 
contains the entire transmembrane redox 
machinery, in which electrons are transferred from NADPH on the cytoplasmic 
side via FAD and two non-equivalent hemes to molecular oxygen, the electron 
acceptor, thereby generating superoxide anion (Groemping and Rittinger 2005). 
Although gp91
PHOX
 is the catalytic component of flavocytochrome b558, 
its partner, p22
PHOX
, is essential for optimal activity. p22
PHOX 
is a non-
glycosylated integral membrane protein containing two transmembrane 
segments. Its C-terminal cytoplasmic tail contains a proline-rich region, which 
serves as an anchoring site for p47
PHOX
 (Sumimoto, Miyano and Takeya 2005). 
 The specific roles for each of the cytosolic subunits have also been 
established. After extensive phosphorylation, p47
PHOX
 is responsible for 
transporting the cytosolic complex from the cytosol to the membrane during 
oxidase activation. The effect of p47
PHOX
 is to tighten, by nearly 100-fold, the 
binding between each of the other cytosolic proteins to the assembled oxidase. 
p67
PHOX
 is an essential subunit; inactivation of this subunit will cause inhibition 
of the oxidase. Its activation domain stimulates electron transfer to the flavin of 
cytochrome b588, which is the rate-determining step in superoxide generation. 
Less is known about p40
PHOX
 than the other subunits. However, it is believed that 
during cell activation, p40
PHOX 
facilitates membrane translocation of p67
PHOX 
and 
p47
PHOX
, leading to enhanced superoxide production by the NADPH oxidase. 
The N-terminal of p40
PHOX 
is capable of specifically and strongly binding to 
phosphatidylinositol 3-phosphate, a lipid enriched in the phagosomal membrane, 
and thus considered to play a role in recruiting the protein complex correctly to 
the phagosome (Sumimoto, Miyano and Takeya 2005). It has also been shown 
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that interfering with p40
PHOX
 binding to p67
PHOX
 reduces O2
-
 production by 50%, 
implying p47
PHOX
 is a stimulatory subunit (Tsunawaki, et al. 1996). 
 
 
Figure 1.13: Activation of NADPH oxidase. In the resting cell, the subunits of 
the oxidase are distributed between the cytosol (p40
PHOX
, p47
PHOX
, p67
PHOX
 and 
Rac1) and the membranes (Rap1A and cytochrome b558, a p22
PHOX
, gp91
PHOX
 
complex). When the cell is activated, p47
PHOX
 becomes heavily phosphorylated 
and the cytosolic subunits migrate to the membrane, where they bind to 
cytochrome b558 to assemble the active oxidase (www.genkyotex.com). 
 
1.4.3 Bradykinin 
 
Bradykinin (BK) is a short (9 aa) vasoactive peptide that induces 
vasodilation. BK is produced mainly in plasma through the kinin-kallikrein 
system by the proteolytic cleavage of the plasma precursor kininogen (H-
kininogen). BKs larger homologue, kallidin (KD), is produced predominantly in 
tissues from a low molecular mass variant of kininogen (L-kiningoen). In 
addition, KD can be converted to BK by the enzyme aminopeptidase-N (Sharma 
and Al-Sherif 2011). 
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The principle pharmacological action of BK in the regulation of blood 
pressure is through vasodilation in most areas of the circulation, a reduction of 
total peripheral vascular resistance and a regulation of sodium excretion from the 
kidney (Adetuyibi and Mills 1972). BK contributes to the maintenance of 
cardiovascular homeostasis by opposing the vasoconstrictor activity of Ang II 
(Madeddu, et al. 1998). Reduced local BK generation and blunted NO formation 
have been reported in microvessels of failing human hearts (Kichuk, et al. 1996).  
 BK exerts its action through the activation of two GPCR sub-types, B1 
and B2. The B1 receptor is poorly expressed in normal tissue and is activated by 
metabolic products of BK. B1 expression is up-regulated in pathological states 
associated with inflammation and tissue injury (Marceau, Hess and Bachvarov 
1998). B1 receptors have been observed in sympathetic neurons, macrophages, 
fibroblasts, vascular SMCs and ECs. After stimulation B1 receptors are not 
internalised, and after the up-regulation, receptor activity persists in damaged or 
inflamed tissues. The B1 receptor is linked to chronic pain, vasodilation, plasma 
extravasation, neutrophil accumulation and further release of mediators such as 
IL-6, IL-1β and TNF-α, which sustain a positive feedback loop between B1 
receptor expression and inflammation (Abraham, Scuri and Farmer 2006, 
Mombouli and Vanhoutte 1999). 
The B2 receptor is constitutively expressed in many cell types and tissues 
of the central and peripheral nervous system, the vascular endothelium and 
inflammatory cells. The binding of BK activates the B2 receptor, which is then 
rapidly desensitised and internalised. B2 receptors mediate important 
physiological functions including blood pressure regulation, smooth muscle 
contraction and pain (Leeb-Lundberg, et al. 2005). Bartus et al. have previously 
demonstrated that BK permeabilises the blood brain barrier (BBB) in a dose-
related fashion and that tachyphylaxis occurs with continuous administration of 
BK (Bartus, et al. 1996). Tachyphylaxis describes a decrease in the response to a 
drug due to previous exposure to that drug, and is related to depletion of 
receptors available for ligand binding.  
Termination of BK signalling is controlled by zinc metallopeptidases 
(Rawlings and Barrett 1993, Turner 2003). It has been previously demonstrated 
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that degradation of BK in human plasma is dependent upon its concentration. At 
physiologically relevant levels of BK, ACE is the major source of BK hydrolysis. 
However, at higher concentrations, the major degrading enzyme is 
carboxypeptidase N (CPN), with ACE playing a minor role (Kuoppala, et al. 
2000). CPN cleaves BK at the Phe
8
-Arg
9
 bond, yielding a ligand for B1 receptors 
and as such can be implicated in pathological states associated with inflammation 
and tissue injury. However, ACE can again cleave this ligand at the Phe
5
-Ser
6 
bond to produce an active metabolite (BK 1-5) that has been implicated as a 
selective inhibitor of thrombin-induced platelet activation (Hasan, Amenta and 
Schmaier 1996). TOP and neurolysin cleave full-length BK at the Phe
5
-Ser
6 
bond 
to produce the same metabolite. Jeske et al. have shown that TOP and neurolysin 
are co-localised with the B2 receptor on the exofacial leaflet of plasma 
membranes and in lipid rafts, indicating a potential physiologic role for TOP in 
modulating BK activation and sensitisation of nociceptors (Jeske, Glucksman 
and Roberts 2004). 
The hydrolysis of BK by ECE is exclusively at the Pro
7
-Phe
8
 bond (ACE 
and NEP also cleave BK at this site) whilst NEP can also hydrolyse BK at the 
Gly
4
-Phe
5
 bond (Figure 1.14). NEP has also been shown to degrade KD, at the 
same bond sites as in BK. Hence NEP not only inactivates BK but can also 
inhibit BK production, again highlighting NEP as an important therapeutic target 
in cardiovascular research.   
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Figure 1.14: The amino acid structure of BK. The hydrolysis sites of zinc 
metallopeptidases within BK.  
 
1.4.4 Nitric oxide 
 
In the early 1980s Furchgott and Zawadzhi reported the production of an 
endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadzki 1980), 
which was later identified as the gas NO.  NO has since emerged as a ubiquitous 
signalling messenger molecule involved in diverse pathophysiologic processes 
such as neurotransmission, inflammatory and immune responses, and vascular 
homeostasis (Gong, et al. 2004). NO is a biatomic free radical gas that contains 
an unpaired electron and has a half-life of approximately 5-10 seconds. The best 
known stimulants of NO production include shear stress and cyclic 
circumferential strain. NO levels are also attenuated in response to hormones 
such as estrogens, autacoids such as bradykinin and histamine, and platelet-
derived factors such as serotonin and adenosine diphosphate (ADP), as well as 
products of blood coagulation such as thrombin (Vanhoutte, Perrault and Vilaine 
2007). 
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NO produced in endothelial cells permeates into the underlying SMCs 
and, by preventing calcium entering the SMCs, causes vascular relaxation. NO is 
also released into the bloodstream where, before inactivation by oxyhemoglobin, 
it can remain biologically active in close proximity to the endothelial surface and 
inhibit leukocyte adhesion, augment fibrinolysis and inhibit platelet adhesion and 
activation synergistically with prostaglandin I2 (PGI2) (Gryglewski 1995). 
NO also undergoes a number of reactions, acting either as a weak oxidant 
or as a reducing compound. It is synthesised from the terminal guanidine 
nitrogen atom of the amino acid L-arginine and molecular oxygen, in an enzyme-
catalysed reaction producing NO and the amino acid L-citrulline. The enzyme 
involved in the reaction is nitric oxide synthase (NOS) (Figure 1.15).  
 
 
Figure 1.15: NO synthesis. Mammalian NO synthesis is catalysed by three 
isoforms of NOS that have different tissue distributions: neuronal NOS (nNOS), 
endothelial NOS (eNOS) and inducible NOS (iNOS). L-arginine is the substrate 
for all three isoforms of NOS in the production of NO (Leiper & Nandi, 2011). 
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Three major isoforms of NOS have been identified: NOS 1, NOS 2 and 
NOS 3, each being the product of a distinct gene. NOS 1 or neuronal-type NOS 
(nNOS) is found predominantly in central and peripheral nerves, platelets and in 
pancreatic islet cells. nNOS assists in vasoneuronal coupling and the regulation 
of cerebral blood flow, as well as in modulating the tone of peripheral vessels by 
nitrergic neurons. NOS 2 or inducible NOS (iNOS), is an inducible form of nitric 
oxide synthase, found in macrophages, neutrophils, and to a lesser degree in 
hepatocytes and SMCs. It is induced by bacterial lipopolysaccharides and 
cytokines, so that its levels are high during inflammatory states. iNOS-derived 
NO has been associated with several vascular disease states. iNOS-deficient mice 
have elevated cholesterol levels and an increased incidence of atherosclerotic 
plaques (Ihrig, Dangler and Fox 2001). Also, inhibition of iNOS in 
atherosclerotic plaques is associated with increased expression of matrix 
metalloproteinase-9 that may destabilise the lesion (Knipp, et al. 2004). NOS 3 
or endothelium-type NOS (eNOS) is found predominantly in ECs and is also 
expressed to a lower extent in cardiac myocytes, renal mesangial cells, 
osteoblasts and osteoclasts. Through NO production, eNOS sustains the anti-
coagulant, anti-adhesive, and anti-proliferative properties of vascular 
endothelium. A mitochondrial NOS has also been discovered (mtNOS), a 
calcium-dependent enzyme that appears to play a regulatory role in respiration, 
matrix pH and transmembrane potential in mitochondria (Napoli, et al. 2006). 
In endothelial cells, eNOS is located close to the inner surface of the 
apical cell membrane and localises mainly in caveolae, small cholesterol-rich 
invaginations of the plasma membrane that contain the transmembrane protein 
caveolin and a number of signalling molecules such as GPCRs and protein 
kinases. The targeting of eNOS to caveolae depends on dual acylations of the 
protein by myristoylation and palmitoylation. Myristoylation of eNOS occurs at 
its N-terminus and is essential in transporting the protein to the caveolae, and its 
subsequent anchorage. Palmitoylation of eNOS is a reversible post-translational 
event that occurs at two cysteine residues near the N-terminus (Yeh, et al. 1999). 
eNOS binds caveolin or CaM in a mutually exclusive manner. In the resting 
condition, the caveolin binding suppresses eNOS activity. During activation, 
increased cytosolic calcium promotes a reversible dissociation of eNOS from 
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caveolin and induces CaM binding, which augments eNOS activity. Although 
eNOS depends primarily on calcium and CaM, evidence has shown a shear 
stress-dependent activation of eNOS (Vanhoutte, Perrault and Vilaine 2007). 
The principal biological effect of NO within the endothelium is as a 
vasodilator, and as a result, NO is generally viewed as atheroprotective as it 
regulates the flow of blood to tissues. The effect of NO in the control of vascular 
tone is attenuated by the presence of ROS, in particular O2
-
, H2O2 and 
•
OH. O2
- 
is 
produced by phagocytes and other inflammatory cells in large quantities. It has 
also been shown that endothelial cells release O2
-
 generated by enzymes 
including NADPH oxidase, xanthine oxidase and also NOS itself (NOS 
generates O2
-
 in preference to NO in situations where either L-arginine or 
tetrahydrobiopterin (BH4) are deficient or if low-density lipoprotein is present). 
O2
-
 is converted to H2O2 in a reaction catalysed by the enzyme SOD. Moreover 
O2
- 
reacts spontaneously and rapidly with NO, leading to the production of 
peroxynitrite (ONOO
-
), a particularly powerful oxidant and cytotoxic agent 
(Jourd'heuil, et al. 2001). 
The ability of laminar flow to up-regulate NOS expression has been 
widely studied.  Indeed, NOS is so positively up-regulated by flow that nine 
repeats of the –GAGACC- SSRE have been identified in the 5‟ promoter region 
of the gene encoding eNOS (Loscalzo and Welch 1995). Production of eNOS as 
a result of shear is biphasic. Initially, there is a Ca
2+
/CaM dependent disruption 
of eNOS interaction with caveolin-1, resulting in the production of NO. Then 
there is a more Ca
2+
-independent, slow production of NO in response to 
sustained steady laminar flow (Cunningham and Gotlieb 2004).  
Microparticles, membranous vesicles released from activated T 
lymphocytes with pro-coagulant and pro-inflammatory properties, induce 
endothelial dysfunction by decreasing eNOS expression and over-expressing 
cavelolin-1 in ECs activated during artherogenesis (Martin, et al. 2004). This 
observation shows that once the atheroprotective role of the endothelium, in part 
through its eNOS activity, has been compromised, a vicious cycle of vascular 
wall injury and remodelling, inducing plaque formation and subsequent 
disruption in blood flow, can facilitate atheroma progression and potentially 
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impart vulnerability onto atherosclerotic lesions. However, studies have shown 
that antioxidants may re-establish NO-dependent endothelial function (Keaney, 
et al. 1993, Keaney Jr, et al. 1995). 
 
1.5 Study hypothesis  
   
Blood flow-associated laminar shear stress (LSS) generally imparts an 
atheroprotective stimulus on vascular endothelial cells, which is essential to 
vessel wall health and remodelling. As such, flow dysregulation can lead to 
endothelial dysfunction and vascular diseases such as atherosclerosis, coronary 
artery disease, stroke, heart failure, and hypertension. The starting points for 
many of these diseases usually arise at sites of disturbed shear, such as at 
bifurcations and curvatures in large vessels.  
TOP and NEP are essential to endothelial function and remodelling 
events and frequently manifest opposing effects in the vascular wall. Using 
vascular EC models, it has previously been shown in our laboratory that NEP 
expression is attenuated by laminar shear stress in a ROS-dependent manner 
(Fitzpatrick, et al. 2009) whilst TOP is up-regulated by physiologically relevant 
levels of cyclic strain (Cotter, et al. 2004). cDNA analysis has revealed the 
presence of a single copy SSRE in the promoter region of both enzymes, 
suggesting regulation by hemodynamic forces. It is therefore hypothesized that: 
 
(i) Both NEP and TOP expression in vascular ECs are regulated by shear 
stress in a divergent manner. 
(ii) Shear-dependent regulation of NEP and TOP expression is ROS-
dependent (and specifically, on NADPH oxidase-generated 
superoxide). 
(iii) The shear-induced changes in NEP/TOP expression have functional 
consequences on the endothelium.  
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1.6 Thesis Overview  
 
The data presented in the following chapters examines the regulatory 
effect of laminar shear stress on zinc metallopeptidases, specifically TOP and 
NEP in cultured BAECs and HAECs.  It also examines the role played by ROS 
produced by NADPH oxidase, with special emphasis on O2
-
, in the differential 
regulation of these peptides. Over-expression plasmids and siRNAs were used 
also to examine the functional consequences of the dysregulation of NEP and 
TOP. The research findings of this thesis are presented in the following chapters. 
 
Chapter 3: Preliminary characterisation studies and investigation of shear-
mediated regulation of neprilysin (NEP) expression. 
 
Chapter 4: Investigation of the effects of shear stress on thimet oligopeptidase 
(TOP) expression. 
 
Chapter 5: Functional consequence(s) of the shear-mediated regulation of NEP 
and TOP in vascular endothelial cells.  
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Chapter 2: 
 
Materials and Methods 
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2.1 Materials 
 
Abcam (MA, USA) 
Mouse anti-TOP monoclonal IgG antibody, rabbit anti-vWF polyclonal IgG 
antibody. 
 
Aktiengeselischaft and Company (Numbrecht, Germany) 
T25 tissue culture flasks, T75 tissue culture flasks, T175 tissue culture flasks, 6-
well tissue culture plates, 2 ml, 5 ml, 10 ml and 25 ml serological pipettes, 15 ml 
falcons, 50 ml flat-bottom falcons, cryovials, cell scrapers. 
 
Amaxa Biosystems (Köln, Germany) 
Basic nucleofector kit for primary mammalian endothelial cells, Primocin. 
 
Applied Biosystems (CA, USA) 
Fast optical 96-well reaction plates (with adhesive covers), high capacity cDNA 
reverse transcription kit, TOP siRNA (s14110), p47 siRNA (8087).  
 
Barloworld-Scientific (London, UK) 
White flat-bottomed 96-well plates. 
 
BioLegend (CA, USA) 
Mouse anti-MHC class I IgG antibody. 
 
BioRad (CA, USA) 
Coomassie stain, Precision Plus protein marker, thick mini trans-blot filter paper.  
 
Calbiochem (San Diego, CA) 
Apocynin, NSC23766 (Rac1 Inhibitor). 
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Carl Stuart Ltd. (Dublin, Ireland) 
Agilent RNA 6000 NANO kit. 
 
Cayman Chemical Company (MI ,USA) 
Mouse anti-eNOS polyclonal IgG antibody. 
 
Corriell Cell Repository (NJ, USA) 
Bovine Aortic Endothelial Cells (BAECs). 
 
Enzo Life Sciences (NY, USA) 
Bradykinin ELISA kit. 
 
Eurofins MWG Operon (Ebersberg, Germany) 
Primer sets: NEP, GAPDH (human and bovine), TOP, p47, eNOS. 
 
Fermentas (York, UK) 
Green Taq, DNA ladder 100 bp and 1 Kb, dNTPs, 10X Buffer, MgCl2. 
 
GE-Healthcare (Bucks, UK) 
Hyperfilm, ECL Secondary Ab (donkey anti-rabbit). 
 
ibidi (Martinsried, Germany) 
Mounting medium, µ-slide I, µ-slide y-shaped. 
 
Invitrogen (Groningen, The Netherlands) 
Alexa Fluor
®
 488 F(ab‟)2 fragment of rabbit anti-goat IgG (H+L), CFSE kit, 
DH5α E-coli competent cells, Ultra Pure water, SyberSafe®, Trizol.  
 
Labtech (East Sussex, UK) 
ADAM
TM
 Counter kit, Microporation kit, Microporator tubes, solution E buffer, 
solution R buffer, 10 and 100 µl gold tips. 
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Medical Supply Company (Dublin, Ireland) 
0.2 and 0.5 ml PCR tubes. 
 
Millipore (MA, USA) 
Millicell hanging cell culture transwell inserts (6-well format, 0.4 µm pore size, 
24 mm filter diameter). 
 
Mirus (WI, USA) 
TransIT
®
-2020 Reagent, TransIT-siQUEST
® 
Reagent.  
 
PALL Corporation (Dun Laoghaire, Ireland) 
Acrodisc 32 mm syringe filter with 0.2 µm super membrane, nitrocellulose 
membrane. 
 
Pierce Chemicals (Cheshire, UK) 
BCA protein assay kit, Supersignal West Pico chemilumescent substrate. 
 
Promega (WI, USA) 
Dual-Glo Luciferase assay. 
 
PromoCell (Heidelberg, Germany) 
Endothelial cell growth medium MV, Human Aortic Endothelial Cells (HAECs).  
 
Qiagen (West Sussex, UK) 
HiSpeed Midi-prep kit.  
 
R&D Systems (MN, USA) 
Goat anti-neprilysin polyclonal IgG antibody. 
 
Roche Diagnostics (Basal, Switzerland) 
E plate, FastStart universal SYBR green (ROX), protease and phosphatase 
inhibitor cocktail. 
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Sigma-Aldrich (Dorset, UK)   
2,3-diaminonaphthalene, autoradiography developing and fixer solutions, 
acetone, agarose, ammonium persulfate, ampicillin sodium salt, bradykinin, 
bromophenol blue, DAPI, DMSO, DNAse kit, EDTA, fetal bovine serum, FITC-
dextran (40 kDa), glucose, glycerol, HEPES, LB agar, LB broth, magnesium 
sulphate, monopotassium phosphate, PBS tablets, penicillin-streptomycin 
(100X), Ponceau S solution, phosphoramidon, RPMI-1640 medium, sodium 
bicarbonate, sodium chloride, sodium deoxicholate, sodium dodecyl sulphate, 
sodium fluoride, sodium phosphate, sucrose, TEMED, trypsin-EDTA solution 
(10X), Triton
®
 X-100, trizma base, tryptone, Tween
®
20. 
 
Terumo (NJ, USA) 
10 ml syringe without needle. 
 
Thermo Fisher Scientific (Leicestershire, UK) 
BCA reagent kit, BSA, buffer solution pH4 (phthalate), buffer solution pH7 
(phosphate), buffer solution pH10 (borate), glycine, isopropanol, trizmabase, 
weigh boats, RNase Away. 
 
Tocris (MO, USA) 
HOE140 (BK antagonist). 
 
VWR International Ltd. (West Sussex, UK) 
Methanol. 
 
Whatman International Ltd. (Maidstone, England)  
Whatman chromatography paper. 
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2.2 Cell culture methods 
 
 All cell culturing techniques were carried out in a clean and sterile 
environment using a Holten Lamin Air laminar flow cabinet.  Cells were 
visualised using a Nikon Eclipse TS100 phase-contrast microscope. 
 
2.2.1 Endothelial cells 
 
2.2.1.1 Culture of bovine aortic endothelial cells (BAECs) 
 
Differentiated BAECs were obtained from Coriell Cell Repository (New 
Jersey, USA). The cells were derived from a 1 yr old male Hereford cow post-
mortem. Cells were maintained in RPMI-1640 medium supplemented with 10% 
(v/v) fetal bovine serum (FBS), 100 U/ml penicillin and 100 g/ml streptomycin.  
Cells were cultured in T175 cm
2
, T75 cm
2
, T25 cm
2
 and 6-well plates.  Cells 
between passages 5-14 were used for experimental purposes, and were 
maintained in a humidified atmosphere of 5% CO2/95% air at 37°C. 
 
2.2.1.2 Culture of human aortic endothelial cells (HAECs) 
 
Differentiated HAECs were obtained from PromoCell GmbH 
(Heidelberg, Germany). The cells were derived from the thoracic aorta of a 21 yr 
old human male post-mortem. Cells were maintained in Endothelial cell growth 
medium MV supplemented with a separate SupplementMix
®
 of growth factors 
containing ECGS/H 0.4% (v/v), FBS 5.0% (v/v), EGF 10 ng/ml and 
hydrocortisone 1 μg/ml. 100 U/ml penicillin and 100 g/ml streptomycin were 
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also added. Cells between passages 5-11 were used for experimental purposes 
and were maintained in a humidified atmosphere of 5% CO2/95% air at 37°C. 
 
2.2.2 Trypsinisation of cells 
 
As all cell lines used were adherent, trypsinisation was required for the 
purposes of sub-culturing. Briefly, growth medium was removed from flasks and 
cells washed 2-3 times in sterile PBS to remove -macroglobulin, a trypsin 
inhibitor present in FBS. An appropriate volume of trypsin-EDTA (10% (v/v) in 
PBS) was subsequently added to the cells and incubated at 37°C for 3 min (or 
until the cells began to detach from the flask surface). Growth medium 
containing FBS was added to prevent further trypsinisation and cells were 
collected from suspension by centrifugation at 100 x g for 5 min at room 
temperature. Cells were resuspended in growth medium (or freeze medium) and 
counted using either a Neubauer chamber haemocytometer or ADAM
TM
 Counter. 
Cells were routinely split at a 1:5 ratio for BAECs or a 1:3 ratio for HAECs 
either for further sub-culturing or to be cryopreserved. 
 
2.2.3 Cryogenic preservation and recovery of cells 
 
For long term storage, cells were maintained in a liquid nitrogen cryo-
freezer unit (Taylor-Wharton, USA). Following trypsinisation, cells to be stored 
were centrifuged at 100 x g for 5 min at room temperature and the resultant pellet 
was resuspended in the appropriate medium for the cell line, containing 20% 
(v/v) FBS, dimethylsulphoxide (DMSO) 10% (v/v) and 1% (v/v) 
penicillin/streptomycin.  1 ml aliquots were transferred to sterile cryovials and 
frozen in a –80°C freezer at a rate of –1°C/minute using a Mr Freeze® cryo-
freezing container. Following overnight freezing at –80°C, the cryovials were 
transferred to the cryo-freezer unit. 
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For recovery of cells, cryovials were thawed rapidly in a 37°C 
water bath and added to a cell culture dish containing pre-warmed 
(37°C) growth medium to dilute the DMSO. After 24 hrs the medium was 
removed, the cells were washed in PBS and fresh growth medium added.  
 
2.2.4 Cell counting 
 
2.2.4.1 Haemocytometer 
 
To aid in reproducibility of experiments, cells were seeded at precise 
numbers and densities. This was done using a Neubauer chamber 
haemocytometer following trypan blue staining for cell viability. 20 l of trypan 
blue was added to 100 l of cell suspension and the mixture left to incubate for 2 
min. 20 l of this mixture was loaded into the counting chamber of the 
haemocytometer and cells visualized by light microscopy (Figure 2.1).  Viable 
cells excluded the dye, whilst dead cells stained blue due to compromise of the 
cell membrane.  Cells that touch the top and right lines of a square were not 
counted, while cells on the bottom and left side were counted. The number of 
cells was calculated using the following equation:  
 
Average Cell No. x Dilution Factor x 1x10
4
 (area under cover slip mm
3
) = Viable 
cells/ml 
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Figure 2.1: The haemocytometer, indicating the counting grid.  
 
2.2.4.2 ADAM
TM
 Counter  
 
Cell counts were also made using an Advanced Detection and Accurate 
Measurement (ADAM
TM
) cell counter (Digital Bio, Korea) which utilises 
fluorescent cell staining to determine total and viable cell count in a given 
sample. Cells are mixed with two solutions; Solution N, containing propidium 
iodide (PI), a fluorescent dye that will intercalate with DNA, but which cannot 
enter cells with intact membranes. Therefore, only non-viable cells will fluoresce 
with PI alone. The second, Solution T, contains PI and a detergent that will 
disrupt viable cell membranes allowing PI to stain both viable and non-viable 
cells. ADAM
TM
 contains both laser optics and image analysis software that 
allows parallel determination of both total and viable cell numbers in a sample 
from these two staining methods. 
Two 12 µl aliquots of a cell sample were taken; one aliquot 
was mixed with 12 µl of Solution N accustain and the second with 12 
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µl Solution T accustain. 20 µl of each cell mixture was then loaded 
into the appropriate labelled chamber in an AccuChip. The AccuChip 
was then loaded into the ADAM
TM
 counter where 40-60 images were taken of 
the cell chambers and average cell number and viability calculated using the 
integrated image analysis software (Figure 2.2).  
 
(A)         (B) 
 
Figure 2.2: (A) The ADAM
TM
 counter and (B) loading of an AccuChip and 
reading.  
 
2.2.5 Shear stress experiments  
 
2.2.5.1 Orbital rotation  
 
For laminar shear stress studies, orbital rotation was applied as in 
previous publications (Colgan, et al. 2007, Fitzpatrick, et al. 2009), BAECs and 
HAECs were seeded onto cell culture grade 6-well plates and allowed to adhere 
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for 24 hrs, then grown to 90% confluency. Culture medium was then removed, 
replenished with 4 ml of fresh medium and cells were exposed to laminar shear 
stress (0-10 dynes/cm
2
, 0-24 hrs) using an orbital rotator (Stuart Scientific Mini 
Orbital Shaker, Staffordshire, UK) set to the appropriate speed as determined by 
the following equation (Hendrickson, et al. 1999) (Figure 2.3). 
 
 
 
Where    = radius of rotation in cm 
   = density of liquid in g/l 
  n = liquid viscosity 7.5 x 10
-3
 dynes/cm
2
 @ 37°C 
 f = rotation per second 
 
Control plates containing un-sheared “static” endothelial cells were 
cultured in the same incubator but on a different shelf to avoid vibrations caused 
by the orbital rotator.  Studies were carried out for differing periods of time (0-48 
hrs, 0–10 dynes/cm2).  Following shearing experiments, the cells were either: (i) 
harvested for Real-Time PCR measurement of mRNA expression levels; (ii) 
harvested for Western blotting to determine protein expression levels; (iii) fixed 
in situ for immunocytochemical staining; (iv) transplanted into Millicell hanging 
cell culture inserts for transendothelial permeability assays; (v) used in 
proliferation experiments; or (vi) BK experiments.  
67 
 
 
Figure 2.3: Orbital rotation model used in laminar shear stress studies. 
 
2.2.5.2 Disturbed shear  
 
For disturbed shear stress studies, BAECs and HAECs were seeded onto 
cell culture grade 6-well plates and allowed to adhere for 24 hrs, then grown to 
90% confluency. Culture medium was then removed, replenished with 4 ml of 
fresh medium and cells were exposed to disturbed oscillatory shear stress (0-24 
hrs) using a see-saw rocker (Stuart Scientific Rocker SSL4, Staffordshire, UK) 
set to 70 rpm (Figure 2.4). 
Control plates containing un-sheared “static” endothelial cells were 
cultured in the same incubator but on a different shelf to avoid vibrations caused 
by the rocker. Following shearing experiments, the cells were either: (i) 
harvested for real-time PCR measurement of mRNA expression levels; (ii) 
transplanted into Millicell hanging cell culture inserts for transendothelial 
permeability assays; or (iii) fixed in situ for immunocytochemical staining.   
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Figure 2.4: Disturbed shear model used in shear stress studies. 
 
2.2.5.3 ibidi
®
 (Integrated BioDiagnostics) flow system  
 
The ibidi
®
 pump system is a novel perfused flow system for exposing 
ECs to shear stress on ibidi
®
 μ-slides (Figure 2.5). Prior to cell seeding, slides, 
tubing and medium were equilibrated overnight at 37°C in a tissue culture 
incubator. The following day, HAECs were seeded onto slides at a density of 
1x10
6
 cells/ml and allowed to adhere. HAECs were allowed to grow to 
confluency at which point the μ-slides were connected to the pump system via its 
luer connectors in accordance with the manufacturer‟s instructions and previous 
publications (Walsh, et al. 2011), taking care not to introduce air bubbles. The 
cells were then exposed to either laminar or oscillatory shear stress at varying 
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doses. Following shear experiments, cells were fixed in situ for 
immunocytochemical staining and phase-contrast imaging.   
 
  
 
 
Figure 2.5: ibidi
®
 μ-slide flow system. (A, B) Flow systems with custom CO2 
incubator in situ. (C) Schematic illustrating air and medium flow paths. Air pump 
operates on a 10 second reciprocation cycle to ensure steady forward flow of 
medium (Walsh, et al. 2011).  
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2.2.6 Transendothelial permeability assay 
 
For analysis of permeability, following shear experiments, BAECs and 
HAECs were trypsinised and re-plated at high density (1x10
5
 cells/well) into 
Millicell hanging cell culture inserts (6-well format, 0.4 μm pore size, 24 mm 
filter diameter). When cells had re-adhered to the surface of the membrane (24 
hrs), transendothelial permeability was monitored as previously described 
(Collins, et al. 2005). In brief, fresh culture medium was added to the upper 
(abluminal) and lower (subluminal) chambers of the Millicell insert within the 6-
well dish (2 ml: upper, 4 ml: lower). At time t=0, FITC-labelled dextran (40 kDa) 
was added to the abluminal chamber (giving a final concentration of 250 μg/ml) 
and transwell diffusion allowed to proceed (Figure 2.6). Medium samples (28 μl) 
were collected every 30 min from the subluminal compartment (for up to 3 hrs), 
diluted to a final volume of 400 μl with appropriate complete medium, and 
monitored for FITC-dextran fluorescence (as 3x100 μl replicates in a 96-well 
fluorescence microplate). Using a TECAN Safire 2 fluorospectrometer (Tecan 
Group, Switzerland), excitation and emission wavelengths of 490 and 520 nm, 
respectively, were selected. % transendothelial exchange (%TE) of FITC-dextran 
40 kDa is expressed as the total subluminal fluorescence at a given time point 
(from 0-180 min) expressed as a percentage of total abluminal fluorescence at 
t=0 min. 
 
2.2.7 Treatment with anti-oxidants and pharmacological 
inhibitors 
 
Prior to treatment with anti-oxidants or pharmacological inhibitors, 
BAECs were grown until approximately 80% confluent, after which the growth 
medium was removed and cells washed in PBS. Inhibitors and anti-oxidants were 
reconstituted in a suitable diluent. Working concentrations were then made up in 
RPMI-1640 medium with FBS and antibiotics. For DMSO-soluble compounds, a 
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suitable stock concentration was prepared so that the final concentration of 
DMSO in working solutions was less than 0.5%.   
 
 
Figure 2.6: Transendothelial permeability assay. (A) Shows FITC-labelled 
dextran in the upper compartment (abluminal chamber) at t=0, which diffuses 
through the BAEC/HAEC monolayer and semi-permeable membrane, into the 
lower compartment (subluminal chamber) (B), from which samples (28 μl) are 
collected every 30 min over 3 hrs. 
 
For anti-oxidant studies, working solutions were made up fresh and 
adjusted for pH immediately prior to incubation. N-Acetyl-L-cysteine (NAC), a 
broad spectrum anti-oxidant, was applied at a concentration of 5 mM.  Anti-
oxidants were applied to the cells for 1 hrs immediately prior to, or 4 hrs after, 
the commencement of shearing. 
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Studies to explore shear-dependent signal transduction pathways 
employed the following pharmacological inhibitors: apocynin (10 mM, NADPH 
oxidase), and NSC23766 (50 µM, Rac1).  These studies mirrored those of the 
anti-oxidants, in that inhibitors were prepared in complete culture medium and 
applied to the cells for 1 hrs immediately prior to, or 4 hrs after, the 
commencement of shearing. Concentrations used were gained from both current 
literature and manufacturer‟s recommendations. 
 
2.3 mRNA preparation and analysis 
 
2.3.1 RNase-free environment 
 
As RNA is easily degraded by ubiquitous RNases, standard procedures 
were employed to avoid this potential hazard (Sambrook, Fritsch and Maniatis 
1989). Prior to working with RNA, any apparatus or surfaces to be used were 
treated with RNase AWAY spray (Thermo Fisher, Leicestershire, UK) to remove 
RNases. As hands are a major source of RNase contamination, gloves were used 
at all times and changed frequently. 
 
2.3.2 RNA preperation 
 
 Trizol
®
 is a ready-to-use reagent for the isolation of total RNA, DNA 
and/or protein from cells and tissues. RNA isolation was developed by 
Chomczynski and Sacchi (Chomczynski and Sacchi 1987). Trizol
®
 reagent 
maintains the integrity of the RNA while disrupting the cells and dissolving the 
cell components. 
Following shear experiments, cells were lysed directly in culture plates 
by the addition of 1 ml of Trizol
®
 per 10 cm
2
. A volume less than this can result 
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in contamination of the RNA with DNA. To ensure complete homogenization, 
cells were lysed by scraping the plate with a cell scraper. The samples were then 
incubated for 5 min at room temperature to allow complete dissociation of 
nucleoprotein complexes. 0.2 ml of chloroform was added per 1 ml of Trizol
®
 
reagent used, then mixed vigorously for 15 sec before being incubated for 10 min 
at room temperature. Samples were then centrifuged at 7,000 x g for 15 min at 
4°C. The mixture separated into a lower red phenol-chloroform phase, an 
interphase and an upper colourless aqueous phase. RNA remains exclusively in 
the upper aqueous phase. 
The aqueous phase was carefully removed and transferred to a fresh, 
sterile tube. The RNA was then precipitated out of solution by the addition of 0.5 
ml of isopropanol per 1 ml of Trizol
®
 used. Samples were inverted 5-8 times and 
incubated for 10 min at room temperature and then centrifuged at 7,000 x g for 
10 min at 4°C. The RNA precipitate forms a gel-like pellet on the side of the 
tube.  The supernatant was removed and the pellet washed in 1 ml of 75% 
ethanol per ml of Trizol
®
 used followed by centrifugation at 7,000 x g for 5 min 
at 4°C. The resultant pellet was air-dried for 5-10 min before being re-suspended 
in DEPC-treated water. This was then incubated for 10 min at 60°C, to 
homogenize the sample prior to quantification. The concentration of total RNA 
was determined using a NanoDrop
®
, as outlined below. The sample was then 
stored at –80°C until used.   
 
2.3.3 The NanoDrop
®
 ND-1000 Spectrophotometer 
 
The NanoDrop
®
 ND-1000 Spectrophotometer was used to determine 
nucleic acid sample concentrations. An undiluted 1.2 μl sample was pipetted onto 
the end of a fibre optic cable (the receiving fibre). A second fibre optic cable (the 
source fibre) was then brought into contact with the liquid sample causing the 
liquid to bridge the gap between the fibre optic ends. (The gap is controlled to 
both 1 mm and 0.2 mm paths by the computer). A pulsed xenon flash lamp 
provided the light source and a spectrometer was used to analyse the light after 
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passing through the sample. The instrument was controlled by special software 
run from a PC, and the data were logged in an archive file on the PC. 
The NanoDrop
® 
automatically calculates the purity of the nucleic acid 
samples by reading the absorbance at 260 nm and the absorbance at 280 nm and 
then determining the ratio between the two (ABS260/ABS280) (Figure 2.7).  Pure 
DNA which has no protein impurities has a ratio of 1.8 whereas pure RNA has a 
ratio of 2.0.  Lower ratios indicate the presence of proteins, higher ratios imply 
the presence of organic reagents. Purification of RNA samples was achieved 
using a DNase treatment kit (Sigma-Aldrich, Dorset, UK) as described below. 
 
2.3.4 DNase treatment of mRNA 
 
The RNA sample for analysis was digested with 1 μl RNase-free DNase I 
along with 1 μl 10X DNase Buffer and incubated for 15 min at 37°C. 1 μl DNase 
stop solution was added to the reaction mixture and was incubated for a further 
10 min at 70°C to denature the DNase enzyme. The RNA could then be 
synthesised to cDNA. 
 
2.3.5 Reverse transcription 
 
In this process, mRNA was transcribed into cDNA by the enzyme reverse 
transcriptase. A high capacity cDNA reverse transcription kit (Applied 
Biosystems, CA, USA) was used as described below.  
 20 µl reactions were made up as follows; 
 
RT Buffer (10X)       2 µl 
dNTP mix (100 mM)                0.8 µl 
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Random Primers (10X)       2 µl 
MultiScribe Reverse Transcriptase      1 µl 
Nuclease-free H2O    4.2 µl  
 
A 
 
B      C 
 
Figure. 2.7: Figure shows (A) the NanoDrop
®
 machine and typical graph 
readouts for (B) RNA and (C) DNA.  
 
This was added to a 0.2 ml PCR tube containing 1000 ng RNA diluted in 
nuclease-free water to 10 µl. Samples were spun down briefly in a centrifuge and 
then placed into a desktop PCR machine and run at 25°C for 10 min, 37°C for 
120 min and finally 85°C for 5 min. cDNA products were then quantified on a 
NanoDrop
® 
(Section 2.2.8.3) to check concentration and purity of samples.  
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2.3.6 Polymerase chain reaction (PCR)  
 
Desktop PCR was used to optimize primer sets and to rule out primer 
dimerisation before their use in quantitative Real-Time PCR (qPCR). 25 l PCR 
reaction mixtures were prepared as follows: 
 
Forward primer (10 M)          1 l 
Reverse primer (10 M)          1 l 
cDNA sample            1 µl 
Reaction buffer (10X)                   2.5 l 
dNTP (10 mM)           2 l 
MgCl2 (25 mM)        1.5 l 
Taq Polymerase      0.25 l 
RNase free water    15.75 l 
 
The solution was then placed into an MJ Mini thermal cycler with hot-lid (Bio-
Rad, CA, USA). Samples were then subjected to the following cycling 
conditions:  
 
Denature   95°C  5 min 
 
Cycling Denature 95°C  15 sec 
Annealing 55-60°C 30 sec       40 cycles 
   Extension 72°C  15 sec 
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   Extension 72°C  5 min 
                   Hold  4°C  Forever 
 
Annealing temperatures varied as they were specific to primer sets (Table 2.1).  
 
Target Gene Primer Sequence   Product    Annealing 
                  size       Temp °C 
NEP For  5` caa agc caa aga aga aac ag 3` 290 bp  55 
NEP Rev  5` cat ctc tta aaa tgt caa a 3`   
TOP For  5` tga agg tca ccc tca agt a 3`  401 bp  56 
TOP Rev  5` tcc acc tgg ttc atg tag ta 3`   
Bovine GAPDH For 5‟ agg tca tcc atg acc act tt 3`  337 bp  55 
Bovine GAPDH Rev 5‟ ttg aag tcg cag gag aca a 3`   
Human GAPDH For 5‟ gag tca acg gat ttg gtc gt 3` 238 bp  56 
Human GAPDH Rev 5‟ ttg att ttg gag gga tct cg 3`   
eNOS For                    5‟ gct tga gac cct cag tca gg 3`  300 bp  59 
eNOS Rev  5‟ ggt ctc cag tct tga gct gg 3‟ 
p47 For  5‟ acc cag cca gca cta tgt gt 3‟ 288 bp  58 
p47 Rev  5‟ agt agc ctg tga cgt cgt ct 3` 
 
Table 2.1: Table shows primer sequences, product size and annealing 
temperature used for PCR and qPCR. All primer sets, with the exception of 
bovine GAPDH, were produced from human sequences, with consensus overlap 
with bovine sequences.  
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2.3.7 Quantitative real-time polymerase chain reaction 
 
After optimisation of primers by RT-PCR, they were used in qPCR. This 
technique follows the general principle of RT-PCR with amplified DNA 
quantified in real-time as it accumulates in the reaction. This quantification was 
facilitated using SYBR green, a dye that fluoresces only when bound to the 
minor groove of double stranded DNA. This fluorescence is then read by a laser 
at the end of every cycle and the amount of cDNA product formed during the 
PCR cycles can be quantified in real time and graphed. To normalise the optical 
system involved in real-time analysis, ROX, a passive dye, is incorporated into 
the SYBR mastermix. This is achieved by the signal of the reporter dye (SYBR) 
being measured against the passive reference dye (ROX) signal to normalise for 
non-PCR-related fluorescence fluctuations occurring from well to well. The 
threshold cycle represents the refraction cycle number at which a positive 
amplification reaction was measured and was set at 10 times the standard 
deviation of the mean baseline emission calculated for PCR cycles 3 to 15. The 
results were analysed according to the Comparative CT method (ΔΔCT) as 
described by (Livak and Schmittgen 2001). 
qPCR was carried out using an Applied Biosystems 7900HT Fast real-
time PCR machine. Each reaction was set up in triplicate as follows: 
 
Forward primer (10 M)    1.0 l 
Reverse primer (10 M)    1.0 l 
cDNA        2.0 l 
SYBR Green     11.5 l 
 RNase free water     9.5 l 
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Samples were then subjected to an initial denaturation step of 95°C for 10 
min followed by 40 cycles of 95°C for 15 sec and a primer-specific temperature 
of between 55-60°C for 1 min. Data were collected during the annealing step. 
Quantification of cDNA target was normalised for differences across 
experiments/samples using an endogenous housekeeper control, GAPDH, as an 
active reference gene. 
Routinely, melt curve analysis was carried out to ensure single product 
formation and to rule out possible contamination of product by non-specific 
binding and primer dimerisation. Samples from both RT-PCR and qPCR 
reactions were then visualized on 1% agarose gels as described below. 
 
2.3.8 Agarose gel electrophoresis 
 
Agarose gels were prepared by boiling 1 g of agarose in 100 ml of 1X 
TAE buffer (40 mM Tris-Acetate pH 8.2, 1 mM EDTA) to make a 1% gel. After 
sufficient cooling (~60°C) 10 l SYBR Safe (Invitrogen, The Netherlands) was 
added to the gel, mixed by swirling and then poured into a casting rig. A comb 
was inserted for formation of wells.  The gel was allowed to cool and polymerise 
before filling the chamber with 1X TAE and removing the comb.  
As the 10X buffer in the RT-PCR reaction already contained a loading 
and tracking dye 15 l of RT-PCR product was loaded directly to the gel. A 1 
KB or 100 bp DNA ladder was also added to one well as a molecular weight 
marker for reference. The gel was run at constant voltage (5 V/cm, usually 100 
V), for 1 to 2 hrs. Samples were then visualised using the transilluminator 
settings on a G:BOX (Syngene, UK). Images could then be saved for later 
densitometric analysis.  
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2.4 DNA preparation and analysis 
 
2.4.1 Reconstituting plasmid DNA 
 
Reconstitution of DNA-based plasmids on air dried filter paper was 
achieved by adding a 1 cm
2 
area of filter paper containing the appropriate 
plasmid to a sterile micro-centrifuge tube. Approximately 100 μl of sterile, 
endotoxin-free TE-buffer was added to the micro-centrifuge tube. This mixture 
was vortexed for 10 sec and subsequently incubated at room temperature for 5 
min. Following this incubation the mixture was again vortexed for 10 sec and the 
tube was then centrifuged for 15 sec at 100 x g. Approximately, 1-10 μl of 
supernatant was used in subsequent bacterial transformations. 
 
2.4.2 Bacterial transformations  
 
A 95 μl aliquot of competent DH5α E. coli were placed in a pre-chilled 
microfuge tube containing 5 μl DNA (~100 ng/10 μl). The contents of the tube 
were mixed gently by flicking and incubated on ice for 30 min, during which 
time an aliquot of SOC medium was pre-heated to 37°C. After 30 min on ice, the 
cells were heat-shocked in a water bath at 42°C for 50 sec, and were then 
removed immediately for incubation on ice for a further 2 min. A 900 μl aliquot 
of pre-heated SOC was added to the cells which were then incubated at 37°C in a 
shaking incubator for 1 hrs. The cells were then pelleted by centrifugation for 3 
min at 3,420 x g. Following centrifugation, 900 μl of supernatant was removed 
and discarded. The cells were re-suspended in the remaining supernatant and 
plated out (with the controls) on LB plates containing 50 µg/ml ampicillin, and 
incubated overnight at 37°C. Plasmids carrying the antibiotic resistance gene 
confer this resistance to the transformed cells and thus only transformed cells 
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will yield colonies. These colonies were subsequently used to prepare broth 
cultures for DNA midi-preparations.   
 
2.4.3 Midi-preparation of plasmid DNA 
 
Successfully transformed colonies were picked from selective agar plates 
using a flame sterilised inoculating loop, and then grown overnight in sterilised 
baffled culture flasks containing 150 ml of LB broth supplemented with 50 
µg/ml ampicillin at 37°C with 150 rpm agitation. Following bacterial culture, 
DNA purification was carried out using a Qiagen plasmid midi-prep kit as per 
the manufacturer‟s instructions. 
Bacterial cells were pelleted at 3,000 x g for 15 min at 4°C. The 
supernatant was decanted and the cell pellet was suspended completely in 6 ml of 
Buffer P1 containing RNase A (100 μg/ml). The bacterial cells were then lysed 
by addition of 6 ml Buffer P2 and vigorous shaking for 30 sec followed by 
incubation at room temperature for 5 min. Following incubation, 6 ml of pre-
chilled Buffer P3 was added (to precipitate genomic DNA, protein, cell debris 
and SDS), mixed thoroughly by inverting the tube 5-6 times and poured into a 
prepared filter cartridge and incubated for 10 min at room temperature, allowing 
the precipitant to rise. 
The Qiagen-tip 100 column was equilibrated by applying 4 ml of QBT 
buffer and allowing the column to empty by gravity.  The column does not dry 
out at this stage, as the flow of buffer will stop when the buffer reaches the upper 
filter.  Following equilibration, the cell lysate was filtered into the column and 
allowed to flow through the resin where the plasmid binds.  The Qiagen-tip was 
washed with 20 ml of Buffer QC, to flush out any bacterial cell proteins.  DNA 
was then eluted with 5 ml of Buffer QF.  DNA was precipitated by adding 3.5 ml 
of isopropanol. The DNA/isopropanol mixture was then filtered through a Qia-
precipitator and the bound plasmid was subsequently washed with 2 ml of 70% 
(v/v) ethanol. The precipitator was then dried by flushing air through and the 
bound plasmid eluted into a sterile 1.5 ml micro-centrifuge tube by the addition 
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of 1 ml of sterile Buffer TE. The eluted DNA was flushed through the 
precipitator once more to remove any unbound DNA. DNA was then quantified 
on a NanoDrop
®
 (Section 2.3.3), and quality of the DNA was checked by agarose 
gel electrophoresis (Section 2.3.8) (Adapted from the manufacturer‟s protocol 
Qiagen
®
 Plasmid Purification Handbook, 2005). 
 
2.4.4 Preparation of glycerol stocks  
 
Glycerol enables long term storage of bacteria as glycerol prevents water 
in the broth from forming ice crystals that can puncture and kill bacterial cells. 
Glycerol stocks of bacterial cultures were prepared by adding 0.5 ml of a 50% 
(v/v) glycerol solution to 0.5 ml of the overnight bacterial culture of interest, 
mixing and storing at -80°C for future use. 
 
2.5 Transfection methods 
 
2.5.1 Amaxa
TM
 nucleofection 
 
Nucleofection is a novel transfection technique in which DNA/siRNA is 
transported directly into the nucleus to give high transfection efficiency and cell 
viability. The technique itself is a non-viral based method that is based on a 
combination of unique electrical parameters and cell specific solutions. For all 
nucleofector transfections the basic endothelial cell kit was used in accordance 
with the manufacturer‟s instructions. 
Briefly, for each well of a 6-well plate to be transfected, 2.5 ml of pre-
warmed culture medium was added and equilibrated in a tissue culture incubator. 
HAECs and BAECs were trypsinised, counted and pelleted. Residual medium 
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was removed by washing the cell pellets with PBS. Following this, cells were 
centrifuged at 100 x g for 5 min and residual PBS was removed by aspiration; 
finally, cells were re-suspended at a final concentration of 5 x 10
5
 cells/100 μl, in 
nucleofection solution. Care was taken not to store the cell suspension in 
nucleofection solution longer than 15 min as this would result in a serious loss of 
cell viability. For each individual sample, 100 μl cell suspension (5 x 105 cells) 
was mixed with 1.5-3.0 μg DNA and the sample was transferred to a 
nucleofection cuvette. At this stage, any bubbles in the cuvette were carefully 
removed and the cuvette was closed. The cuvette was then inserted into the 
Amaxa
TM 
nucleofector (Lonza, Cologne, Germany) (Figure 2.8). For BAECs and 
HAECs, the programme used to nucleofect the cells was M-003. Immediately 
following nucleofection, 500 μl of pre-warmed 37°C culture medium containing 
serum but no antibiotic was added. The nucleofected sample was then carefully 
transferred to the pre-incubated well of a 6-well plate and incubated overnight in 
a tissue culture incubator at 37°C. Culture medum was replaced the following 
day. 
 
 
Figure 2.8: The Amaxa
TM
 nucleofector for electroporation (www.amaxa.com). 
 
 
84 
 
2.5.2 Microporation 
 
Microporation is a unique transfection technique that utilises a gold-
plated pipette tip as an electroporation device. This allows for a more uniform 
electric field to be generated with minimal heat generation, metal ion dissolution, 
pH variation and oxide formation that are consistent difficulties in conventional 
electroporation protocols. Microporation was carried out using a microporation 
solution kit in accordance with the manufacturer‟s instructions. 
Cells were trypsinised and centrifuged at 100 x g for 2 min at room 
temperature and the solution aspirated. The remaining pellet was washed using 
PBS. The cells were then counted, re-suspended and divided into aliquots 
containing a final density of 500,000 cells/100 μl. Aliquots of cell suspension 
were centrifuged at 100 x g for 5 min at room temperature. To each well of a 6-
well plate to be transfected, 2 ml of pre-warmed culture medium containing 
serum (but without antibiotics), was added and equilibrated in a tissue culture 
incubator. Aliquoted cell pellets were re-suspended in 110 μl/transfection of 
Buffer R. Re-suspended cells were transferred to a 1.5 ml eppendorf tube and 3 
µg plasmid DNA or 1-100 nM siRNA/500,000 cells was added. Upon addition of 
3 ml Buffer E, the microporation tube was inserted into the pipette station to 
form the microporation unit (Labtech, East Sussex, UK) (Figure 2.9). The 
suspension was then pipetted into a 100 μl gold-tip using the microporator 
pipette. For BAECs, the desired pulse conditions were set; 1450 V, 20 pulse 
width (ms) and 2 pulse number. For HAECs, the desired pulse conditions were 
set; 1000 V, 30 pulse width (ms) and 3 pulse number.  After microporation each 
100 μl sample was transferred to a well of the 6-well plate, each well containing 
2 ml pre-incubated culture medium. Cells were allowed to recover overnight, 
after which the culture medium was changed. 
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Figure 2.9: The microporator. (A) The microporation unit that generates the 
electrical parameters necessary for the transfection of DNA and siRNA into 
cells; (B) The microporation unit consisting of the microporation tube 
(containing the electroporation buffer) and the microporation pipette used to 
deliver the electroporation parameters to the cells suspended in the gold-plated 
pipette tip; (C) The microporation kit containing the necessary microporation 
solutions, tips and microporation tubes. (www.microporator.com) 
 
2.5.3 TransIT-siQUEST
®
 transfection reagent 
 
TransIT-siQUEST
®
 is a high efficiency, low toxicity, siRNA-specific 
transfection reagent for mammalian cells. Transfection was carried out in 
accordance with the manufacturer‟s instructions. 
BAECs and HAECs were trypsinised and seeded to 6-well plates at the 
required concentration, allowed to adhere, and come to 80% confluency with 
regular medium changes. Prior to transfection, TransIT-siQUEST
®
 reagent was 
warmed to room temperature. 250 µl per transfection of pre warmed culture 
medium was added to a 1.5 ml micro-centrifuge tube. 7 µl of TransIT-siQUEST
®
 
reagent and the required concentration of siRNA were added to the medium and 
left to form complexes at room temperature for 30 min. Fresh medium was added 
to the cells (2 ml per well) and the transfection suspension then added to each 
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well. Cells were placed into a 37°C incubator overnight and experiments carried 
out after this time.  
 
2.5.4 TransIT-2020
®
 transfection reagent 
 
TransIT-2020
® 
is a high-performance, animal-origin free, broad spectrum 
transfection reagent for mammalian cells. Transfection was carried out in 
accordance with the manufacturer‟s instructions. 
BAECs and HAECs were trypsinised and seeded to 6-well plates at the 
required concentration, allowed to adhere, and come to 80% confluency with 
regular medium changes. Prior to transfection, TransIT-2020
® 
reagent
 
was 
warmed to room temperature. 250 µl per transfection of pre warmed culture 
medium was added to a 1.5 ml micro-centrifuge tube. 7 µl of TransIT-2020
® 
reagent
 
and the required concentration of plasmid DNA were added to the 
medium and left to form complexes at room temperature for 30 min. Fresh 
medium was added to the cells, 2 ml per well, and the transfection suspension 
then added to each well. Cells were placed into a 37°C incubator overnight and 
experiments carried out after this time.  
 
2.6 Immunodetection techniques 
 
2.6.1 Western blotting studies 
 
2.6.1.1 Preparation of whole cell lysates 
 
For the purposes of Western blotting, cells were harvested in the 
following manner. On ice or at 4°C, culture medium was removed and cells were 
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washed three times in PBS solution. Following complete aspiration of PBS, 1X 
radioimmunoprecipitation assay (RIPA) lysis buffer (20 mM Tris, 150 mM 
NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton X-100 (v/v), 2.5 mM sodium 
pyrophosphate, 1 mM -glycerophosphate, 1 mM sodium orthovanadate, 1 
g/ml leupeptin) was added to the cells, which were then harvested using a cell 
scraper. The resultant lystaes were frozen and thawed three times followed by 
three cycles of ultrasonication for 5 sec on ice using a sonic dismembrator (Vibra 
Cell, Sonics and Materials Inc, CT, USA). Cell lysate samples were either stored 
at -80°C for later analysis or used immediately in a BCA assay or Western blot. 
 
2.6.1.2 Bicinchoninic acid (BCA) protein microassay 
 
 The BCA assay is a biochemical assay for quantifying the total amount of 
protein in a solution. This is achieved by Cu
2+
 reacting with protein under 
alkaline conditions to produce Cu
+
, which in turn reacts with bicinchoninic acid 
(green) to form a complex (purple) that strongly absorbs light at 562 nm.  
Two separate reagents were supplied in this commercially available assay 
kit (Pierce Chemicals, Cheshire, UK); (A) an alkaline bicarbonate solution and 
(B) a copper sulphate solution.  One part solution B is mixed with fifty parts 
solution A; 200 l of this mixture is added to 10 l of protein lysate or BSA 
standards (standard curve in the range 0-2 mg/ml) in a 96-well plate.  Each 
protein lysate sample and BSA standard were assayed in triplicate. The plate was 
then incubated at 37°C for 30 min and the absorbance read at 560 nm using a 
ELx800 microplate reader (BioTek, VT, USA). 
 
2.6.1.3 SDS-polyacrylamide gel electrophoresis of proteins 
 
SDS-polyacrylamide gel electrophoresis (PAGE) resolves cellular 
proteins based solely on their electrophoretic mobility. During SDS-PAGE, 
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proteins are driven by an applied current through a mesh of cross-linked 
polyacrylamide gel. PAGE is carried out in the presence of the negatively 
charged detergent sodium dodecylsulphate (SDS), which binds to all types of 
protein molecules, denaturing the protein to its primary structure. Electrostatic 
repulsion between the bound SDS molecules causes the proteins to unfold into a 
similar rod-like shape, removing secondary and tertiary structure as a factor in 
separation. As the amount of SDS bound is proportional to the molecular weight 
of the polypeptide and is sequence independent, SDS-polypeptide complexes 
migrate through polyacrylamide gels in accordance with the size of the 
polypeptide (Laemmli 1970). 
 
2.6.1.3.1 Preparation of SDS-polyacrylamide gels 
 
Denaturing SDS-PAGE were performed using resolving gels 10% (v/v) 
and 5% (v/v) stacking polyacrylamide gels according to the method of (Laemmli 
1970). The gels were prepared as follows:  
 
Resolving Gel: 1.5 ml  Buffer A (1.5 M Tris pH 8.8) 
   1.5 ml  40% (w/v) acrylamide stock 
   3 ml  Distilled water 
   60 µl  10% (w/v) SDS 
30 µl  10% (w/v) ammonium persulphate 
   7 µl  TEMED 
 
Stacking Gel:  0.75 ml  Buffer B (0.5 M Tris pH6.8) 
   0.375 ml  40% (w/v) acrylamide stock 
   1.85 ml Distilled water 
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   30 µl  10% (w/v) SDS 
15 µl  10% (w/v) ammonium persulphate 
   7 µl  TEMED 
 
Protein samples were prepared as follows; 4X loading buffer (8% SDS 
(w/v), 20% -mercaptoethanol (v/v), 40% glycerol (v/v), Brilliant Blue R in 0.32 
M Tris pH 6.8) was added to the protein samples, which were then boiled at 
95°C for 5 min, and immediately placed on ice.  Samples were then loaded into 
the appropriate lanes along with 3 μl of Precision Plus® protein molecular weight 
marker (BioRad). Both samples and protein markers were electrophoretically 
separated for 120 min at 100 V. 
 
2.6.1.4 Wet transfer 
 
The wet or tank transfer method of Towbin et al. was utilized for 
electrotransfer of proteins to membrane in all circumstances (Towbin, Staehelin 
and Gordon 1979). This was accomplished using a Mini PROTEAN
®
 Trans Blot 
Module (BioRad, CA, USA) according to the manufacturer‟s instructions. 
Following SDS-PAGE electrophoresis, gels were removed from glass plates and 
the stacking gel was discarded. The resolved gel was then soaked for 10 min in 
transfer buffer (25 mM Tris, 192 mM Glycine, 20% methanol) to remove any 
SDS complexes bound to the gel that could affect successful protein transfer. At 
this time, the transfer cassette was assembled and nitrocellulose membrane 
(Millipore) was cut to the exact dimensions of the resolving gel and allowed to 
soak in transfer buffer for 5 min. Following the gel and membrane pre-soakings, 
the transfer cassette accompanying the Mini-PROTEAN
®
 electrophoresis system 
(BioRad, CA, USA) was assembled as in Figure 2.10 below.  
Once assembled, the cassette was checked to be free of air bubbles by 
rolling a 2 ml pipette over the cassette while submerged in transfer buffer to 
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remove any residual bubbles. The cassette was then placed in the Trans Blot 
Module with the correct orientation and subjected to 100 V for 2 hrs. 
 
 
 
 
Figure 2.10: Figure shows the layout of the transfer cassette used to transfer 
electrophoresed proteins from an SDS-PAGE gel to nitrocellulose membrane. 
The black coloured side is assembled face down, overlaid with a fibre pad, filter 
paper, resolved gel, nitrocellulose membrane, filter paper, and fibre pad, and 
sealed using the cassette clamp.  
 
2.6.1.5 Ponceau S staining 
  
To visually confirm uniform transfer of protein to the nitrocellulose 
membrane, Ponceau S stain was applied. Ponceau S is a negative stain, which 
binds to positively charged amino acid groups of proteins. It also binds non-
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covalently to non-polar regions of proteins. Transferred protein was detected as 
red bands on a white background. This staining technique is reversible to allow 
further immunological analysis. Following electrophoretic transfer, the 
nitrocellulose membrane was immersed in 20 ml Ponceau S solution (Sigma-
Aldrich, Dorset, UK) and stained for 3 min with constant agitation. After 
proteins were visualised, the membrane was washed in several changes of dH2O 
until all the stain had been washed away. The membrane was then used for 
immunological probing.   
 
2.6.1.6 Immunoblotting and chemiluminescence band detection 
 
Membranes were blocked for 90 min in blocking solution (5% (w/v) BSA 
in Tris Buffered Saline (TBS), 10 mM Tris pH 8.0, 150 mM NaCl).  Membranes 
were then incubated overnight at 4°C with primary antibody (Table 2.2), with 
gentle agitation on a rocker (Stuart Scientific, Rocker SSL4, Staffordshire, UK).  
 
Primary Antibody 
Primary 
Dilution 
Secondary 
Antibody 
Secondary  
Dilution 
vWF (Abcam)     8 µg/ml   Rabbit      1:2000 
NEP (Alpha Diagnostics)     2 µg/ml    Goat     1:500 
TOP (AbCam) 0.5  µg/ml    Mouse     1:2000 
MHC I (BioLegend)  10 µg/ml   Mouse     1:1000 
GAPDH (Santa Cruz)  0.4 µg/ml   Rabbit     1:3000 
 
Table 2.2: Primary and secondary antibody dilutions. This table displays the 
optimised primary and secondary antibody dilutions for proteins monitored by 
Western blot, and the commercial sources of antibodies. 
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Following primary incubations, membranes were washed 3 times for 5 
min in wash buffer (0.5% TBST). Membranes were subsequently incubated with 
the appropriate secondary antibody in TBST (5% BSA (w/v)) for 2 hrs with 
gentle agitation at room temperature. Membranes were then washed again using 
the same conditions described above. 
Supersignal
®
 West Pico (Pierce, Cheshire, UK) was the 
chemiluminescent substrate used for detection of horseradish peroxidise (HRP)-
conjugated secondary antibodies. This was prepared according to the 
manufacturer‟s instructions and incubated with the membranes for 5 min, 
following which excess substrate was removed and the chemiluminescent signal 
was detected in a dark room by autoradiography (GE-Healthcare, Bucks, UK).  
 
2.6.1.7 Coomassie gel staining 
 
Coomassie gel staining is used to visualise protein bands on an SDS-
PAGE gel. This is a useful technique to ensure that the transfer method worked 
as expected. In brief, the SDS-PAGE gel was overlaid with filtered (0.25 μm) 
coomassie solution whilst rocking for approximately 4 hrs. The gel was then de-
stained, whilst rocking, in a methanol:acetic acid (50:50) solution until the 
protein bands appeared clear and distinct with no background staining, changing 
the de-stain solution regularly. 
 
2.6.2 Immunocytochemistry 
 
 In order to visually monitor the expression and/or subcellular localization 
of proteins, cells were prepared for immunocytochemical analysis as previously 
described by Groarke et al. with some minor modifications (Groarke, et al. 
2001).  BAECs and HAECs were washed 3 times in PBS and fixed with 3% (v/v) 
formaldehyde for 15 min. Cells were subsequently washed in PBS 3 times; at this 
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point samples could be stored in PBS for up to 2 days at 4°C. Permeabilisation 
was achieved using 0.2% (v/v) Triton X-100 for 15 min, following which cells 
were again washed 3 times. Cells were then blocked for 30 min in PBS 
containing 5% (w/v) BSA solution. After blocking, cells were incubated with the 
appropriate primary antisera or stain  (Table 2.3), followed by 3 washes in PBS 
and a 1 hrs incubation with 1:400 Alexa Fluor 488 anti-mouse (TOP) or anti-goat 
(NEP) antisera. Again cells were washed 3 times in PBS after which, nuclear 
DAPI staining was performed by incubating cells with 500 ng/ml DAPI for 3 
min. Samples were then washed for a final time and mounting medium was 
added to the cells. Samples were visualised by standard fluorescent microscopy 
(Nikon Eclipse Ti, Tokyo, Japan).  
 
Primary Antibody/Stain Dilution 
NEP (R&D Systems)    1:20 (1 hrs) 
TOP (Abcam)    1:25 (1 hrs) 
F-actin (Invitrogen)    1:50 (1 hrs) 
DAPI    1:2000 (2 min) 
 
Table 2.3: Immunocytochemistry primary antibody dilutions. Table displays the 
optimised incubations for all primary antibody and stain dilutions of proteins 
monitored by immunocytochemistry. 
 
2.7 Luciferase assay 
 
Following transfection of HAECs with pRL-CMV Renilla vector 
(normalising control) and either pGL3-TOP or pGL3-CONT firefly vector (TOP 
or empty vector) (Morrison and Pierotti 2003), cells were sheared and promoter 
activity was determined by means of a dual glow luciferase assay. Firefly 
luciferase from the firefly Photinus pyralis, a monomeric 61 kDa protein, and 
Renilla luciferase, a 36 kDa protein, both catalyse luciferin oxidation using ATP-
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Mg
++
 as a co-substrate. In this luminescent reaction, light is produced by 
converting the chemical energy of luciferin oxidation through an electron 
transition to form oxyluciferin. In the conventional assay for luciferase, a flash of 
light is generated that decays rapidly after the enzyme and substrates are 
combined.   
Luciferase assay reagent was prepared by reconstituting luciferase assay 
substrate with luciferase assay buffer (Promega, WI, USA) and stored in aliquots 
protected from light at -80°C. Sufficient time was allocated to allow the 
luciferase detection reagent to equilibrate to room temperature before use. A 
volume of 20 μl of cell lysate was dispensed into individual wells in a white 96-
well plate, along with 20 μl of 1X lysis buffer to act as a blank. Subsequently, 
100 μl of luciferase assay reagent was added to the lysate and mixed by repetitive 
pipetting ensuring no bubbles were produced. This was read on a luminometer 
(Labsystems, Luminoskan 391A, NJ, USA) to obtain Firefly luciferase activity 
results. 100 µl „Stop and Glow‟ reagent was then added to each well; this 
quenches the luminescence from the firefly reaction by at least 10,000-fold and 
provides the substrate for Renilla luciferase. This latter activity was then read on 
the luminometer.  
 
2.8 Flow cytometry 
 
Flow cytometry may be defined as a technology to measure properties of 
cells as they move, or flow, in liquid suspension. Most flow cytometers can 
measure two kinds of light from cells, light scatter and fluorescence. Light scatter 
is the interaction of light and matter. All materials, including cells, will scatter 
light. In the flow cytometer, light scatter detectors are located opposite the laser 
(relative to the cell), and to one side of the laser, in-line with the fluid-flow/laser 
beam intersection. The measurements made by these detectors are called forward 
scatter and side scatter, respectively. Forward scatter provides information on the 
relative size of individual cells, whereas side scatter provides information on the 
relative granularity of individual cells. Fluorescence is the property of a molecule 
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to absorb light of a particular wavelength and re-emit light of a longer 
wavelength. The wavelength change relates to an energy loss that takes place 
during the process.  
FACS analysis was performed for optimisation of transfection reagents 
and machines, using a GFP marker. FACS analysis was also carried out for cell 
proliferation studies (Section 2.8.1). 
 
2.8.1 CFSE staining 
 
Carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) is a highly 
cell-permeable reagent. CFDA-SE is non-fluorescent; however, as it enters the 
cytoplasm of cells, intracellular esterases remove its acetate groups. This 
converts the molecule to the fluorescent ester, carboxyfluorescein succinimidyl 
ester (CFSE), which is retained within cells and covalently couples to 
intracellular molecules. Due to this covalent coupling reaction, fluorescent CFSE 
is retained within the cell, for extremely long periods. Also, due to this stable 
linkage, once incorporated within cells the dye is not transferred to adjacent cells. 
Thus, decreasing levels of CFSE in cells is a useful index of cellular 
proliferation.   
Post-shear BAECs and HAECs were trypsinised and a cell count 
performed. Cells were then seeded to 6-well plates, 50,000 cells per well. After 4 
hrs, samples were washed in 1X PBS and stained with CFSE, 5 µM/ml in 0.1% 
BSA/PBS, for 15 min at 37°C. Cells were then washed in PBS and fresh medium 
added. After 30 min, cells were trypsinised and analysed on the FACS Guava 
(Millipore, MA, USA) (Figure 2.11). Cells were then analysed every 24 hrs.   
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Figure 2.11: Figure shows the Millipore FACS Guava system, with analysis 
software and 96-well plate sample reading format.  
 
2.9 Proliferation 
 
2.9.1 xCELLigence
®
 
 
The xCELLigence
®
 system (Roche, Basal, Switzerland) monitors cellular 
events in real time without the incorporation of labels. The system measures 
electrical impedance across micro-electrodes integrated on the bottom of tissue 
culture E-Plates. The presence of the cells on top of the electrodes affects the 
local ionic environment at the electrode/solution interface, leading to an increase 
in the electrode impedance. The more cells that are attached on the electrodes, 
the larger the increases in electrode impedance (Figure 2.12). Thus making this 
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system ideal for the monitoring of adhesion and proliferation patterns in both 
BAECs and HAECs. 
       Following shear experiments, cells were trypsinised and a cell count 
performed (Section 2.2.4.2); 4,000 cells per condition were then added per well 
in a 16-well E-Plate. Initial adhesion of the cells was measured at 5 min intervals 
from 0-7 hrs. After this, measurements were extended to every 25 min for up to 6 
days for the monitoring of cell proliferation. Feeding of cells occurred every 24 
hrs just after a time point, to minimize the effect of the medium change on 
results. This was done by removing 100 µl of medium from each well and 
replacing it with 100 µl of fresh medium. Water levels were also maintained in 
reservoirs surrounding each well, to provide an efficient heat transfer to the 
medium.   
 
 
Figure 2.12: Figure shows the xCELLigence
®
 system with E-plate attached. 
Figure also demonstrates how cell impedance is measured (www.roche-applied-
science.com).  
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2.10 Bradykinin ELISA 
 
HAECs were transfected with either TOP siRNA (1 µM) or a TOP over-
expression plasmid (3 ng) and sheared for 24 hrs at 10 dynes/cm
2
, after which 
they were washed in sterile 1X PBS. HEPES-Krebs buffer was then added to 
cells at 2 ml per well. Inhibitors were added to each well for blockade of ACE 
(Captopril 10 µM), ECE and NEP (Phosphoramidon 2 nM) activity. After 30 
min, bradykinin was added (20 ng) per well and cells left to incubate for 12 hrs at 
37°C. Following incubation, medium samples were collected for analysis, using 
a BK ELISA kit (Enzo Life Sciences, NY, USA), following the manufactures 
instructions.  
Briefly, 150 µl of assay buffer was added to non-specific binding wells 
and 100 µl of assay buffer into the Bo wells (0 ng/ml standard). 100 µl of 
standards and samples were also added to the appropriate wells. 50 µl of BK 
conjugate and 50 µl of BK antibody were then added to the appropriate wells. 
The plate was then sealed and incubated on an orbital rotator for 2 hrs at 300 rpm 
at room temperature. The wells were then washed three times with 400 µl of 
wash buffer and the plate tapped dry onto lint-free paper. 200 µl of HRP 
conjugate was added to the appropriate wells and the plate sealed and incubated 
on an orbital rotator for 30 min at 300 rpm at room temperature. The wells were 
then washed again, as above. 200 µl tetramethylbenzidine (TMB) substrate was 
added to each well and the plate sealed and left for 30 min at room temperature, 
without shaking. 50 µl of stop solution was added to each well and the plate was 
read at 450 nm on an ELx800 microplate reader (BioTek, VT, USA) (Figure 
2.13). (Note. Amount of signal is inversely proportional to the level of BK in the 
sample).  
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Figure 2.13: Figure shows the principle steps in the BK elisa. (1-2) Incubation of 
standards and samples in pre-coated wells of a 96-well plate; (2-3) after washing 
of the plate, HRP conjugate is added to the wells and incubated; (3-4) after 
further wash steps, TMB substrate is added to the wells and incubated again; (4-
5) the reaction is quenched using a stopping buffer and results are obtained using 
plate reader at 450 nm (http://www.enzolifesciences.com).    
 
2.12 Statistical analysis 
 
Results are expressed as mean±sem. Experimental points were performed in 
triplicate with a minimum of three independent experiments (n=3). Statistical 
comparisons between controls versus treated groups were made by Student‟s 
unpaired t-test and Wilcoxon Signed-Ranked test (for non-parametric 
comparisons). A value of *P≤ 0.05 (or ΦP≤ 0.05) was considered significant. 
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Chapter 3: 
 
Preliminary characterisation studies and 
investigation of shear-mediated regulation of 
neprilysin (NEP) expression. 
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3.1 Introduction 
 
 As a consequence of its unique location, the ability of the endothelium to 
sense and respond to changes in the vascular environment is of paramount 
importance to vascular health. ECs utilise the presence of mechanosensors in 
their plasma membrane to convert the physical pressure of hemodynamic forces, 
such as cyclic strain and shear stress, into biochemical signals that can alter the 
cells gene expression profile. In addition to changes in gene expression, shear 
activates various signalling pathways which can modulate cell morphology, 
barrier function, proliferation and migration. Of direct relevance to this thesis is 
the shear-sensitive zinc metallopeptidase family. Various members of this family 
have been shown to possess vasoconstrictive (NEP) or vasodilatory (TOP) 
properties, and as a result are viable targets for therapeutic applications. In view 
of the relevance of flow to endothelial health and dysfunction, therefore, it is 
necessary to determine how these enzymes are regulated by flow in ECs and the 
signalling pathways involved.  
 Of specific interest to this chapter is the vasoconstrictor NEP, a pivotal 
regulator of natriuresis and vascular tone. It has previously been shown to be a 
shear-sensitive enzyme and to contain a SSRE in its promoter region (-
GAGACC-), similar to that found in the ACE and ECE gene promoter regions 
(Kim, et al. 2003, Li, et al. 1995). Previous work from this laboratory has also 
confirmed NEP down-regulation under shear to be dependent on a Gβγ signalling 
pathway, with evidence also suggesting roles for NADPH oxidase and ROS 
(Fitzpatrick, et al. 2009).  
The aims of this chapter are four fold: (i) to characterise the cell types 
studied as endothelial; (ii) to assess the effects of physiologically relevant levels 
of laminar and disturbed shear on the morphology and barrier function of both 
BAECs and HAECs; (iii)  to assess the effects of physiologically relevant levels 
of laminar and disturbed shear on NEP expression (with relation to dose and 
time) using qPCR and immunocytochemistry; and (iv) to examine the role of 
NADPH oxidase and ROS in the shear-dependent regulation of NEP expression 
levels.  
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3.2 Results 
 
3.2.1 Characterisation of endothelial cells 
 
3.2.1.1 Endothelial cell markers 
 
Endothelial cells contain specific markers that are easily characterised to 
ensure the validity of our commercially-sourced cell lines. These include Von 
Willebrand Factor (vWF) and endothelial nitric oxide synthase (eNOS). vWF 
protein was clearly expressed in both BAECs and  HAECs (Figure 3.1 A). eNOS 
mRNA was detected in both BAECs and  HAECs (Figure 3.1 B).  
 
Figure 3.1: Characterisation of endothelial cells. (A) Shows the presence of the 
endothelial cell marker vWF as detected by Western blot in (i) BAECs and (ii) 
HAECs. (B) Shows the presence of endothelial cell marker eNOS as detected by 
RT-PCR in (i) BAECs and (ii) HAECs. Blots are representative. 
 
3.2.1.2 Endothelial cell morphology 
 
BAEC and HAECs were grown to confluency and monitored by phase-
contrast microscopy for characteristic growth patterns and typical „cobblestone‟ 
shaped morphology (Figure 3.2). Following application of LSS (10 dynes/cm
2
, 
24 hrs), cells realign in the direction of flow. The cells now have a more 
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streamlined shape to minimise the frictional force of shear, the tapered end of 
each cell pointing in the direction of flow.  
 
 
Figure 3.2: Endothelial cell morphological alterations in response to LSS 
compared to static control cells. BAECs were sheared by orbital rotation, while 
HAECs were sheared using the ibidi
®
 system. White arrows indicate the 
direction of the flow. Images are representative.  
 
3.2.1.3 Actin realignment in response to shear  
 
BAECs and HAECs (Figure 3.3) were exposed to either LSS (10 
dynes/cm
2
) or disturbed shear stress (DSS) for 24 hrs. The realignment of the 
structural actin filaments becomes visible within 6 hrs of LSS onset and is fully 
evident after 24 hrs. However, as a result of the non-uniform and multi-
directional flow of medium in the disturbed shear samples, the DSS-treated cells 
are not able to adjust their morphology in response to the shear stimulus and 
resemble static control cells. This was visualised using fluorescence microscopy 
with phalloidin stain for F-actin (Invitrogen, Groningen, The Netherlands).   
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Figure 3.3: F-actin staining. Confluent BAECs (A,B) and HAECs (C) were 
exposed to LSS (10 dynes/cm
2
, 24 hrs), and monitored for F-actin realignment 
using fluorescent microscopy (phalloidin stain for F-actin). BAEC and HAEC F-
actin filaments realign in the direction of flow under LSS. No F-actin 
realignment is observed under DSS conditions, which instead closely resemble 
static control cells. Images are representative. 
 
3.2.1.4 The effect of shear stress on EC barrier integrity 
 
Under physiological levels of LSS, barrier function in ECs is increased, 
thus preventing unwanted solutes from crossing the endothelium and consistent 
with the „atheroprotective‟ nature of LSS. This is most prominent in the blood-
brain barrier of the microvasculature, but is an effect also seen throughout the 
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macrovasculature. A weakened barrier can be caused by disturbed shear and it is 
at these sites that endothelial dysfunction may occur and atherosclerotic plaques 
may be initiated.   
Both BAECs and HAECs were grown to confluency and subjected to 
either LSS, 10 dynes/cm
2
, (Figure 3.4) or DSS (Figure 3.5) for 24 hrs. Barrier 
integrity was then measured by transendothelial permeability assay as previously 
described (Walsh et al., 2011) using FITC-dextran (40 kDa). Higher levels of 
FITC-dextran in the basolaterally-harvested medium samples indicates a 
weakening of EC barrier integrity. As can be seen with both BAECs and HAECs 
(Figure 3.4), barrier integrity is significantly enhanced under LSS over a 24 hrs 
period. Conversely, with DSS of both BAECs and HAECs (Figure 3.5), barrier 
integrity is slightly weakened. 
 Blood flow in different areas of the vasculature can vary greatly, ranging 
from almost static in parts of the liver to 30 dynes/cm
2
 in the aorta (Vanhoutte 
1989). Blood flow can also fluctuate as a result of plaque build-ups and 
blockages in the vasculature. As a consequence, it was also decided to investigate 
the effect of varying levels of LSS on both BAEC and HAEC barrier integrity. 
Confluent BAECs and HAECs were exposed to low (1 dyne/cm
2
, 24 hrs) or 
normal (10 dynes/cm
2
, 24 hrs) LSS. Barrier integrity was then measured by 
transendothelial permeability assay. Results indicated that there was no 
significant change in barrier integrity under low LSS conditions when compared 
to static control cells. Data not shown.  
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(A)                                                          (B)  
 
(C)                                                                 (D) 
 
Figure 3.4: The effect of LSS on paracellular permeability in BAECs (A, B) and 
HAECs (C, D). Confluent BAECs and HAECs were subjected to LSS (10 
dynes/cm
2
, 24 hrs), harvested and replated in transwell inserts and monitored by 
transendothelial permeability assay, as described in methods. (A, C) Line graphs 
showing the % trans-endothelial exchange of FITC-Dextran over 3 hrs. (B, D) 
histograms showing the difference in permeability after 2 hrs of exchange. 
Results are averaged from three independent experiments ±SEM; *P≤0.05 vs 
static control cells. 
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(A)                                                            (B) 
 
(C)            (D) 
 
Figure 3.5: The effect of DSS on paracellular permeability in BAECs (A, B) and 
HAECs (C, D). Confluent BAECs and HAECs were subjected to DSS (10 
dynes/cm
2
, 24 hrs), harvested and replated in transwell inserts and monitored by 
transendothelial permeability assay, as described in methods. (A, C) Line graphs 
showing the % trans-endothelial exchange of FITC-Dextran over 3 hrs. (B, D) 
histograms showing the difference in permeability after 2 hrs of exchange. 
Results are averaged from three independent experiments ±SEM; *P≤0.05 vs 
static control cells. 
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3.2.2 The effect of shear on NEP expression 
 
3.2.2.1 Primers and MIQE guidelines 
 
The Minimum Information for publication of Quantitative real-time PCR 
Experiments (MIQE) guidelines set out to standardise the publication of qPCR 
results (Bustin, et al. 2009). All primers used for qPCR in this thesis fall within 
these new guidelines. NEP primers are calculated to be 90% efficient with an R
2
 
value of 0.9997. NEP primers were used on both bovine and human samples. The 
reference gene for all qPCR normalisation in this thesis is GAPDH.  Bovine 
GAPDH primers were found not to amplify human samples and as a result 
human GAPDH primers were also designed. Bovine GAPDH primers were 
found to have an efficiency of 103% with an R
2
 value of 0.9940, whilst human 
GAPDH primers were found to be 91% efficient with an R
2
 value of 0.9993.   
 
3.2.2.2 NEP primer validation 
 
To confirm that NEP primers were specific to NEP and do not amplify 
non-specific targets, extensive bioinformatical analysis was carried out during 
the primer design stage. Standard RT-PCR was performed using these primers 
and the products were characterised on a 1% agarose gel.  One clear band at the 
expected product size of 290 bp was visualised (Figure 3.6 A). All qPCR 
experiments performed in this study employed SYBR green detection. As SYBR 
green detects all amplification and is not sequence specific, dissociation, or melt 
curve analysis, was routinely carried out after qPCR to again ensure only NEP 
was being amplified (Figure 3.6 B). This involved a stepwise 1°C incremental 
increase in temperature over a set range, with fluorescence exhibited by the 
sample monitored during this time. SYBR green dye associates with double-
stranded DNA. Therefore, at the temperature threshold at which the generated 
PCR product dissociates to yield a single-stranded product, there is a drop in the 
fluorescence activity. Thus, a sample with a single PCR product will demonstrate 
only one peak corresponding to the melting temperature of the product. 
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 As a reference gene for all qPCR experiments, GAPDH was used to 
normalise results. Again RT-PCR and disassociation curves were used to ensure 
primers were specific to their target (Figure 3.6 C-F). 
 
3.2.2.3 LSS down-regulates NEP expression in a time-dependent manner  
 
It has previously been shown from work carried out in this laboratory that 
NEP mRNA/protein expression in BAECs is down-regulated by LSS (10 
dynes/cm
2
, 24 hrs) (Fitzpatrick, et al. 2009), however, neither dose- nor time-
dependency studies were done for this paper. Results from the present study now 
demonstrate how this attenuation temporally progresses over a 24-48 hrs period.  
BAECs were grown to confluency and subjected to LSS for 0-48 hrs at 
10 dynes/cm
2
. NEP mRNA levels were then monitored using qPCR. Results 
demonstrate that NEP mRNA expression is fully down-regulated (~42%) within 
24 hrs and maintained at this reduced level thereafter compared to static control 
cells (Figure 3.7). 
 
3.2.2.4 LSS down-regulates NEP expression in a dose-dependent manner 
 
Areas of the vasculature which are experiencing atherosclerotic plaque 
build up are often associated with areas of low, high or disturbed blood flow. As 
such, altered expression levels of vasoactive zinc metallopeptidases might be 
expected in these areas. This makes the effect of low or disturbed shear on the 
expression profile of ECs highly important (e.g. as NEP is a vasoconstrictor, 
higher expression levels at low shear would lead to elevated blood pressure and 
related pathologies). 
Both BAECs and HAECs were exposed to low (1 dyne/cm
2
,
 
24 hrs) or 
normal (10 dyne/cm
2
, 24 hrs) LSS levels. NEP mRNA expression was then 
monitored by qPCR. The trend of NEP down-regulation at 10 dynes/cm
2 
(but not 
at 1 dyne/cm
2
), is observed in both BAEC and HAEC (Figure 3.8). 
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Figure 3.6: NEP, bovine GAPDH and human GAPDH primer validation. (A, C, 
E) Shows RT-PCR products run out on a 1% agarose gel, giving a single band at 
the expected product size for NEP, bovine GAPDH and human GAPDH. (B, D, 
F) Shows the corresponding dissociation curves. Blots and scans are 
representative. 
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Figure 3.7: The time-dependent down-regulation of NEP mRNA in BAECs by 
LSS. BAECs were grown to confluency and subjected to LSS of 10 dynes/cm
2
 
for 3, 6, 12, 24 and 48 hrs. Cells were harvested and analysed by qPCR. 
Histogram shows the time-dependent attenuation of NEP expression levels. 
Results are averaged from three independent experiments ±SEM; *P≤ 0.05 vs 
control.   
 
3.2.2.5 The effect of DSS on NEP expression levels 
  
BAECs and HAECs were grown to confluency and subjected to DSS for 
24 hrs. Cells were then harvested and analysed by qPCR. In direct contrast to 
NEP mRNA down-regulation observed under LSS conditions, DSS was not 
found to cause NEP mRNA attenuation in either BAECs or HAECs when 
compared to static control cells (Figure 3.9).  
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(A)       (B) 
 
Figure 3.8: Magnitude-dependent effects of LSS on NEP mRNA expression. 
BAECs (A) and HAECs (B) were subjected to low (1 dyne/cm
2
, 24 hrs) and 
normal (10 dynes/cm
2
, 24 hrs) levels of LSS. Cells were harvested and analysed 
by qPCR. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control. Western blot insert in (A) shows down-regulation of NEP protein 
at 10 dynes/cm
2
 (Fitzpatrick et al., 2009). Blot is representative.  
 
3.2.2.6 Immunocytochemical analysis of NEP expression under shear  
 
To analyse the effect of shear variations on NEP levels, the ibidi
®
 micro-
fluidic slide-flow system was employed. Slide chambers simulate the vascular 
environment. HAECs were seeded onto ibidi
®
 Y-slides and grown to confluency. 
Cells were then sheared using LSS (10 dynes/cm
2
, 24 hrs) or oscillatory shear 
stress (OSS) (+/-10 dynes/cm
2
, 24 hrs). Cells were then prepared for 
immunocytochemical staining for NEP as described in methods (Figure 3.10). 
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(A)       (B)  
  
Figure 3.9: The effect of DSS on NEP mRNA expression levels.  (A) BAECs 
and (B) HAECs were grown to confluency and exposed to DSS for 24 hrs. Cells 
were harvested and analysed by qPCR. Results are averaged from three 
independent experiments ±SEM. 
 
Figure 3.10: The regulation of NEP protein expression by LSS (10 dynes/cm
2
) 
and OSS (+/- 10 dynes/cm
2
). Top row shows HAECs under phase-contrast view. 
Bottom row shows HAEC IC images for NEP. HAECs can be seen to realign in 
the direction of flow under LSS. However in OSS image cells are less clearly 
aligned. White arrows indicate the direction of flow. Images are representative. 
Insert in top left-hand corner image illustrates ibidi
®
 Y-slide format. 
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3.2.3 NEP signal transduction pathway 
 
Previous work from our laboratory has demonstrated a role for ROS in 
the shear-dependent down-regulation of NEP (Fitzpatrick, et al. 2009). 
Moreover, as the major source of ROS (specifically O2
-
) in ECs is due to the 
activity of NADPH oxidase, it was decided to fully elucidate this by testing an 
siRNA directed towards the p47 subunit of the enzyme complex (the 
aforementioned paper only used apocynin as a test reagent). To expand on this 
work, it was also decided to examine the temporal relationship between shear-
dependent ROS production and NEP down-regulation. Specifically, NAC was 
added 1 hrs before shear onset to allow sufficient time to scavenge its target, O2
-
. 
NAC was also added at the 4 hrs time point as it has previously been 
demonstrated that a ROS „burst‟ occurs between 0-3 hrs after shear onset 
(Fitzpatrick et al., 2009; see paper in appendix); thus, addition of NAC at 4 hrs 
(i.e. after the surge) should indicate how significant this early ROS surge is in 
NEP regulation in response to shear onset. 
 
3.2.3.1 p47 primer validation 
 
To confirm that p47 primers were specific to p47 and not amplifying non-
specific targets extensive bioinformatical analysis was carried out during the 
primer design stage. Standard RT-PCR was carried out using the primers and the 
products were characterised on a 1% agarose gel.  One clear band at the expected 
product size of 288 bp was visualised (Figure 3.11 A). Dissociation curves were 
routinely carried out after qPCR to ensure only p47 was being amplified (Figure 
3.11 B). As a reference gene for all qPCR experiments GAPDH was used to 
normalise results. As in section 3.2.2.1, p47 primers were subjected to the MIQE 
guidelines and found to be 102% efficient with an R
2
 value of 0.9983. 
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Figure 3.11: p47 primer validation. (A) Shows the product of a RT-PCR, run out 
on a 1% agarose gel, giving a single band at the expected product size for p47. 
(B) Shows the corresponding dissociation curve.  
 
3.2.3.2 Effect of p47 siRNA 
 
 HAECs were transfected with p47 siRNA (15 nM), as determined by 
optimisation experiments (Figure 3.12). Controls included either mock 
transfection (use of transfection reagents without siRNA) or 15 nM scrambled 
siRNA, as both had negligible effects on NEP expression and so were used as 
controls. Post-transfection, cells were allowed overnight recovery before the 
application of LSS (10 dynes/cm
2
, 24 hrs). Cells were then harvested for mRNA 
and analysed by qPCR. Results of this assay show that silencing of the NADPH 
oxidase subunit p47 leads to a negation of the expected down-regulatory effect of 
LSS on NEP mRNA expression (Figure 3.13). 
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Figure 3.12: Optimisation of p47 siRNA concentrations in HAECs. Control 
study indicating how increasing concentrations of p47 siRNA (0, 7.5 and 15 nM) 
caused a marked decrease in p47 mRNA expression levels. N=1.  
 
 
Figure 3.13: The role of NADPH oxidase in NEP mRNA expression. HAECs 
were transfected with p47 siRNA (15 nM) and subjected to LSS (10 dynes/cm
2
, 
24 hrs). Control cells demonstrated the expected NEP down-regulation in 
response to LSS. However, the introduction of p47 siRNA negates this effect, 
bringing NEP mRNA expression back to control levels. Results are averaged 
from three independent experiments ±SEM; *P≤ 0.05 vs control. MT= mock 
transfection. 
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3.2.3.3 Effect of N-Acetyl-L-cysteine (NAC)  
 
The antioxidant NAC (5 mM) was added to confluent BAECs 1 hrs 
before or 4 hrs after the onset of LSS (10 dynes/cm
2
, 24 hrs). The results show 
that the LSS down-regulation of NEP is negated by the introduction of NAC 1 
hrs prior to shear onset, but not 4 hrs post shear onset (i.e. after the ROS surge) 
(Figure 3.14).  
 
 
Figure 3.14: Temporal effect of NAC on shear-dependent modulation of NEP 
expression. BAECs were grown to confluency and NAC was added to samples 1 
hrs before or 4 hrs after onset of LSS (10 dynes/cm
2
, 24 hrs). N=1. 
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3.4 Discussion 
 
Our initial investigation in this chapter consisted of control studies that 
were focused on the characterisation of our commercial cell lines through the 
detection of known endothelial markers. Both cell lines (BAEC and HAEC) were 
found to express vWF and eNOS, established endothelial markers (Jaffe, Hoyer 
and Nachman 1973). Moreover, characteristic endothelial cell morphological and 
actin filament realignment in response to physiological levels of LSS were also 
observed (Suciu, et al. 1997). There were various reasons behind the use of two 
different endothelial cell lines in this study. Earlier preliminary studies by 
Fitzpatrick et al. (2009) from this research group were performed in BAECs, thus 
serving as a platform for pursuit of further studies on NEP and TOP. HAECs 
were also introduced into studies because of their heightened suitability for 
transfection studies (particularly using the microporation system) and ultimately 
because of their greater translational relevance.  
In further characterisation studies, the effect of physiological versus non-
physiological levels of LSS on endothelial barrier integrity was compared, with 
significant levels of barrier strengthening (i.e. reduced permeability) noted at the 
higher physiological levels of shear (Krizanac-Bengez, et al. 2006, Walsh, et al. 
2011). When compared with ECs that were subjected to disturbed shear (DSS), 
typical of curvatures and bifurcations in blood vessels, areas of high risk of 
developing atherosclerotic plaques, we can see that DSS results in a slight 
weakening of barrier integrity. This indicates a role for LSS in atheroprotection 
of the vasculature. It also demonstrates the role played by disturbed shear on the 
endothelium and the detrimental effect it may have if ECs are exposed to this 
pathological stimulus for long periods of time (Cunningham and Gotlieb 2004).     
In subsequent investigations, we examined the regulation of the zinc 
metallopeptidase, NEP, by various patterns of shear stress. It can be seen from 
the results presented that NEP expression is attenuated in both a dose- and time-
dependent manner by LSS. As NEP has been shown to act by degrading a 
number of vasodilatory peptides, such as those of the natriuretic peptide family 
for example, we can conclude that lower levels of NEP under LSS will result in 
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potentation of the vasodilatory effects of natriuretic peptides, with likely 
beneficial consequences for vascular tone and remodelling.   
One can further speculate that high levels of NEP in the endothelium will 
invariably lead to a constriction of blood vessels through the elevated 
degradation of vasodilatory peptides. In this regard, results presented in this 
chapter have shown that under disturbed shear conditions, no NEP attenuation is 
observed. If DSS is applied for a prolonged period, therefore, this will likely 
induce higher levels of NEP production in conjunction with weakened EC barrier 
integrity. This will cause the affected area of the endothelium to become 
dysfunctional, with associated up-regulation of pro-atherogenic and pro-
inflammatory genes, as well as altered migratory and proliferative profile of cells 
(Figure 3.15).   
 
Figure 3.15: The differential responses of the endothelium to various patterns of 
shear stress. Physiologically relevant LSS promotes endothelial cell quiescence, 
induces the expression of anti-atherogenic and anti-inflammatory genes, and 
promotes endothelial barrier integrity. In contrast, disturbed flow induces 
endothelial activation, extracellular matrix production, and expression of pro-
inflammatory and apoptotic genes, which may lead to vascular remodelling and 
propagate endothelial barrier dysfunction, atherogenesis, and inflammatory 
processes in the vasculature (Shepro 2006). 
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 It has been previously published that members of the zinc 
metallopeptidase family are shear-sensitive, namely ECE and ACE. Studies have 
also demonstrated that regulation of these zinc metallopeptidases occurs in a 
ROS-dependent manner under LSS- ACE (Ackermann, et al. 1998), ECE 
(Masatsugu, et al. 2003). Therefore, the role of ROS in the shear-dependent 
regulation of NEP expression was also considered in this chapter, and 
specifically the role of NADPH oxidase, the major superoxide producer in ECs 
(Griendling, Sorescu and Ushio-Fukai 2000). In this respect, a p47 siRNA 
construct was employed to silence p47 subunit expression and effectively inhibit 
NADPH oxidase in endothelial cells. This subunit is known to interact with the 
p40 and p67 subunits to facilitate NADPH oxidase activation during a stimulus-
induced temporal ROS surge (Sumimoto et al., 2005).  
Our results indicate that the silencing of p47 expression (confirmed by 
qPCR) negates the down-regulatory effect of LSS on NEP mRNA expression 
levels, confirming a role for NADPH oxidase in the LSS-dependent regulation of 
NEP. This finding is consistent with the recent study of Fitzpatrick et al. (2009) 
who reported a similar result, albeit using apocynin (a pharmacological inhibitor 
of NADPH oxidase).  
 As NADPH oxidase was proven to be involved in the regulation of NEP 
and, as previously stated, it is also the major source of superoxide (O2
-
) in ECs, it 
was therefore decided to examine the role of ROS in NEPs regulation. 
Specifically, we were interested in the role of the early ROS surge following 
shear onset. Duerrschmidt et al. previously demonstrated that there is a transient 
activation of O2
-
 formation by short term LSS (2-24 hrs) (Duerrschmidt, et al. 
2006). A similar study in this laboratory showed that a ROS „burst‟ occurs within 
0-3 hrs post LSS onset (Fitzpatrick, unpublished data, figure 3.16 B). The levels 
of ROS eventually decrease to baseline levels (similar to cells under static 
conditions), most likely due to temporal activation of cellular anti-oxidant 
mechanisms, an observation consistent with the atheroprotective effects of 
laminar flow (Hahn and Schwartz 2009) (Figure 3.16 A).   
A preliminary study was conducted whereby the antioxidant NAC was 
used to scavenge ROS 1 hrs prior to and 4 hrs post shear onset, bracketing the 
121 
 
reported ROS burst. Results indicate that the scavenging of ROS
 
1 hrs prior to, 
but not 4 hrs post, shear onset inhibits the effect of LSS on NEP attenuation. This 
clearly points to the importance of ROS production during the early phase of 
shear onset in the LSS-induced down-regulation of NEP expression. 
 
 
 
Figure 3.16: Early LSS-induced ROS production. (A) Cells under laminar flow 
(blue line) transiently activate various inflammatory signalling pathways, 
including production of ROS. Disturbed shear activates the same pathways in a 
sustained manner (Hahn and Schwartz, 2009). (B) Dihydroethidium staining to 
illustrate intracellular ROS induction (shown in pink) in BAECs under LSS 
(Fitzpatrick, unpublished result). Images are representative.  
 
In conclusion, we have demonstrated the LSS-dependent increase in 
barrier function, which is absent under DSS conditions. Moreover, we have 
demonstrated the down-regulation of NEP in both a time- and dose-dependent 
manner under physiologically relevant levels of LSS, but not DSS. Finally, we 
have conclusively demonstrated the involvement of NADPH oxidase in this 
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signalling cascade, most likely via generation of an early ROS surge during shear 
onset (0-3 hrs), leading to activation of downstream signalling effectors. 
Downstream of oxidant production, signalling effectors mediating NEP 
regulation by LSS may include mitogen activated kinases (MAPKs), such as p38 
and JNK (Go, et al. 1999, Huot, et al. 1997, Hashimoto, et al. 2001, Chen and 
Keaney Jr 2004).  
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Chapter 4: 
 
Investigation of the effects of shear stress on 
thimet oligopeptidase (TOP) expression. 
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4.1 Introduction 
 
In the previous chapter the regulation of NEP by shear stress was 
examined. In this chapter, the regulation of TOP will be investigated. Indeed, no 
published information on the shear-dependent nature of this latter enzyme 
currently exists, although a previous study by Cotter et al. (2004) has reported 
the up-regulation of TOP by cyclic circumferential strain. It should also be noted 
that, like NEP, TOP has a SSRE in its promoter region, suggesting likely 
regulation by shear stress in endothelial cells (Cummins, Cotter and Cahill 2004).  
TOP has a number of alternative physiological functions. Firstly, it can 
transform an inert precursor neuropeptide into an active peptide (Acker, 
Molineaux and Orlowski 1987). Secondly, it acts as a convertase, changing one 
bioactive peptide into a different peptide that either binds to a different receptor 
or binds to the same receptor but conveys different downstream messages 
(Bourguignon, et al. 1994). Finally, TOP has a biomodulating action, forming a 
peptide product that opposes the action of its parent peptide (Chappell, et al. 
1994). As a result, TOP serves to balance the action of several vasoactive 
peptides, both centrally and peripherally, with consequences for vascular tone. 
Thus, understanding TOP regulation by shear stress is of potentially high 
importance to cardiovascular research. 
 
The aims of this chapter are three-fold; (i) confirm the role of TOPs 
SSRE with respect to its shear-dependent regulation; (ii) assess the effects of 
physiologically relevant levels of laminar and disturbed shear on TOP expression 
(with relation to dose and time) using qPCR and immunocytochemistry; (iii) 
examine the role of NADPH oxidase and ROS in the shear-dependent regulation 
of TOP expression.  
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4.2 Results 
 
4.2.1 The effect of shear on TOP  
 
4.2.1.1 The relevance of the -GAGACC- SSRE in the TOP promoter 
 
 HAECs were transfected with either pGL3-TOP (Firefly luciferase vector 
containing the full length rat TOP promoter -901/+120) or pGL3-CONT (empty 
vector, as mock control) (Morrison and Pierotti 2003). The pRL-CMV Renilla 
vector was also included in all transfections as a normalising control. Cells were 
then exposed to LSS (10 dynes/cm
2
, 24 hrs) and promoter activity 
(Firefly/Renilla) was monitored using the Promega Dual-Glow
TM
 Luciferase 
assay, as described in methods. A statistically insignificant fold increase in 
baseline luciferase levels was observed under the non-sheared condition relative 
to mock transfections (1.31±0.15 fold). By contrast, we observed a substantial 
fold increase in luciferase levels relative to mock transfections under sheared 
conditions (5±0.21 fold) (Figure 4.1). 
 
4.2.1.2 TOP primer validation 
 
To confirm that TOP primers were specific to TOP and were not 
amplifying non-specific targets, extensive bioinformatical analysis was carried 
out during the primer design stage. Standard RT-PCR was carried out using the 
primers and the products were characterised on a 1% agarose gel. One clear band 
at the expected product size of 401 bp was visualised (Figure 4.2 A). 
Dissociation curves were routinely carried out after qPCR to ensure only TOP 
was being amplified (Figure 4.2 B). As a reference gene for all qPCR 
experiments, GAPDH was used to normalise results. As in section 3.2.2.1, TOP 
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primers were subjected to the MIQE guidelines and found to be 95% efficient 
with an R
2
 value of 0.9961.   
 
 
 
 
Figure 4.1: Effect of shear stress on TOP promoter activity. HAECs were 
transfected with either pGL3-TOP or pGL3-CONT and exposed to LSS (10 
dynes/cm
2
, 24 hrs). The pRL-CMV Renilla vector was also included in all 
transfections as a normalising control for the Promega Dual-Glo luciferase 
assay. Firefly/Renilla luciferase ratios under static and shear conditions are 
expressed as fold change to associated empty vector controls (each normalised to 
a value of 1). Results are averaged from three independent experiments ±SEM; 
*P≤ 0.05 vs control. 
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Figure 4.2: TOP primer validation. (A) Shows the product of a RT-PCR, run out 
on a 1% agarose gel, giving a single band at the expected product size for TOP. 
(B) Shows the corresponding disassociation curve. 
 
4.2.1.3 LSS up-regulates TOP expression in a time-dependent manner  
 
It has previously been shown from work carried out in this laboratory that 
TOP expression and activity in BAECs is up-regulated in response to 
physiological cyclic strain (Cotter, et al. 2004). In the present study we 
investigate if this up-regulation also occurs as a result of flow associated-LSS.  
BAECs were grown to confluency and subjected to LSS for 0-48 hrs at 
10 dynes/cm
2
. TOP mRNA levels were then monitored using qPCR. Results 
demonstrate that TOP mRNA expression is up-regulated (~45%) by 24 hrs and 
maintained at this increased level thereafter compared to static control cells 
(Figure 4.3). 
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Figure 4.3: The time dependent up-regulation of TOP in BAECs by LSS. 
BAECs were grown to confluency and subjected to LSS of 10 dynes/cm
2
 for 3, 6, 
12, 24 and 48 hrs. Cells were harvested and analysed by qPCR. Histogram shows 
the time-dependent up-regulation of TOP expression levels. Results are averaged 
from three independent experiments ±SEM; *P≤ 0.05 vs control.   
 
4.2.1.4 LSS up-regulates TOP expression in a dose-dependent manner 
 
Both BAECs and HAECs were grown to confluency and exposed to low 
(1 dyne/cm
2
,
 
24 hrs) or normal (10 dyne/cm
2
, 24 hrs) LSS levels. TOP mRNA 
expression was then monitored by qPCR. The trend of TOP up-regulation at 10 
dynes/cm
2 
(but not at 1 dyne/cm
2
) is observed in both BAECs and HAECs 
(Figure 4.4).  
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(A) (B) 
 
 
Figure 4.4: Magnitude-dependent effects of LSS on TOP mRNA expression. (A) 
BAECs and (B) HAECs were subjected to low (1 dyne/cm
2
, 24 hrs) and normal 
(10 dynes/cm
2
, 24 hrs) levels of LSS. Cells were harvested and analysed by 
qPCR. Results are averaged from three independent experiments ±SEM; *P≤ 
0.05 vs control.  Western blot inset in (A) shows up-regulation of TOP protein at 
10 dynes/cm
2
 (Fitzpatrick, Endothelial Biology Group, unpublished data). Blot is 
representative. 
 
4.2.1.5 The effect of DSS on TOP expression levels 
  
BAECs and HAECs were grown to confluency and subjected to DSS for 
24 hrs. Cells were then harvested and analysed by qPCR. In direct contrast to 
TOP mRNA up-regulation observed under LSS conditions, DSS was not found 
to cause TOP mRNA enhancement in BAECs. Results also indicate that in 
HAECs, TOP mRNA expression levels were actually down-regulated in a 
significant manner under DSS when compared to static control cells (Figure 4.5).  
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(A)                                                          (B) 
 
Figure 4.5: The effect of DSS on TOP mRNA expression levels.  (A) BAECs 
and (B) HAECs were grown to confluency and exposed to DSS for 24 hrs. Cells 
were harvested and analysed by qPCR. Results are averaged from three 
independent experiments ±SEM; *P≤ 0.05 vs control. 
 
4.2.1.6 Immunocytochemical analysis of TOP expression under shear 
 
To analyse the effect of shear variations on TOP levels, the ibidi
®
 micro-
fluidic slide-flow system was employed. Slide chambers simulate the vascular 
environment. HAECs were seeded onto ibidi
®
 Y-slides and grown to confluency. 
Cells were then sheared using LSS (10 dynes/cm
2
, 24hrs) or oscillatory shear 
stress (OSS) (+/-10 dynes/cm
2
, 24 hrs). Cells were then prepared for 
immunocytochemical staining for TOP as described in methods (Figure 4.6). 
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Figure 4.6: The regulation of TOP protein expression by LSS and OSS. Top row 
shows HAECs under phase-contrast view. Middle and bottom rows show HAEC 
IC images for TOP at 10x and 40x magnifications. HAECs can be seen to realign 
in the direction of flow under LSS. However, in OSS image cells are less clearly 
aligned. Images are representative. White arrows indicate the direction of flow. 
Insert in top left corner image illustrates ibidi
®
 Y-slide format.  
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4.2.2 TOP signal transduction pathway 
 
As with NEP, the shear signalling pathway for TOP is yet to be fully 
determined. It is logical however to speculate that it is regulated in a ROS-
dependent manner, as we have shown for NEP, and as previously published work 
has shown for other shear-sensitive zinc metallopeptidases such as ACE 
(Ackermann, et al. 1998) and ECE (Masatsugu, et al. 2003).   
It was therefore decided to examine the temporal relationship between 
shear-dependent ROS production and TOP up-regulation. A short preliminary 
study by Fitzpatrick et al. in this laboratory (unpublished data) has previously 
demonstrated the ROS-dependence of TOP up-regulation by shear stress (see 
Appendix). We decided to extend this work by confirming the involvement of 
NADPH oxidase in these events (using apocynin and p47 siRNA). Moreover, the 
temporal relationship between TOP up-regulation and the shear-induced ROS 
surge were determined. As with NEP, pharmacological reagents were added to 
BAECs 1 hrs before or 4 hrs after shear onset (essentially bracketing the ROS 
surge), and the effects on TOP expression subsequently monitored. Specifically 
agents included NAC, NSC23766 (Rac 1) and apocynin (NADPH oxidase). 
 
4.2.2.1 Effect of N-Acetyl-L-cysteine (NAC)  
 
The antioxidant NAC (5 mM) was added to confluent BAECs 1 hrs 
before or 4 hrs after the onset of LSS (10 dynes/cm
2
, 24 hrs). The results show 
that the TOP LSS up-regulation is fully negated by the introduction of NAC 1 hrs 
prior to shear onset. This effect is lost when NAC is introduced 4 hrs post shear 
onset (Figure 4.7).  
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Figure 4.7: Temporal effect of NAC on shear-dependent modulation of TOP 
expression. BAECs were grown to confluency and NAC was added to samples 1 
hrs before or 4 hrs after onset of LSS (10 dynes/cm
2
, 24 hrs). Results are 
averaged from three independent experiments ±SEM; *P≤ 0.05 vs control, ΦP≤ 
0.05 vs shear. 
 
4.2.2.2 Effect of NSC23766 
 
 The Rac1-specific pharmacological inhibitor NSC23766 (50 µM) was 
introduced to BAECs 1 hrs before or 4 hrs after the onset of LSS (10 dynes/cm
2
, 
24 hrs). The results show that TOP LSS up-regulation is almost fully negated by 
the introduction of NSC23766 1 hrs prior to shear onset. This effect is lost when 
NSC23766 is introduced 4 hrs post shear onset (Figure 4.8).  
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Figure 4.8: Temporal effect of NSC23766 on shear-dependent modulation of 
TOP expression. BAECs were grown to confluency and NSC23766 was added to 
samples 1 hrs before or 4 hrs after onset of LSS (10 dynes/cm
2
, 24 hrs). Results 
are averaged from three independent experiments ±SEM; *P≤ 0.05 vs control, 
ΦP≤ 0.05 vs shear. 
 
4.2.2.3 Effect of apocynin 
 
The NAPDH oxidase inhibitor apocynin (50 µM) was introduced to 
BAECs 1 hrs before or 4 hrs after the onset of LSS (10 dynes/cm
2
, 24 hrs). The 
results show that the TOP LSS up-regulation is substantially negated by the 
introduction of apocynin 1 hrs prior to shear onset. This effect is lost when 
apocynin is introduced 4 hrs post shear onset (Figure 4.9).  
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Figure 4.9: Temporal effect of apocynin on shear-dependent modulation of TOP 
expression. BAECs were grown to confluency and apocynin was added to 
samples 1 hrs before or 4 hrs after onset of LSS (10 dynes/cm
2
, 24 hrs). Results 
are averaged from three independent experiments ±SEM; *P≤ 0.05 vs control, 
ΦP≤ 0.05 vs shear. 
 
4.2.2.4 Effect of p47 siRNA 
 
 HAECs were transfected with p47 siRNA (15 nM). Either mock 
transfection (use of transfection reagents without siRNA) or 15 nM scrambled 
siRNA demonstrated negligible effects on TOP expression and so were used as 
controls. Post-transfection, cells were allowed overnight recovery before the 
application of LSS (10 dynes/cm
2
, 24 hrs). Cells were then harvested for mRNA 
and analysed by qPCR. Results of this study show that silencing of the NADPH 
oxidase p47 subunit leads to a negation of the expected up-regulatory effect of 
LSS on TOP mRNA expression (Figure 4.10). 
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Figure 4.10: The role of NADPH oxidase in TOP mRNA expression. HAECs 
were transfected with p47 siRNA (15 nM) and subjected to LSS (10 dynes/cm
2
, 
24 hrs). Control cells demonstrated the expected TOP up-regulation in response 
to LSS. However, the introduction of p47 siRNA negates this effect, bringing 
TOP mRNA expression back to control levels. Results are averaged from three 
independent experiments ±SEM; *P≤ 0.05 vs control, ΦP≤ 0.05 vs shear MT. 
MT= mock transfection.  
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4.3 Discussion 
 
It has been widely reported that ECs exhibit secreted and membrane-
associated forms of TOP, thereby allowing it to putatively degrade peptides 
intracellularly and extracellularly (Crack, et al. 1999). Cotter et al. (2004) 
demonstrated for the first time the role of cyclic strain in regulating the 
expression and enzymatic activity of TOP, and its closely related zinc-
metallopeptidase family member neurolysin, in BAECs. Their findings 
demonstrated that strain significantly increased TOP‟s soluble activity in a force- 
and time-dependent manner, with a 2.3 fold increase after 24 hours at 10% strain, 
in addition to up-regulating TOPs mRNA levels by 42%. That study also 
concluded that cyclic strain modulates the release of TOP from BAECs and thus 
may have a significant influence on TOP‟s extracellular functions (Cotter, et al. 
2004). Interestingly, examination of TOP‟s protein sequence shows neither a 
readily identifiable secretory signal sequence nor a conventional hydrophobic, 
membrane-spanning domain, structural elements normally associated with 
extracellularly-acting peptidases. However, TOP is now believed to be secreted 
through non-classical pathways, e.g. lipid rafts (Jeske, et al. 2006).  
In view of the multitude of studies demonstrating roles of TOP (EP24.15) 
in vasoactive peptide metabolism peripheral and cerebral vascular beds 
(Chappell, et al. 1994, Norman, et al. 2003b, Norman, et al. 2003a, Rioli, et al. 
2003, Santos, et al. 1992) , and the up-regulation of TOP activity seen in 
response to cyclic strain (Cotter, et al. 2004), we hypothesised that TOP levels 
would be regulated in vascular endothelium by shear stress. This chapter 
comprehensively examined, for the first time, the regulatory relationship between 
shear stress and TOP in macrovascular endothelial cells, and sheds light on the 
mechanotransduction pathway mediating any observed regulatory events.  
 It has previously been shown that TOP contains a -GAGACC- SSRE in 
its promoter sequence, and as such is believed to be shear-sensitive (McCool and 
Pierotti 1998). The initial investigation focused on the transfection of a pGL3 
vector containing TOP‟s full length promoter sequence (pGL3-TOP) into 
HAECs and subsequently monitoring shear-dependent TOP promoter activation 
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via luciferase reporter assay. The results show that in the absence of shear, little 
or no luciferase activity is present in cells transfected with pGL3-TOP (i.e. 
versus empty vector pGL3-CONT). When HAECs are sheared, however, 
significantly elevated levels of luciferase activity are observed in pGL3-TOP 
transfected cells, clearly pointing to the mechao-sensitive nature of the TOP 
promoter.  
We next examined how TOP may be regulated by LSS in a time- and 
magnitude-dependent manner.  It can be seen from the results presented that TOP 
mRNA expression levels in both BAECs and HAECs are significantly up-
regulated by normal LSS (10 dynes/cm
2
) over a 24 hrs period and are maintained 
at this level even up to 48 hrs. Data also shows a relationship between shear 
magnitude and TOP regulation with normal LSS (10 dynes/cm
2
), but not low (1 
dyne/cm
2
) or static (0 dynes/cm
2
), causing significant up-regulation of TOP 
mRNA expression. These findings are in line with those of Cotter et al. (2004) 
who reported a similar increase in BAEC TOP mRNA expression levels, albeit 
under an alternative hemodynamic force, cyclic strain. Interestingly, results 
presented in this chapter have also shown that under DSS, no significant up-
regulation of TOP is observed in BAECs, whilst in HAECs a significant decrease 
in TOP mRNA expression occurs. Collectively, these data suggest that TOP is 
up-regulated under atheroprotective conditions, and vice versa. As such, its 
dysregulation under conditions of compromised shear may contribute to a net 
alteration in local peptide balance, leading to endothelial dysfunction.  
Immunocytochemical staining of TOP was also performed in HAECs 
exposed to laminar and oscillatory shear stress using an ibidi
®
 micro fluidic slide 
flow system. An up-regulation of TOP immunostaining is clearly visible in 
HAECs under LSS (10 dynes/cm
2
), when compared to static control cells. 
Interestingly, this up-regulation is not visible when HAECs were exposed to OSS 
(+/- 10 dynes/cm
2
, 24 hrs). There also appears to be a visible subcellular 
relocation of TOP immunoreactivity, with TOP being located close to the 
nucleus in static control cells, whilst having a more ubiquitous expression pattern 
under LSS and OSS conditions (Figure 4.6). Importantly, these IC findings are 
consistent with observations for LSS and DSS effects on TOP mRNA/protein 
levels.   
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As with NEP, we next attempted to determine the role played by NADPH 
oxidase and ROS in the mechanotransduction pathway involved in TOP‟s shear-
dependent regulation. In this respect, preliminary studies within the Endothelium 
Biology Group at DCU (unpublished data) have demonstrated that shear-
dependent up-regulation of TOP can be blocked by ROS-sequestering agents. 
Moreover, treatment of static endothelial cells with either H2O2 or ROS-inducing 
Ang-II was found to up-regulate TOP expression (Appendix).  
We therefore began by identifying a role for NADPH oxidase in these 
events. It has previously been published that p47 is responsible for transporting 
the cytosolic subunits of NADPH oxidase from the cytosol to the membrane 
during oxidase activation. The effect of p47 is to tighten the binding between 
each of the other cytosolic proteins to the assembled oxidase (Sumimoto, Miyano 
and Takeya 2005). Our results indicate that the silencing of p47 expression using 
an siRNA completely attenuates the effect of LSS up-regulation on TOP mRNA 
expression levels, strongly implicating a role for NADPH oxidase.  
As in Chapter 3, the temporal ROS burst that occurs 0-3 hrs after the 
onset of shear was the main focus of the next set of experiments. Therefore, we 
utilised pharmacological inhibitors, NSC23766 (Rac1) and apocynin (p47), to 
disrupt NADPH oxidase and monitor the effect on the regulation of TOP under 
LSS conditions. A key step in the NADPH oxidase activation cascade occurs 
when Rac1 binds to the p67 subunit and migrates to the membrane along with the 
core cytosolic complex (Koga, et al. 1999). Zimmerman et al. (2004) 
demonstrated for the first time that a Rac1-dependent NADPH oxidase is a key 
source of O2
-
 production in neurons. Apocynin is also known to inhibit the 
production of ROS by NADPH oxidase, by blocking migration of p47 to the 
membrane (Stolk, et al. 1994). 
The results of the inhibition of Rac1 by NSC23766 indicate that 
disruption of the NADPH oxidase subunit leads to a attenuation of the effect of 
LSS on TOP when introduced to samples 1 hrs before shear onset. However, 
when NSC23766 is introduced 4 hrs after shear onset this effect is lost, implying 
a role for Rac1 in the early stages of shear activation of TOP. When BAECs were 
incubated with the NADPH oxidase inhibitor, apocynin, the same trend is again 
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seen, with the LSS shear-dependent up-regulation of TOP inhibited by addition 
of apocynin to BAECs 1 hrs before, but not 4 hrs after, shear onset. These results 
indicate that NADPH oxidase is essential in the regulation of TOP under LSS 
conditions during early shear onset phase.  
As the zinc metallopeptidases ACE and ECE were previously shown to 
be regulated by shear stress in a ROS-dependent manner, the role of ROS in 
regulating TOP was next investigated. Again the temporal ROS burst that occurs 
0-3 hrs after the onset of shear was the main focus of this experiment. Therefore, 
NAC was used to scavenge O2
- 
in BAECs 1 hrs prior to and 4 hrs post shear 
onset. The results of this experiment indicate that the scavenging of O2
- 
1 hrs 
prior to, but not 4 hrs post, shear onset inhibits the effect of LSS on TOP 
attenuation, again confirming the role of this early ROS burst in the regulation of 
TOP under LSS conditions.  
In conclusion, through the use of our shear stress model, we have shown 
that the LSS-induced up-regulation of TOP is likely due to the presence of an 
SSRE in its promoter region. This up-regulation was also shown to be both time- 
and dose-dependent under physiologically relevant levels of laminar shear, with 
opposite effects observed under conditions of disturbed or oscillatory shear. 
Finally this chapter demonstrates the role played by NADPH oxidase and ROS in 
the up-regulation of TOP by shear stress during the early phase of shear onset. 
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Chapter 5: 
 
Functional consequence(s) of the shear-mediated 
regulation of NEP and TOP in vascular 
endothelial cells. 
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5.1 Introduction 
 
 In the previous chapters, the shear-dependent regulation of the zinc 
metallopeptidases, NEP and TOP, have been investigated. Numerous in vivo and 
in vitro studies have already ascribed roles to these enzymes in the regulation of 
net vasopeptide balance within the vasculature, with consequences for vascular 
tone. Moreover, studies in the previous two chapters clearly indicate that the 
expression of these enzymes is regulated in an opposing or divergent manner.  
The putative functional consequence(s) of their regulation by shear will therefore 
be examined in this chapter.  
NEP is capable of efficiently degrading a number of bioactive peptides 
and cytokines including endothelin-1 (ET-1), enkephalins, atrial natriuretic 
peptide (ANP) and bombesin-like peptides (Turner and Tanzawa 1997). 
Inhibition of NEP increases levels of ANP and C natriuretic peptide (CNP), as 
well as bradykinin (BK). By simultaneously inhibiting the renin-angiotensin 
system and potentiating the natriuretic peptide and kinin systems, vasopeptidase 
inhibitors (i.e. towards ACE, ECE and NEP) reduce vasoconstriction, enhance 
vasodilation, improve sodium/ water balance and, as a result, decrease peripheral 
vascular resistance and blood pressure and improve local blood flow. Within the 
blood vessel wall, this leads to a reduction of vasoconstrictor and proliferative 
mediators such as angiotensin II and increased local levels of BK (and, in turn, 
nitric oxide) and natriuretic peptides (Corti, et al. 2001). Thus, the regulation 
(and dysregulation) of NEP within the endothelium is clearly of major 
importance to vascular health and vessel homeostasis. 
Much of the work published on TOP has focused on its activity within the 
extracellular space, despite subcellular fractionation experiments indicating that 
the majority (generally >80%) of TOP is localised to the cytosol (Crack, et al. 
1999). BK, a common substrate of zinc metallopeptidases, is a potent 
inflammatory mediator which produces vascular leakage and endothelium 
dependent vasodilation (Bhoola, Figueroa and Worthy 1992). A small proportion 
of total cellular TOP has been shown to be localised with the bradykinin B2 
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receptor on the exofacial leaflet of plasma membranes and in lipid rafts, 
indicating a potential physiologic role for TOP in modulating BK activation and 
sensitisation of nociceptors (Gomez, et al. 2011, Jeske, Glucksman and Roberts 
2004, Norman, et al. 2003, Sandén, et al. 2008). Very importantly, exciting new 
studies have also identified an important hydrolytic role for cytosolic TOP in the 
immune system, where it participates in the degradation of proteosomal peptide 
fragments typically used by the cell in MHC class I antigen presentation 
(Kessler, et al. 2011, Kim, et al. 2003, Demasi, et al. 2008).  
By employing strategies to selectively over-express and/or inhibit NEP 
and TOP under both static and shear conditions, the following preliminary 
functional analyses have been performed.  
NEP: Barrier function, proliferation. 
TOP: Proliferation, BK hydrolysis, MHC I presentation. 
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5.2 Results  
 
5.2.1 NEP blockade and over-expression studies 
 
5.2.1.1 NEP and barrier function  
 
As shown in Chapter 3, endothelial permeability and NEP expression are 
both decreased in response to LSS. To investigate if there is a link between these 
events the effect of NEP inhibition and over-expression on barrier function was 
examined in static and sheared cells, respectively. 
HAECs were first treated with phosphoramidon, an NEP (and ECE) 
inhibitor, to investigate if NEP blockade may further potentiate the shear-induced 
reduction in endothelial permeability. HAECs were grown to confluency and 
phosphoramidon (1 µM) added to cells before they were subjected to LSS (10 
dynes/cm
2
, 24 hrs). Barrier integrity was measured by transendothelial 
permeability assay as previously described (Walsh et al., 2011). Results indicate 
that barrier integrity is significantly enhanced under LSS, with no additional 
tightening of barrier witnessed under shear following the addition of 
phosphoramidon (Figure 5.1). 
HAECs were next transfected with an NEP over-expression vector 
(NEP
++
, the generous gift of Dr. Nanus at Cornell University, New York) to 
investigate if NEP over-expression can reverse the shear-induced reduction in EC 
permeability. Following transfection and recovery, cells were subjected to LSS 
(10 dynes/cm
2
, 24 hrs). Barrier integrity was again measured by transendothelial 
permeability assay as previously described (Walsh et al., 2011). Results indicate 
that barrier integrity was enhanced under laminar shear (i.e. manifested as 
reduced permeability). Results also show that in ECs, NEP over-expression 
significantly weakened the endothelial barrier by increasing monolayer 
permeability to FITC-dextran (40 kDa) (Figure 5.2). A similar result was seen in 
BAECs transfected with NEP
++
 (data not shown). 
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(A)                (B)  
 
Figure 5.1: The effect of phosphoramidon on paracellular permeability in 
HAECs. Phosphoramidon (1 µM) was incubated with HAECs for 24 hrs on both 
control and LSS cells (10 dynes/cm
2
, 24 hrs). Cells were then harvested and re-
plated in transwell inserts and monitored by transendothelial permeability assay. 
(A) Line graphs showing the % trans-endothelial exchange of FITC-Dextran over 
3 hrs. (B) histograms showing the difference in permeability after 2 hrs of 
exchange. Results are averaged from three independent experiments ±SEM; 
*P≤0.05 vs static control cells. PHOS= phosphoramidon.  
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(A) (B) 
 
Figure 5.2: The effect of NEP over-expression on paracellular permeability in 
HAECs. HAECs were transfected with NEP
++
 and subjected to LSS (10 
dynes/cm
2
, 24 hrs). Cells were then harvested and re-plated in transwell inserts 
and monitored by transendothelial permeability assay as described in methods. 
(A) Line graph showing the % trans-endothelial exchange of FITC-Dextran over 
3 hrs. (B) Histogram showing the difference in permeability after 2 hrs of 
exchange. N=2. Inset (B) shows NEP
++
 plasmid (prepared as described in 
methods) run out on a 1% agarose gel, giving a single band at the expected 
product size of (8.55 kb). 
 
5.2.1.2 HAEC proliferation  
 
 It has previously been published that LSS has an anti-proliferative effect 
on ECs (White, et al. 2001). As a control study, HAECs were therefore grown to 
confluency and subjected to LSS (10 dynes/cm
2
, 24 hrs). Cells were then 
harvested and a cell count performed. Cells were then re-plated at 4000 cells/well 
of a 16-well xCELLigence
®
 plate (Roche). Proliferation was measured over 6 
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days by impedance (Figure 5.3 A), as described in methods. In a parallel control 
experiment, 50,000 cells/well (post-shear) were re-plated into a 6-well plate and 
stained with CFSE for proliferation analysis by FACS after 4 days (Figure 5.3 
B), as described in methods. Results with both methods indicate that LSS 
increases cell doubling times and so decreases the rate of EC proliferation. 
 
5.2.1.3 NEP and proliferation 
 
 To investigate if there is a link between shear-dependent decreases in 
NEP expression and proliferation rate, it was decided to examine the effects of 
NEP over-expression on shear-induced reduction in EC proliferation rate. 
HAECs were transfected with an NEP
++
 (3 ng) and left to recover for 24 hrs. 
Cells were then sheared under LSS (10 dynes/cm
2
, 24 hrs). Cells were harvested 
and a cell count performed. Following this, cells were re-plated at 4,000 
cells/well of a 16-well xCELLigence
®
 plate. Proliferation was measured by 
impedance over 6 days (Figure 5.4 A), as described in methods.  In a parallel 
experiment, 50,000 cells/well (post-shear) were re-plated into a 6-well plate and 
monitored for proliferation by CFSE FACS analysis (Figure 5.4 B), as described 
in methods. Results would indicate that the over-expression of NEP has no effect 
on the shear induced reduction of EC proliferation rate. 
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(A)
 
    
Figure 5.3: The effect of LSS on HAEC proliferation. HAECs were grown to 
confluency and subjected to LSS (10 dynes/cm
2
, 24 hrs). Cells were then 
harvested, counted and re-plated in xCELLigence
®
 E-Plates or regular 6-well 
plates and monitored for proliferation by (A) impedance or (B) CFSE staining, 
respectively, as described in methods. Table in (A) shows change in HAEC 
doubling time (hrs) across the indicated time window (shaded box) using the 
xCELLigence
®
 E-plate method. (B) shows the result of CFSE staining on day 4 
post staining. Curve shift to the left indicates higher proliferation rate due to 
cellular „dilution‟of CFSE dye, and vice-versa. 
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(A)  
 
(B) 
 
Figure 5.4: The effect of NEP
 
over-expression on rate of HAEC proliferation. 
HAECs were transfected with NEP
++
 (3 ng) and subjected to LSS (10 dynes/cm
2
, 
24 hrs). Cells were harvested, re-plated in xCELLigence
®
 E-Plates or regular 6-
well plates and monitored for proliferation by (A) impedance or (B) CFSE 
staining, as described in methods. Table in (A) shows change in HAEC doubling 
time (hrs) across the indicated time window (shaded box) using the 
xCELLigence
®
 E-plate method. (B) shows the result of CFSE staining on day 4 
post staining. Curve shift to the left indicates higher proliferation rate due to 
cellular „dilution‟of CFSE dye, and vice-versa.  
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5.2.2 TOP blockade and over-expression studies 
 
5.2.2.1 TOP siRNA optimisation  
 
Following optimisation experiments to identify a working concentration 
of TOP siRNA (Figure 5.5) HAECs were transfected with TOP siRNA (1 µM) to 
monitor TOP knock-down under shear conditions. For control purposes, both 
mock transfection (use of transfection reagents without siRNA) and scrambled 
siRNA (1 µM) were employed (both found to have negligible effects on TOP 
expression). Post-transfection, cells were allowed overnight recovery before the 
application of LSS (10 dynes/cm
2
, 24 hrs). Cells were then harvested for mRNA 
and analysed by qPCR (Figure 5.6). Results indicate that TOP siRNA 
significantly negates the expected up-regulation of TOP mRNA expression levels 
under LSS.  
 
 
Figure 5.5: Optimisation of TOP siRNA concentrations. Control study 
demonstrates that increasing concentrations of TOP siRNA (0-1 µM) caused a 
marked decrease in TOP mRNA expression levels in static HAECs.  
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Figure 5.6: The effect of TOP siRNA on TOP mRNA expression under LSS. 
HAECs were transfected with TOP siRNA (1 µM) and subjected to LSS (10 
dynes/cm
2
, 24 hrs). Cells were harvested and analysed by qPCR. Results are 
averaged from three independent experiments ±SEM; *P≤ 0.05 vs control, ΦP≤ 
0.05 vs shear. 
 
5.2.2.2 TOP siRNA and proliferation 
 
In similar experiments, HAECs were transfected with TOP siRNA (1 
µM) and left to recover overnight. Cells were then exposed to LSS (10 
dynes/cm
2
, 24 hrs). Post-shear, cells were harvested and a cell count performed. 
Cells were then plated at 4,000 cells/well in a 16-well xCELLigence
®
 plate and 
proliferation monitored via impedance over 120 hrs (Figure 5.7), as described in 
methods. Results indicate that siRNA silencing of TOP appears to modestly 
decrease the anti-proliferative effects of shear (~28%). 
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Figure 5.7: The effect of TOP silencing on rate of HAEC proliferation. HAECs 
were transfected with TOP siRNA (1 µM) and subjected to LSS (10 dynes/cm
2
, 
24 hrs). Cells were harvested, re-plated in E-Plates and monitored for 
proliferation by impedance, as described in methods. Table shows change in 
HAEC doubling time (hrs) across the indicated time window (shaded box) using 
the xCELLigence
®
 E-plate method.  
 
5.2.2.3 TOP and MHC I expression 
 
It has previously been published that MHC I expression is attenuated in 
ECs under LSS (Martin-Mondiere, et al. 1989). Moreover, an early study by Kim 
et al. (2003) demonstrated that TOP (i.e. EP24.15) can reduce MHC I expression 
in cytotoxic T-lymphocytes. We therefore decided to investigate a possible 
relationship between shear-dependent MHC I reduction and TOP induction. To 
this end, a preliminary investigation was conducted whereby the effect of a TOP 
siRNA on shear-induced reduction of MHC I levels was examined.  
HAECs were transfected with TOP siRNA (1 µM) and left to recover for 
24 hrs. Cells were then subjected to LSS (10 dynes/cm
2
, 24 hrs) and harvested 
for immunoblot analysis of MHC I, as in methods. Results show a decrease in 
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MHC I expression under LSS conditions, an effect which is reversed upon 
addition of TOP siRNA (Figure 5.8). 
 
5.2.2.4 TOP and bradykinin (ELISA) 
 
It has been previously published that extracellular termination of BK 
signalling is controlled by zinc metallopeptidases (Rawlings and Barrett 1993). 
Crack at al. demonstrated that TOP has an extracellular association with the 
plasma membrane and has an ecto-enzymatic activity (Crack, et al. 1999). 
Moreover, Cotter et al. showed that cyclic strain modulates the release of TOP 
from BAECs and thus may have a significant influence on TOP‟s extracellular 
functions (Cotter, et al. 2004). Therefore, it was decided to investigate a putative 
contribution of TOP induction in the extracellular hydrolysis of BK under LSS 
conditions. In this regard, we hypothesised that shear-induced TOP up-regulaton 
may putatively enhance extracellular degradation of BK. To test this hypothesis, 
it was necessary to inhibit a range of zinc metallopeptidases also known to 
hydrolyse BK using pharmacological inhibitors (in order to narrow hydrolysis 
down to TOP). These included the ACE inhibitor, captopril, and a dual 
ECE/NEP inhibitor, phosphoramidon.  
HAECs were transfected with either TOP siRNA (1 µM) and allowed to 
recover overnight. Cells were then subjected to LSS (10 dynes/cm
2
, 24 hrs), after 
which they were washed in sterile 1X PBS. HEPES-Krebs buffer was then added 
to cells at 2 ml per well. Inhibitors were added to each well for blockade of ACE 
(captopril, 10 µM), and ECE/NEP (phosphoramidon, 2 nM) activity. After 30 
min, bradykinin was added (20 ng/per well) and cells left to incubate for either 3 
or 12 hrs at 37°C. Following incubation, medium samples were collected for BK 
analysis by ELISA kit (Enzo Life Sciences, USA) (Figure 5.9), as in methods. 
(Assay based on a modification of the method of Norman et al. 2003) 
 
154 
 
 
Figure 5.8: Impact of TOP siRNA on shear-induced MHC I reduction. HAECs 
were transfected with TOP siRNA and left to recover for 24 hrs. Cells were then 
subjected to LSS (10 dynes/cm
2
, 24 hrs) and harvested for immunoblot analysis. 
(A) Immunoblots showing both MHC I and GAPDH. (B) Histogram of relative 
MHC I expression (i.e. MHC I/GAPDH) derived by scanning densitometry. N=2. 
MT= mock transfection.  
 
Results clearly indicate significant depletion in BK medium levels 
between 3-12 hrs. Surprisingly, there is only marginal difference in levels of 
extracellular BK peptide hydrolysis between static control cells and sheared 
cells, with the latter conditions showing slightly lower levels of hydrolysis (i.e. 
higher BK levels found in medium) at both 3 and 12 hrs. In control cells at t=12 
hrs, TOP blockade by siRNA appears to significantly slow extracellular BK 
peptide hydrolysis. In sheared cells at 12 hr, no significant difference is observed 
between conditions.  
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Figure 5.9: Extracellular BK hydrolysis by TOP. HAECs were transfected with 
TOP siRNA (1 µM) and allowed to recover for 24 hrs. Cells were then subjected 
to LSS (10 dynes/cm
2
, 24 hrs), after which HEPES-Krebs buffer containing 
captopril (10 µM) and phosphoramidon (2 nM) was added to cells 30 min before 
the addition of BK (20 ng). Samples were harvested after 3 and 12 hrs and 
analysed by ELISA. (A) Graph shows BK standard curve used to calculate BK 
concentration from ELISA results. Histogram of BK (pg/ml) remaining per well 
after (B) 3 hrs and (C) 12 hrs of incubation with BAECs. Results are averaged 
from three independent experiments ±SEM; *P≤ 0.05 vs untreated control.  
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5.3 Discussion 
 
This chapter‟s initial studies were focused on the putative relationship 
between shear-induced changes in both NEP and EC barrier function. It was 
shown in Chapter 3 that LSS increases EC barrier integrity whilst down-
regulating NEP expression, observations that were seen to be reversed/absent 
under DSS conditions. In this chapter, we demonstrate that NEP over-expression 
(using NEP
++
) significantly reverses the reductions in permeability induced by 
shear stress (LSS) on HAECs. Thus by preventing the down-regulation of NEP 
expression by shear (i.e. by adding NEP
++
), enhancement of barrier function 
appears to have been blocked, suggesting a possible link between these two 
shear-dependent phenomena. The lack of effect of phosphoramidon (an NEP 
inhibitor) on shear-induced permeability reduction (i.e. we anticipated an even 
further reduction or „additive‟ effect) may reflect an artefact/limitation of the 
permeability assay or may point to a possible non-enzymatic role for NEP in 
these events. In this respect, „signalling‟ roles for NEP have previously been 
identified (Osman, et al. 2004). In summary therefore, the present data suggest a 
possible link between NEP down-regulation and permeability under LSS. Whilst 
the nature of this link is as yet unidentified, a possible mechanism may include 
focal adhesion kinase (FAK). FAK is a ubiquitously expressed cytoplasmic 
protein tyrosine kinase involved in the regulation of numerous endothelial cell 
functions (Grinnell and Harrington 2011). By transiently over-expressing various 
forms of FAK, previous publications have demonstrated cross-talk between FAK 
and adherens junctions in the regulation of endothelial barrier function (Usatyuk 
and Natarajan 2005, Quadri and Bhattacharya 2007). Indeed loss of FAK not 
only augments barrier deterioration, but it also delays barrier recovery in 
endothelial monolayers (Patterson 2005). Importantly Sumitomo et al. have 
previously reported that NEP enzymatic activity inhibits FAK phosphorylation 
and cell migration by affecting neuropeptide-induced interaction of FAK with 
cSrc (Sumitomo, et al. 2000).  
Another main topic of this chapter concerns the effect of LSS on the rate 
of EC proliferation. At the cellular level, LSS is known to promote endothelial 
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quiescence (White, et al. 2001, Traub and Berk 1998) an observation confirmed 
in this chapter using both impedance analysis and CFSE FACs analysis. 
Conversely, the effects of DSS are significantly different from those of LSS and 
are typically characterised by increased proliferation, increased apoptosis, and a 
lack of alignment to flow (Kudo, et al. 2005). NEP is known to play important 
roles in neoplastic transformation and tumour progression in certain human 
malignancies through the enzymatic inactivation of bioactive peptides such as 
endothelin-1 (ET-1), angiotensin-II, and bombesin. Indeed, previously published 
data indicate that a loss of NEP in cultured prostate cancer cells results in 
stimulation of cell proliferation and migration (Osman, et al. 2004). Whilst, 
Barber et al. report that the inhibition of NEP promotes an anti-proliferative 
effect on vascular smooth muscle cells (Barber et al., 1995). In this chapter, we 
therefore undertook to investigate if the shear-induced reduction in NEP is 
putatively linked to the anti-proliferative effects of shear. For this purpose, we 
investigate HAEC proliferation in the presence of NEP
++
 under static and shear 
conditions. Data appear to indicate that the over-expression of NEP (effectively 
reversing the shear-induced reduction of NEP) does not affect the anti-
proliferative effects of LSS when compared to mock transfected controls, 
suggesting no role for NEP in this context. 
In the second half of this chapter the functional impact of TOP up-
regulation by shear was assessed with respect to proliferation, MHC I 
presentation and BK hydrolysis. Beginning with proliferation, we investigated 
the effects of TOP up-regulation using the same experimental model as that used 
for NEP. Results demonstrated that silencing of TOP (using TOP
 
siRNA) 
increases the rate of EC proliferation under shear stress (i.e. manifested as an 
decrease in doubling time). These results suggest a putative role for TOP in these 
shear-dependent events. Noteworthy, Cleverly et al. have previously shown that 
TOP could have a role in cellular proliferation of reproductive tissues through its 
regulation of luteinising hormone-releasing hormone (LHRH) levels (Cleverly 
and Wu 2010). Indeed, endothelial cells stimulate LHRH release via NO 
secretion.  
The regulation of extracellular BK levels in ECs by TOP was also 
investigated in this chapter. The principle pharmacological action of BK in the 
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regulation of blood pressure is through vasodilatation in most areas of the 
circulation, a reduction of total peripheral vascular resistance, and a regulation of 
sodium excretion from the kidneys (Adetuyibi and Mills 1972). Reduced local 
BK generation and blunted NO formation have been reported in microvessels of 
failing human hearts (Kichuk, et al. 1996). It is well known that zinc 
metallopeptidases are capable of hydrolysing BK, with ACE, ECE and NEP 
being the main sources of BK hydrolysis. Importantly, Jeske et al. have shown 
that TOP is localised with the B2 receptor on the exofacial leaflet of plasma 
membranes and in lipid rafts, indicating a potential physiologic role for TOP in 
modulating BK activation and sensitisation of nociceptors (Jeske, Glucksman 
and Roberts 2004). Moreover, Cotter et al. showed that cyclic strain modulates 
the release of TOP from BAECs and thus may have a significant influence on 
TOP‟s extracellular functions (Cotter, et al. 2004). Our results subsequently 
showed that under shear conditions, blockade of TOP (siRNA) exhibited little or 
no difference to untreated HAECs with respect to BK hydrolysis levels. This 
would suggest that TOP induction by shear does not influence extracellular BK 
levels. Whilst non-specific BK hydrolysis has been controlled for with respect to 
ACE/ECE/NEP through the inclusion of inhibitors in the assay buffer, the 
possible complication of other peptideass (neurolysin, aminopeptidase N) 
(Kuoppala, et al. 2000) cannot be ruled out in this particular assay model.   
We next turned our attention to a putative intracellular role for TOP: that 
of MHC I specific antigen presentation. Recognition of antigens in the peptide-
binding groove of surface-expressed MHC I and II molecules by specific T-cell 
receptors, for example, is central to T-cell activation. Recently Kessler et al. have 
shown that TOP-mediated processing of intracellular peptides both reduces the 
presentation of proteasomal products by MHC I and also enlarges the MHC I 
peptide repertoire by processing protein-degradation fragments that are not yet fit 
for antigenic presentation (Kessler, et al. 2011). In an earlier study, Kim et al. 
showed that cells over-expressing TOP demonstrated a marked decrease in cell 
surface MHC I staining (Kim et al., 2003). Several human cancers also show 
down-regulation of MHC I, giving transformed cells the same survival advantage 
of being able to avoid normal immune surveillance designed to destroy any 
infected or transformed cells (Wang, et al. 2008). It has also previously been 
159 
 
published that MHC I expression is attenuated in ECs under LSS (Martin-
Mondiere, et al. 1989). In the present study, we investigated therefore if shear-
induced TOP expression impacted MHC I levels in HAECs. In this regard a 
preliminary study has demonstrated that LSS attenuates MHC I expression in 
HAECs and that this effect appears to be blocked by TOP siRNA. This is 
consistent with the aforementioned studies and suggests a role for TOP in MHC 
I-dependent antigen presentation in endothelial cells with shear stress being a 
regulatory factor. Further work will shed light on this increasingly important 
phenomenon.  
In conclusion, results presented in this chapter have shown that NEP is 
putatively involved in the regulation of barrier integrity but not in EC 
proliferation under LSS. Our results also suggest that TOP putatively is involved 
in shear-dependent regulation of EC proliferation and MHC I antigen 
presentation, but not in modulation of extracellular BK levels.  
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Chapter 6: 
 
Final Summary 
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6.1 Final Summary 
 
Cardiovascular disease (CVD) refers to any abnormal condition 
characterised by the dysfunction of the heart or blood vessels, and includes 
coronary heart disease, cerebrovascular disease, hypertension, rheumatic and 
congenital heart disease and heart failure. CVD is the number one cause of death 
globally. The World Health Organisation estimates that 16.7 million people 
around the world die from the disease annually, or 29% of all annual deaths 
worldwide. They also predict a projected increase of this figure to 40% of all 
deaths by 2020, if the current trends continue.  Moreover, it is estimated to have 
cost the EU economy €192 billion in 2008 (Allender, et al. 2008). As a result, 
expanding the knowledge base with respect to the underlying causes of CVD has 
become crucial, and is the focus of much study.  
There are nine easily measurable and potentially modifiable risk factors 
that account for over 90% of the initial acute myocardial infarction. These nine 
factors are cigarette smoking, abnormal blood lipid levels, hypertension, 
diabetes, abnormal obesity, a lack of physical activity, low daily fruit and 
vegetable consumption, alcohol over-consumption and psychosocial index. Other 
uncontrollable factors that place subjects into a risk category for developing 
CVD are age, gender, family history and ethnicity.  
The health of blood vessels can fundamentally be linked to the 
endothelium. The endothelium forms the inner lining of all blood vessels and is 
in direct contact with the blood as it flows through the lumen of the vessel. The 
unique position of this cell monolayer confers on it the ability to sense and 
respond to a variety of blood-borne stimuli. These include neurotransmitters, 
peptide hormones and growth factors (and their associated peptidases), as well as 
blood-flow associated mechanical forces such as shear stress and cyclic strain. 
These stimuli continuously elicit biophysical and biochemical changes within the 
endothelium which influence vessel homeostasis and remodelling on an ongoing 
basis (Traub and Berk 1998, Kakisis, Liapis and Sumpio 2004). In this context, 
the endothelium plays an important role in the control of vascular tone, blood 
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pressure, permeability, proliferation, survival and innate and adaptive immunity. 
Endothelial dysfunction arising from flow anomalies and other risk factors is 
therefore involved in many vascular diseases, either as a primary determinant of 
pathophysiology or as a victim of collateral damage (Aird 2008). 
As mentioned previously, blood flow itself imparts a strong 
biomechanical influence on the vessel wall. Of particular importance are the 
mechanical forces of cyclic strain and shear stress with the latter stimulus being a 
central focus of this thesis. A characteristic response of cultured ECs to LSS is to 
undergo a transition from a cobble stone morphology with no preferred 
orientation (found under static conditions), to a more elongated stream-lined 
morphology aligned in the direction of LSS flow. This adaption to flow helps to 
reduce the effect of shear gradients on the cell surface.  
Controlled transport of nutrients across the endothelium is an essential 
function of the vasculature. In vivo therefore, the endothelium monolayer forms a 
tight junction-dependent barrier between the blood and underlying SMCs. LSS is 
known to elicit a tightening of these junctions and, as a result, ECs can regulate 
the size of molecules that cross this barrier (Figure 6.1). Indeed loss of barrier 
integrity is a prominent feature of vascular diseases. Control studies clearly 
confirm that the regulation of EC barrier function is force-dependent, with 
increasing levels of „atheroprotective‟ LSS inducing a tighter barrier (manifested 
as reduced permeability). As most atherosclerotic plaques form at areas of 
bifurcation or curvature within the macrovasculature, areas that are known to be 
sites of disturbed blood flow, the relationship between shear type and barrier 
integrity was also examined. Results of these studies confirm that, unlike LSS, 
DSS does not impart a tightening of EC barrier function nor a morphological 
realignment of endothelial cells.  
The functional (and transcriptional) impact of shear stress derives from 
the fact that it acts directly on the cellular membrane leading to 
mechanotransduction, the rapid conversion of mechanical signals into 
biochemical signals with the subsequent induction of appropriate cellular 
responses. Of primary importance among these responses is the ability of the 
endothelium to alter expression of vasoactive molecules (and their associated 
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regulatory enzymes) (Cummins, Cotter and Cahill 2004). In this regard, it has 
been previously published that members of the zinc metallopeptidases family are 
shear-sensitive, namely ECE and ACE (Masatsugu, et al. 2003, Ackermann, et 
al. 1998).  Indeed, the promoter region of the ECE gene contains four SSRE 
sequences, whilst the promoter region of ACE contains two SSRE sequences. 
Moreover, shear stress was found to down-regulate both enzymes. More recently 
preliminary studies from our laboratory have demonstrated that NEP and TOP, 
also members of the zinc metallopeptidase family, are subject to shear regulation 
in endothelial cells (NEP:(Fitzpatrick, et al. 2009); TOP: unpublished 
observation), although details are extremely limited. It should also be noted that 
both NEP and TOP have an SSRE (-GAGACC-) within their promoter region.  
 
 
 
Figure 6.1: Transport pathways across the endothelium. The major transport 
pathways are: tight junctions, breaks in the tight junctions, vesicles and leaky 
junctions. The endothelial glycocalyx covers the entrance to all but the leaky 
junctions (Tarbell, 2010).  
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In this thesis we have decided to shed further light on the regulation of 
both NEP and TOP by shear stress in endothelial cells. Consistent with previous 
publications, our results demonstrate a regulatory role for LSS in NEP expression 
with respect to magnitude and duration of shear. NEP expression was also shown 
to be sensitive to the type of shear the cells were exposed to, with LSS but not 
DSS inducing NEP down-regulation. Using the same experimental paradigm we 
next investigated the regulation of TOP. TOP expression was shown to be up-
regulated by LSS in a time- and magnitude-dependent manner, whilst DSS 
induced a down-regulation of TOP mRNA levels. To summarise, therefore, LSS 
appears to regulate NEP and TOP expression levels (mRNA and protein) in a 
divergent or opposing manner.  
 Investigation next focused on determining the signal transduction 
mechanisms through which shear stress altered endothelial NEP and TOP 
expression. Previous studies have shown that shear-dependent expression of 
various zinc metallopeptidases, namely ACE, ECE and NEP, are regulated 
through ROS production (Masatsugu, et al. 2003, Ackermann, et al. 1998, 
Fitzpatrick, et al. 2009). As NADPH oxidase has previously been shown to be 
the major source of superoxide in ECs (Griendling, Sorescu and Ushio-Fukai 
2000), it was decided to confirm the involvement of this enzyme through the 
application of an siRNA targeted to the p47 subunit of the NADPH-oxidase 
complex, thereby neutralising its ROS-producing capability. Results of this study 
clearly indicated that selective blockade of NADPH oxidase attenuated the 
effects of LSS on the down- and up-regulation of both NEP and TOP, 
respectively. This confirms NADPH oxidase as an upstream signalling 
component in the mechanoregulation of NEP and TOP in vascular cells. 
As NADPH oxidase is only „transiently‟ activated by laminar shear 
stress, the result is typically a „temporal‟ ROS surge in endothelial cells within 0-
3 hrs of shear onset (Hahn and Schwartz 2009), that declines to baseline levels 
thereafter. Consistent with this, our experiments have clearly demonstrated that 
blockade of the ROS surge (using apocynin, NSC23766 and NAC) in advance of 
shear onset (-1 hrs), but not after shear onset (+4 hrs), prevents shear-dependent 
changes in NEP and TOP expression.  
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The functional consequences of shear-induced regulation of both NEP 
and TOP were also investigated. In initial studies HAECs over-expressing NEP 
were seen to exhibit a weakened barrier under both control and shear conditions 
when compared to untreated cells (manifested as increased permeability). 
Interestingly however, the use of an NEP inhibitor (phosphoramidon) did not 
show an additive effect towards shear-induced barrier up-regulation. These 
results suggest a possible link between the shear-dependent down-regulation of 
NEP and enhanced barrier function. 
 The link between the shear-induced regulation of NEP/TOP and 
endothelial cell proliferation was also investigated. This entailed shearing studies 
involving over-expression of NEP and TOP, and the silencing of TOP. Results 
presented point to a putative role for TOP, but not NEP, in the regulation of the 
anti-proliferative effects of shear on endothelial cells.  
It has previously been published that MHC I expression is attenuated in 
ECs under LSS (Martin-Mondiere, et al. 1989), whilst Kim et al. demonstrated 
that over-expression of TOP is capable of inducing long-term repression of 
surface MHC I in CTLs. Conversely, the latter author also showed that the use of 
a TOP siRNA increased long-term surface expression of MHC I (Kim, et al. 
2003). It was therefore decided to investigate if TOP plays a role in the 
intracellular shear-dependent regulation of MHC I expression, through the use of 
a TOP siRNA under LSS conditions. Preliminary results of this study suggest 
that TOP is involved in the regulation of MHC I, as the introduction of TOP 
siRNA under shear conditions reversed the down-regulatory effect of LSS on 
MHC I protein expression. 
Within the vasculature, termination of BK signalling is controlled by zinc 
metallopeptidases (Rawlings and Barrett 1993, Turner 2003). As such, we 
examined the functional role that the shear-induced up-regulation of TOP plays 
in the extracellular hydrolysis of BK. This was achieved by over-expressing and 
silencing TOP under both static and shear conditions. However, our results 
indicate that TOP induction by shear does not appear to influence extracellular 
BK levels. 
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Notwithstanding further repeats of some studies to improve statistical 
significance, new areas for investigation could include (i) determining the role of 
junctional proteins such as VE-cadherin and PECAM-1 in the mechano 
regulation of NEP and TOP; (ii) investigation of the NEP and TOP signalling 
pathways downstream of ROS production, in which MAP kinases could be a 
primary focus; (iii) investigation of the putative roles of NEP and TOP in 
endothelial wound healing under LSS; (iv) use of apo-E
-/-
 knockout mouse 
models to monitor NEP and TOP levels in vivo at sites of flow reduction and/or 
turbulence (e.g. aortic arch). 
In conclusion this thesis has demonstrated that expression of both NEP 
and TOP are regulated by LSS in a time- and dose-dependent manner, with LSS 
displaying opposite effects on either enzyme. This study has also confirmed that 
this regulation is mediated by NADPH oxidase-dependent ROS production 
during the early shear phase. Moreover, functional studies have implicated roles 
for NEP in the regulation of endothelial barrier function under shear, whilst 
findings suggest that TOP is involved in the regulation of endothelial 
proliferation and MHC I antigen presentation under shear. These findings 
significantly contribute to our knowledge of vascular physiology and pathology 
by showing how shear regulates therapeutically relevant zinc metallopeptidases 
within the macrovascular endothelium.  
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B 
 
BCA assay standard curve 
 
The BCA assay is a biochemical assay for quantifying the total amount of 
protein in a solution. This is achieved by Cu
2+
 reacting with protein under 
alkaline conditions to produce Cu
+
, which in turn reacts with bicinchoninic acid 
(green) to form a complex (purple) that strongly absorbs light at 562 nm. Results 
of standards and unknown samples are then graphed to obtain protein 
concentrations (Figure A). 
 
 
Figure A: Typical standard curve for a BCA assay, with absorbance on the Y-
axis and concentration on the X-axis. 
 
 
 
C 
 
Unpublished results  
 
Antioxidants 
 
A short preliminary study carried out in this laboratory (unpublished data) 
has previously demonstrated the ROS-dependence of TOP up-regulation by shear 
stress. This was determined through the addition of antioxidants NAC, SOD and 
catalyse (CAT) to cells 1 hrs before the onset of LSS (10 dynes/cm
2
, 24 hrs).   
 
 
Figure B: Effect of antioxidants (NAC, SOD and catalyse (CAT)) in the 
regulation of TOP mRNA levels under both static and LSS (10 dynes/cm
2
, 24 
hrs) conditions. Results are averaged from three independent experiments ±SEM; 
*P≤0.05 vs static/untreated control cells, ΦP≤ 0.05 vs sheared/treated cells. 
 
D 
 
Oxidants 
 
A short preliminary study carried out in this laboratory (unpublished data) 
has previously demonstrated the ROS-dependence of TOP up-regulation by shear 
stress. This was determined through the addition of oxidants H2O2 and Ang-II to 
static cells for 24 hrs and 8 hrs, respectively.  
 
 
Figure C: Effect of oxidants (H2O2 and Ang-II) in the regulation of TOP mRNA 
expression levels under static conditions. Results are averaged from three 
independent experiments ±SEM; *P≤0.05 vs static/untreated control cells. 
 
 
 
 
 
E 
 
Recipes 
 
Ampicillin stock solution 
A stock solution of ampicillin was made up to a concentration of 100 mg/ml in 
dH2O. 
The stock solution was filter sterilised and stored at -20°C. 
 
Coomassie stain 
Coomassie Brilliant Blue R250 0.25g 
Methanol:dH2O (1:1 v/v) 90ml 
Glacial Acetic acid 10ml 
Filter the Coomassie stain using a 0.25μm filter 
 
Coomassie destain solution 
Methanol:Acetic acid mixed in a 50:50 ratio 
 
HEPES-Krebs buffer 
20 mM HEPES 
103 mM NaCl 
4.77 mM KCl 
0.5 mM CaCl2 
1.2 mM MgSO4 
1.2 mM KH2PO4 
F 
 
25 mM NaHCO3 
15 mM Glucose 
0.25% (w/v) BSA 
pH to 7.4 and stored at 4°C. 
 
LB agar 
5 g Tryptone 
2.5 g Yeast extract 
5 g NaCl 
7.5 g Agar 
The volume was adjusted to 500 ml with dH2O, followed by autoclaving and 
agar plates were stored at 4°C. 
 
LB agar with antibiotics 
Antibiotics were added to autoclaved LB broth to a final concentration of 
100μg/ml (ampicillin), after cooling the LB agar to ~50°C. Plates were stored 
at 4°C. 
 
LB broth 
5 g Tryptone 
2.5 g Yeast extract 
5 g NaCl 
The volume was adjusted to 500ml, followed by autoclaving for 20 minutes at 
G 
 
15 lb/sq. and storage at 4°C. 
 
LB broth with ampicllin 
Ampicillin was added to autoclaved LB broth to a final concentration of 100 
μg/ml and stored at 4°C. 
 
Phosphate buffered saline (PBS) 
2 tablets were dissolved in 400 ml dH2O to give a 1X working concentration 
of PBS, and the solution was sterilised by autoclaving. 
 
SOB medium 
10 g Tryptone 
2.5 g Yeast extract 
0.025 g NaCl 
5 ml KCl (250 mM) 
The pH was adjusted to 7.0 with 5M NaOH. 
The volume was adjusted to 500 ml with dH2O and the medium autoclaved. 
2.5 ml of 2M MgCl2 was added after cooling the broth to 5°C and the medium 
was stored at 4°C. 
 
SOC medium 
98 ml SOB medium 
2 ml 1M glucose (filter sterilised) 
H 
 
Stored at 4°C. 
 
Stripping Buffer 
Tris-HCl, pH6.8 62.5 mM 
SDS 2% (w/v) 
Β-Mercaptoethanol 100 mM 
 
1X Tris buffered saline (TBS) 
6.1g Tris base 
8.8g NaCl 
800ml dH2O 
The pH was adjusted to 7.5 with HCl and the volume adjusted to 1 L. Stored 
at room temperature. 
 
TBS-T 
1L 1X TBS 
1ml Tween 20 
Stored at room temperature. 
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